Activation of the ribosomal RNA genes in erythrocyte nuclei of Xenopus laevis by Coveney, Janice
warwick.ac.uk/lib-publications
A Thesis Submitted for the Degree of PhD at the University of Warwick
Permanent WRAP URL:
http://wrap.warwick.ac.uk/111465/
Copyright and reuse:
This thesis is made available online and is protected by original copyright.
Please scroll down to view the document itself.
Please refer to the repository record for this item for information to help you to cite it.
Our policy information is available from the repository home page.
For more information, please contact the WRAP Team at: wrap@warwick.ac.uk
ACTIVATION OF THE RIBOSGMAL RNA GENES IN ERYTHROCYTE NUCLEI OF
XENOPUS LAEVIS 
by
Janice Coveney B.Sc. Hons (London)
Submitted for the Degree of Doctor of Philosophy. 
University of Warwick,
Department of Biological Sciences, 
December, 1982
-ii-
SUKMARY
Xenopus laevls erythrocyte nuclei have been used as a 
source of inactive ribosomal RNA genes to study the regulation of 
gene activity during early embryogenesis. Addition of an oocyte 
extract to the erythrocyte nuclear transcription assay brings 
about transcription by RNA polymerase I. This Is not seen If an 
egg extract is used even though the amounts of RNA polymerase I 
are the same in both preparations. The oocyte-treated nuclei 
synthesize ribosomal RNA as defined by RNA-DNA hybridizations and 
sucrose gradient separation techniques.
The active component of the oocyte extract has been 
semipurlfled to a single peak by Sephadex G100 column 
chromatography and DEAE cellulose salt elution. Its presence and 
absence during oogenesis and early embryogenesls parallels the 
transcription of the ribosomal genes l_n vivo at these stages. 
Within the oocyte itself, the active component is located 
exclusively in the germinal vesicle.
The structure of the rlbo6omal genes in treated nuclei has 
been studied by DNase I digestion. The ribosomal genes in 
erythrocyte nuclei are Insensitive to DNase I, but treatment by 
an oocyte extract or egg extract plus Che semipurified active 
component causes the entire gene repeat to become DNase I 
sensitive. An egg extract alone has no effect. The semipurified 
active component by itself causes only the 5' end of the 
transcribed sequence to become DNase 1 sensitive. The component 
therefore appears to act on the non-transcribed ribosomal genes 
of the erythrocyte nucleus to alter their chromatin conformation 
to a more DNase I sensitive one which permits RNA polymerase 1 
transcription.
The DNase I sensitivity of histone H4, globln, tRNA and 
SSooc RNA genes was also studied. The extracts had no effect on 
the DNase I sensitivity of any of these genes, but those genes 
transcribed by RNA polymerase 111 are DNase I sensitive whatever 
their transcriptional state.
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SIMMARY
Xenopug laevls erythrocyte nuclei have been used as a 
source of Inactive ribosomal RNA genes to study the regulation of 
gene activity during early embryogenesls. Addition of an oocyte 
extract to the erythrocyte nuclear transcription assay brings 
about transcription by RNA polymerase I. This is not seen if an 
egg extract is used even though the amounts of RNA polymerase 1 
are the same In both preparations. The oocyte-treated nuclei 
synthesize ribosomal RNA as defined by RNA-DNA hybridizations and 
sucrose gradient separation techniques.
The active component of the oocyte extract has been 
semipurlfled to a single peak by Sephadex G100 column 
chromatography and DEAE cellulose salt elution. Its presence and 
absence during oogenesis and early embryogenesis parallels the 
transcription of the ribosomal genes l_n vivo at these stages. 
Within the oocyte Itself, the active component Is located 
exclusively in the germinal vesicle.
The structure of the rlbosomal genes In treated nuclei has 
been studied by DNase I digestion. The ribosomal genes In 
erythrocyte nuclei are Insensitive to DNase I, but treatment by 
an oocyte extract or egg extract plus the semlpurifled active 
component causes the entire gene repeat to become DNase 1 
sensitive. An egg extract alone has no effect. The semlpurifled 
active component by Itself causes only the S' end of the 
transcribed sequence to become DNase I sensitive. The component 
therefore appears to act on the non-transcrlbed ribosomal genes 
of the erythrocyte nucleus to alter their chromatin conformation 
to a more DNase I sensitive one which permits RNA polymerase I 
transcription.
The DNase I sensitivity of histone HA, globln, tRNA and 
SSooc RNA genes was also studied. The extracts had no effect on 
the DNase I sensitivity of any of these genes, but those genes 
transcribed by RNA polymerase 111 are DNase I sensitive whatever 
their transcriptional state.
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CHAPTER IJ INTRODUCTION.
Transcription During Oogenesis of Xenopus laevls.
There are three classes of RNA polymerase In eukaryotes, I, 
II, and III (eg. Roeder al, 1970; Tocchlnl-Valentlnl and 
Crippa, 1970; Kedlnger et a^, 1972; Roeder, 1974a; Schwarts 
et al, 1974; Weil and Blatti, 1975; 1976; Hager et al, 
1977; these polymerases have also been called A, B, and C, 
respectively). The three RNA polymerases have different 
templates, physical properties and are likely to have different
control mechanisms. Their transcription can easily be
distinguished since they have different sensitivities to the
fungal toxin, or-amanitln (Jacob £t al, 1970). Thus RNA
polymerase I, which transcribes the rlbosomal RNA genes, is 
Insensitive to or-amanitln, whilst mRNA and hnRNA synthesis by RNA 
polymerase II is Inhibited by only 1 pg/ml cr-amanltln. RNA 
polymerase III transcription of the 4S and 5S RNA genes is
inhibited by 100 pg/ml or-amanitln.
Xenopus laevls was an early species in which RNA
polymerase in development was studied, because material is 
readily available in bulk. Transcription in sea urchins and 
Drosophila is also well characterized, the former due to the 
ease of obtaining and handling large numbers of eggs and embryos, 
and the latter, even though the handling is more difficult, does 
have the advantage of a wide range of well defined mutants not 
available in either Xenopus or sea urchin. The polymerases of
eggs of the moth Manduca sexta have also been well
characterized (Kastern et al, 1981)
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Whilst the oocytes of Xenopus laevls make RNA at all 
stages, the molecular species synthesized vary from stage to 
stage (Malry and Denis, 1971; Ford, 1971), although the relative 
amounts of the three RNA polymerases remain the same (Roeder, 
1974b). The small, pre-vltellogenic oocyte synthesizes a
preponderance of 4S (tRNA) and 5S RNA (Malry and Denis, 1971; 
1972; Thomas, 1974), such that the rRNA 40S precursor molecules 
are outnumbered by about 100:1 (Ford, 1971). In Xenopus there 
are several subtypes of 5S RNA genes, the major type being oocyte 
specific (5Sooc). They are a highly reiterated gene family, 
consisting of about 20,000 copies/haploid genome (Brown ¿t 
al, 1971). There are two other subtypes, a minor oogenetic SS 
set (1300 copies/haploid genome; Brown £t al^ , 1977; Peterson 
et al, 1980) and a somatic specific set (5Ssom; 400
copies/haploid genome; Uegnez e_t al, 1972; Brownlee £t
al, 1972; Ford and Southern, 1973; Peterson £t al, 1980). 
All 5S sequences are transcribed during oogenesis (Uegnez £t 
al, 1972; Denis and Uegnez, 1977), but whilst the SSooc KNA 
molecules are stored in 7S or 42S rlbonucleoprotein particles 
until needed ( Ford, 1971; Picard e^ al, 1980), the SSsom RNA 
molecules do not accumulate (Denis and Wegnez, 1977). Associated 
with each 5Sooc gene is a pseudogene which lacks the final 19 bp 
at the 3'end of the gene (Jacq £t al, 1977). vivo,
this pseudogene is thought not to be transcribed, but this has 
been observed on injection of 5S DNA into Xenopus oocytes 
(Miller and Melton, 1981). The synthesis of 4S and SS RNA 
continues throughout oogenesis, although after vitellogenesis 
begins and rRNA synthesis starts, it assumes a smaller fraction 
of the total oogenetic RNA (Ford, 1971; Malry and Denis, 1971; 
1972; Thomas, 1974)
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Transcription by RNA polymerase II is also seen in 
pre-vitellogenic oocytes (Rosbash and Ford, 1974; Darnborough and 
Ford, 1976; Ruderman and Pardue, 1977; Golden et al, 1980). 
One consequence of this is that there is enough histone H3 mRNA 
to account for that seen in the mature oocyte present in these 
small oocytes (van Dongen et al, 1981). The same is true for 
the ribosomal protein mRNAs (Pierandrei-Amaldi et al, 1982). 
This is despite the fact that the lampbrush chromosome structure 
is not seen until after vitellogenesis. Lampbrush chromosomes are 
the site of intense transcriptional activity, about 100-fold the 
rate seen in normal somatic cells (Anderson and Smith, 1978), but 
whether the RNA transcribed from the lampbrush loops is degraded 
soon after synthesis, or whether it is required to maintain the 
oocyte mRNA pool is not known. This pool could have a turn over 
of relatively stable mRNAs with a half-life of 2 to 3 months, or 
the mRNA synthesized in pre-vitellogenic oocytes could have a 
short half life.
As vitellogenin is processed and deposited in the oocyte, so 
rRNA begins to be transcribed in mass (Malry and Denis, 1971; 
Brown and Littna, 1964a, b). All three RNA polymerases are 
present in approximately equal activities throughout oogenesis 
(Roeder, 1974b), so it is not lack of RNA polymerase I that is 
responsible for the lack of rRNA synthesis seen in the 
pre-vitellogenic oocyte. Neither is it lack of template. The rRNA 
synthesized during oogenesis is transcribed from extrachromosoma 1 
nucleoli (Gall, 1968). These 1400 to 1500 nucleoli (Perkowska 
et al. 1968) are produced at least in part via a rolling 
circle mechanism (Brown and Blackler, 1972; Hourcade e_t al, 
1973; Rochalx et al, 1974) from the chromosomal rDNA, and 
give about a 1000-fold increase in the number of ribosomal rRNA
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genes (Dawid £t al, 197U), from the 1880 chromosomal copies 
to 1.5 to 2.5 million copies. This amplified rDNA is synthesized 
during pachytene (MacGregor, 1968; Kalt and Gall, 1974; van 
Gansen and Schram, 1974), so it is present in even the earliest 
stages of oogenesis.
The rlbosomal genes in Xenopus, as in many other species, 
are repeated many times. Those of Dlctylostellum dlscoldemn 
are located with the 5S genes forming extrachromosomal
palindromic dimers (Cockburn «¡t al, 1976; Malzels, 1976), 
whilst those of Xenopus, Drosophila and mammals are 
chromosomal tandem repeats, unlinked to the 5S genes (Wellauer 
and Dawid, 1977; 1979; Boseley et a_l, 1978; Glover and
Hogness, 1977; Pellegrini £t al, 1977; Cory and Adams, 1977). 
There is a basic repeat unit, in the pattern: gene-nontranscribed 
spacer-gene, where the spacer region is of a variable length. The 
non-transcribed spacer in Xenopus laevls is well 
characterized (Boseley £t al, 1979), and can be divided into 
four sections. The first, at the 3' end of the transcribed 
sequences, is Invariant in length (500 bp) and is not Internally 
repetitive. It is followed by an internally repetitive region of 
variable length (97 bp repeats) and a "Bam Island" (320 bp) which 
is non-repetitlve, centred an a Bam HI site. The final section 
consists of two related repetitive regions (60/81 bp repeats) 
separated by the second Bam Island. Both Bam Islands are similar 
in sequence to each other, and appear to be reduplications of the 
promoter region in the first 20 bp of the 40S rRNA precursor 
molecule (Moss and Blrnstlel, 1979).
There is a further complication in the case of the
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Drosophlla rlbosomal genes; some of Che 28S rRNA gene sequences 
are interrupted by a non-coding segment (Long and Dawid, 1980). 
These genes are not transcribed (Long and Dawid, 1979) although 
the initiation sequences are identical in both types of rRNA 
genes (Long et al, 1981).
By amplifying the rDNA, the time taken to transcribe the 4
ug rRNA found in the mature oocyte is decreased to a manageable
length. The other rlbosomal RNA species - 5S RNA - which is
synthesized earlier than the 40S rRNA, is stored in
rlbonucleoprotein particles until required (Ford, 1971; Picard
et al, 1980). These two ribosome components are therefore
controlled by quite differing mechanisms, not only are they
transcribed by different RNA polymerases, but the stage during
oogenesis when they are transcribed is also different. The
problem of accumulating the two types of rRNA is thus solved in
two ways. In one case by amplification of the genes and
transcription over part of oogenesis, in the other by
transcription from a lesser number of unamplifled genes over a
more extended period. The final number of ribosomes produced is 
12large (10; Perkowska et al, 1968), there are enough ribosomes 
to keep the embryo alive, without further rRNA synthesis, until 
the feeding tadpole stage (Brown and Gurdon, 1964). The Xenopus 
oocyte, unlike that of Drosophila and many other Insects,
synthesizes all of the rRNA that is found in the unfertilized 
egg. There is no lnvolvment from surrounding follicle cells, 
unlike the nurse cells of insects that produce most of the rRNA 
(Hughes and Berry, 1970). This could be a reflection of the 
shorter oogenesis of Insects as compared to Amphibia.
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Transcrlptlon during Early Embryogenests of Xenopus laevls.
The unfertilized egg and early cleavage embryo of Xenopus 
laevls are inactive with respect to RNA synthesis, this Is 
despite there being no loss In the measurable activity, and no 
change in the relative amounts of the RNA polymerases (Roeder 
et al, 1970; Roeder, 1974b). However translation of the mRNAs 
synthesized during oogenesis continues In the egg and early 
cleavage embryos. Thus the stored histone and actln mRNAs are 
made use of in the lag period between the end of oogenesis and 
when new mRNA species begin to be transcribed In the blastula 
sjage embryo (Adamson and Woodland, 1974; Ballantlne e_t al, 
1979).
There has been much controversy concerning the time when 
transcription recommences, since this system does not naturally 
lend Itself to Investigation. The embryo is impermeable to 
labelled RNA precursors, and there is a large pool of cold RNAs 
that were synthesized during oogenesis that may mask a small 
quantity of de novo RNA synthesis; but the major problem Is 
the very few nuclei that are available at the early stages of 
embryogenesls. One solution to this problem is to use 
autoradiography to study early transcription (Bachvarova and 
Davidson, 1966; Gurdon and Woodland, 1969; Newport and Klrschner, 
1982a)
No transcription has been measured In the earliest embryonic 
stages (Shlokawa ¿t al, 1981a; Newport and Klrschner, 1982a). 
4S and mRNA synthesis have been reported to restart In blastulae 
or earlier (Brown and Llttna, 1964b). There would appear to be a 
developmental transition In mldblastula embryos which brings
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about transcription (Newport and Kirschner, 1982a). This is 
initiated by the change in the ratio of nucleus to cytoplasm and 
exerts its effect on the genomic DNA, as well as injected, 
non-homologous cloned genes (Newport and Kirschner, 1982b).
The time of onset of rRNA synthesis is not as clear. 
Originally this was placed at a later stage than other RNA 
species, in gastrulae (Brown and Llttna, 1964a, b). More recent 
work indicates that rRNA synthesis can be measured in mid to late 
blastula stage embryos (Shiokawa et al, 1981a, b). The new 
rRNA transcription is from the chromosomal rDNA, rather than the 
extrachromosomal rDNA which appears to be dispersed during oocyte 
maturation, fertilization and early cleavage divisions (Busby and 
Reeder, 1982). rRNA synthesis is not uniform over the entire 
embryo, in neurula embryos the presumptive endoderm does not 
synthesize as much rRNA as the remainder of the embryonic tissues 
(Woodland and Gurdon, 1968; Mlsumi ejt al, 1980). This 
disparity is gradually decreased, such that the entire embryo 
synthesizes RNA at about the same rate by the swimming tadpole 
stage. Whether the rRNA synthesis seen in blastulae and gastrulae 
is significant, and whether because of the low rate of synthesis 
these genes could be termed 'active' remains a moot point 
(Davidson, 1976). Certainly the rate of rRNA synthesis in the 
early developmental stages is not as great as that seen during 
oogenesis. The actual amount of rRNA synthesized in blastulae, as 
measured by Shiokawa et al (1981b), is very small, 0.02 pg 
rRNA/cell/hour, and this increases to 0.12 pg rRNA/cell/hour in 
neurula embryos. Not all cells in these embryos synthesize rRNA 
(Woodland and Gurdon, 1968; Misumi et al, 1980), so if these 
figures are adjusted to account for only those cells with 
nucleoli, a figure of 0.2 pg rRNA/nucleolated cell/hour is
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reached. The apparent increase in rate of rRNA synthesis between 
blastulae and neurulae is therefore a result of an increasing 
percentage of the embryonic cells having nucleoli. The early 
stage embryos have very few cells with nucleoli visible, whilst 
80Z of the neurulae cells have nucleoli. This Increase in the 
number of cells with nucleoli is paralleled by the decrease in
the percentage of free RNA polymerase molecules and the
concomitant Increase in the number of RNA polymerases on the
chromatin (Thomas et al, 1980). The amount of rRNA
transcribed in these embryonic cells is 40Z of the maximum
capable in rapidly dividing somatic cells, where the rate has
been calculated at 0.5 pg rRNA/cell/hour (Perkowska £t al, 
1968). It would appear, therefore, that the ribosomal genes in 
those embryonic cells that have nucleoli can be described as 
active, although they are not being transcribed at their full 
potential. This does not make them 'inactive' however. Those 
cells without nucleoli could be classed as Inactive with respect 
to their rRNA transcription. The value for the rate of 
transcription of the rRNA genes in embryo cells with nucleoli 
(40Z) can be compared to the number of rRNA genes necessary to 
allow the developing embryo to survive. Anucleolate mutants that 
lack all the rRNA genes and therefore transcribe no new rRNA 
during embryogene8ls do not survive past the swimming tadpole 
stage, by which time the maternal ribosome pool is exhausted 
(Brown and Curdon, 1964). Animals that have Intermediate levels 
of rDNA are known (Knowland and Miller, 1970; Miller and 
Knowland, 1970), and those with 45Z or 60Z of the wild type gene 
number survive, but those that have only 35Z of the wild type 
gene number do not survive much longer than those with no rDNA 
(Miller and Knowland, 1972). This would Indicate that the embryo 
with a normal rDNA content can only transcribe its rRNA genes at
about 4 OX of the maximum rate; in other words, the wild type and 
the viable rDNA deletion mutants have a certain amount of 
redundancy, but the non-vlable mutants fall below the critical 
ribosomal gene content.
Control of Transcription during Oogenesis and Embryogenesls.
As previously mentioned, although the relative levels of the 
three RNA polymerases remain the same during oogenesis (Roeder, 
1974b), the amount of synthesis they achieve in the cell varies 
enormously. Thus the activity of the respective gene classes does 
not seem to be dependent on the amount of each RNA polymerase. 
The same is true for the early embryonic stages. The amount of 
RNA polymerase remains the same as that found in oocytes, but in 
the early stages no RNA synthesis is seen, and once transcription 
recommences different genes in some classes are transcribed. RNA 
polymerase I still transcribes rDNA, but during oogenesis it is 
confined to the extrachromosomal nucleoli rather than the 
chromosomal sequences. The 5S RNA genes transcribed by RNA 
polymerase III are also different. In somatic cells it is the 
SSsom genes that are transcribed, the 5Sooc genes are not used 
(Wegnez e_t al, 1972; Brownlee et al, 1972; Ford and 
Southern, 1973). As the embryo develops and tissues differentiate 
the sequences transcribed by RNA polymerase II also change.
Early work on rRNA synthesis during embryogenesis (Yamana 
and Shiokawa, 1966; Shlokawa and Yamana, 1967; Uada et al, 
1968) Indicated that these genes were regulated by an inhibitor 
molecule. The assay, which Involved incubating dissociated 
neurula cells with extracts from earlier developmental stages, 
showed that blastular extracts could inhibit rRNA synthesis in
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the intact neurula cells. A similar inhibitory factor was 
isolated from stage 6 oocytes that specifically inhibited rRNA 
synthesis in stage 4 oocytes (Crlppa, 1970). However, Crampton 
and Woodland (1979a, b), using a different assay, containing 
isolated cultured cell nuclei, showed that rRNA synthesis is 
regulated by a series of activating molecules present in oocyte 
and neurula extracts. These two systems are quite different in 
character; while the first concentrates on whole cells, the 
second is based upon Isolated nuclei. It is therefore possible 
that both revealed molecules controlling rRNA synthesis in 
vivo.
Whereas the control of rRNA synthesis is not well 
understood, the same is not true of 5S gene transcription. The 
products of these two gene families are present In equimolar 
amounts in ribosomes, but the two genes are transcribed by 
different RNA polymerases and under different control mechanisms. 
It is easily seen that the transcription of the 5S genes is not 
dependent on the transcription of the rRNA genes since 5S RNA 
synthesis is seen before rRNA synthesis during oogenesis (Brown 
and Littna, 1964a, b; Ford, 1971; Mairy and Denis, 1971; 1972; 
Thomas, 1974) and during embryogenesls (Brown and Littna, 1964b; 
Miller, 1973; 1974; Shiokawa et al, 19Bla, b). The lack of 
dependence between rRNA transcription and SS RNA transcription 
can also be shown since anucleolate or nu7nu~ Xenopus laevis 
embryos which lack the rlbosomal RNA genes (Brown and Curdon, 
1964) transcribe the SS genes efficiently (Miller, 1973; 1974). 
Although rRNA transcription is not linked to SS RNA 
transcription, it does have some Influence over the translation 
of the rlbosomal protein mRNA. Anucleolate mutants, although they 
transcribe SS RNA genes to the same extent as their wild type
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slbllngs, do not translate the rlbosonal protein mRNA 
(Plerandrel-Aaaldl et al, 1982).
An oocyte nuclear extract can accurately transcribe 5S DNA 
cloned in a plasmid, although some vector sequences were also
transcribed. When an egg extract is substituted for the oocyte
nuclear extract, all the transcription is non-specific
(Birkenmeler et al, 1978; Ng et al, 1979). This formed
the basis for a transcription assay; various oocyte fractions 
were added to the basic non-specific egg + plasmid assay and 
accurate transcription sought (Engelke e_t al, 1980). A 37000 
dalton protein, called TF111A, was identified which is specific 
for 5Ssom and 5Sooc genes, but not the tRNA genes, which are also 
transcribed by RNA polymerase 111. It binds to the Internal 
control region of the 5S genes, between bases 45-96 independently 
of the RNA polymerase III molecules (Sakonju e_t al, 1980; 
Bogenhagen £t al, 1980). This region is necessary for 
transcription to occur when 5S DNA is injected into Xenopus 
oocytes or used in an ^n vitro transcription assay 
(Uormington £t al, 1981). The areas necessary for 
transcription in the oocyte system and for binding of the 37 kd 
protein are co-extenslve (Sakonju et al, 1981). The protein 
may well be involved in feedback regulation, as it also binds to 
the 5S RNA gene product to form the 7S rlbonucleoproteln complex 
(Pelham and Brown, 1980; Honda and Boeder, 1980) of immature 
oocytes, It is also responsible for the formation of a stable 
transcriptional complex (Bogenhagen et al, 1982; Gottesfeld 
and Bloomer, 1982). There also seems to be an lmiminologlcally 
similar, but not Identical, molecule present in somatic cells of 
39,000 daltons molecular weight (Pelham ejt al, 1981). The 
presence of the two 5S regulatory proteins does not, however,
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solve the problem of 5Sooc and SSsom gene control, since a 
somatic cell transcription assay will transcribe both sets of 
genes with comparable efficiencies (Pelham £t al, 1981).
Oocyte injection transcription assays and systems such as 
those described for 5S DNA have also been used to Identify 
control regions neighbouring genes transcribed by RNA polymerase 
II (Luse and Roeder, 1980; Wasylyk ejt ll, 1980; Luse et 
al, 1981). By deleting and rearranging flanking regions before 
assaying the ability of the genes to initiate and support 
transcription, as well as by the comparison of flanking regions 
between different genes, it has been possible to Identify several 
Important sequences. Apart from the -TATA- or -ATA- sequence 
usually situated 25 to 30 bp upstream from the 5' end of the gene 
(Grosveld e_t al, 1981; Tsai £t al, 1981; Mathis and 
Chambon, 1981), other upstream sites have also been implicated, 
for example, the sequence -CAAT- at about 80 bp upstream (Benolst 
et «1, 1980; Crosveld et aj., 1982). An enhancing element, 
like those found in DNA viruses, for example SV40 (Benolst and 
Chambon, 1981; Gruss e_t al, 1981, Tyndall et al, 1981), 
that would stimulate transcription at an upstream promoter site 
could also be a possibility. The SV40 enhancing sequence is 
located between 113 and 257 bp from the transcription initiation 
site. It is a 72 bp repeated unit that can be ligated to 
eukaryotic cloned genes to Increase their transcription by up to 
2 fold when assayed (Moreau et al, 1981). Also associated 
with the control of these genes are sites downstream from the 
transcribed sequences, the termination site and signals for 
polyadenylation (-AATAAA-, Froudfoot and Brownlee, 1976; Hofer 
et al. 1982). With genes transcribed by RNA polymerase II, 
where the final product is a protein and not the primary
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transcrlpt, the further possibility of translational control 
arises. This possibility is made use of by X.laevls, for 
example in the case of histones and actins, where the pool of 
mRNA synthesized during oogenesis is under - utilized until 
embryogenesis.
Transcription systems for RNA polymerase I have been more 
difficult to set up (Grummt, 1981). One reason for this is the 
that accurate transcription of a cloned rDNA template is 
dependent on the template and RNA polymerase I molecules being 
homologous (Grummt eit jil, 1982). There appear to be no -TATA- 
or -ATA- sequences, but the sequence -AGGTA- has been implicated 
In initiation (Sollner-Webb and Reeder, 1979; Long e£ al, 
1981; Hiller and Sollner-Webb, 1981). However, the actual site of 
initiation in mouse rDNA is unclear (Miller and Sollner-Webb, 
1981). The initiation site of the Xenopus rRNA genes 
(Sollner-Webb and Reeder, 1979; Sollner-Webb and McKnight, 1982) 
is complicated by the presence of a reduplicated promoter 
(Moss and Birnstiel, 1979) within the non-transcribed spacer that 
can initiate transcription. However, it appears to be located 
between -145 bp and +16 bp (Moss, 1982), that is upstream from 
the initiation point. The promoter for RNA polymerase 1, 
therefore, is more like an RNA polymerase 11 promoter than that 
of RNA polymerase III in its upstream location.
The standard assays outlined above have the disadvantage 
that for many of them the template is in the form of naked DNA, 
whereas normally _in vivo the DNA is associated with a 
multitude of histone and non-histone proteins. Therefore many 
transcription assays have been designed about Isolated nuclei
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(eg. Marzluff al, 1973). This does give rise to the 
problem, that for genes transcribed by RNA polymerase II at 
least, the amount of transcription is small, because the gene 
copy number is very low, although this is not an insurmountable 
problem. Isolated nuclei continue to synthesize the same RNA 
species as before isolation, and a variety of newly initiated RNA 
types have been reported, including 5S RNA (Marzluff et al, 
1973), immunoglobulin kappa light chain mRNA (Smith and Huang, 
1976) and Drosophila heat shock protein mRNA (Miller and Elgin, 
1981).
Korn and Gurdon (1981) injected erythrocyte nuclei into 
Xenopus oocytes and looked for 5S RNA synthesis. The chromatin 
of Xenopus erythrocyte nuclei is highly condensed and the only 
transcription seen is elongation by the remaining RNA polymerase 
II molecules (Hentschell and Tata, 1978). The Injected 
erythrocyte nuclei did synthesize SS RNA, but in the oocytes of 
many females it was of the somatic type, as expected from somatic 
cells. Preincubation of the nuclei with the 5S regulatory protein 
(Engelke et al, 1980) did not alter this, although removing 
the non-histone proteins from the nuclei did bring about 5Sooc 
RNA synthesis. The inactivity of the 5Sooc genes injected in this
system is at the level of the gene unit Itself. Cutting the
chromatin into fragments of this size does not alter their
inability to be transcribed (Gurdon £t al, 1982). A few
female Xenopua did produce oocytes that would cause erythrocyte 
nuclei to transcribe both sorts of 5S RNA genes, but the 
difference between the two types of oocytes is unknown.
Crampton and Woodland (1979a, b) showed that rRNA synthesis 
in cell culture nuclei could be Increased by the addition of a
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range of oocyte factors. Unfortunately, because nuclei were used 
that were already actively transcribing their rDNA It was not 
clear exactly how these oocyte factors worked, and whether they 
'activate' genes from a former Inactive state (assuming that 
there is a mixed population of active and Inactive rRNA genes In 
a given nucleus), or Increase the transcription on already active 
genes.
In a different system, studying Insect polymerase II genes, 
Cralne and Kornberg (1981) succeeded in altering the 
transcriptional state of nuclei from Drosophila embryos. By 
incubating nuclei Isolated from non-heat-shocked embryos with 
cytoplasmic extracts from heat-shocked embryos, they showed that 
certain of the heat-shock protein genes become more accessible to 
transcription by E.coll RNA polymerase. However, this region Is 
not normally transcribed, and it does not show that this 'factor' 
can also bring about de novo transcription by the 
Drosophila RNA polymerase II molecules, or that the change In 
accessibility of the E.coll RNA polymerase is reflected In a 
change In chromatin structure.
Changes In Chromatin Structure as a Means of Regulating 
Transcription.
Chromatin structure In Itself has been studied as a 
mechanism for the control of gene activity. The genomic DNA is 
bound to a range of histone and non-hlstone proteins. The 
nucleosome core - an octomer of two molecules of each of histones 
H2A, H2B, H3 and H4 - is encircled by about 200 bp of DNA , which 
after a short "linker" of about 15 bp DNA, continues on around 
another nucleosome. Histone HI Is associated with this "linker"
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DNA, although Its exact function Is unclear. It may be concerned 
with locking the DNA about the nucleosome. In some tissues, 
histone HI Is replaced by an HI variant, for example, histone Ho 
found In sperm nuclei and histone H5 In mature erythrocyte 
nuclei. In chicken erythrocytes, which are transcriptionally 
almost inert, the HI molecules are gradually replaced by histone 
H5. It gradually replaces the HI molecules as erythropoelsls 
proceeds and transcription gradually ceases (Appels et al, 
1972; Appels and Wells, 1972; Billett and Hlndley, 1972; Sotlrov 
and Johns, 1972).
The position of the nucleosomes upon the DNA has been 
postulated as a method of regulating transcription. Nucleosomes 
can either be in random positions on the DNA, or have a fixed 
location on a given stretch of DNA, or have a limited number of 
possible locations. Experiments on viral systems have shown that 
the origin of replication of SV40 and Polyoma virus DNA are 
nucleosome-free (Varshavsky £t al, 1979; Saragosti e£ al, 
1980; Scott and Wigmore, 1978). This presumably aids replication 
of the viral genome during infection. The case in other phyla 
though is far from clear. Early work gave no decisive results and 
was taken as an Indication of random nucleosome phasing. More 
recent work favours a set of non-random nucleosome positions In a 
variety of genes and species. The occurence of a non-random 
nucleoaome phasing appears to be favoured by those genes that are 
being transcribed. Drosophila histone and SS genes are packaged 
in a non-random way (Samal et al, 1981; Louis et al. 
1980), as are the chicken embryo tRNA(Lys-2) genet. However, 
transcribed tRNA genes In Xenopus laevla do have a regular, 
but random, relationship between DNA sequence and nucleosome 
position, whilst non-transcrlbed tRNA genes are in one major
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phase (Bryan e£ al, 1981). The nucleosome arrangement for 5S 
RNA genes of Xenopua laevls Is also non-random, In one of 
four alternative phases, but this phasing Is present for both 
transcribed and non-transcrlbed sequences (Gottesfeld and 
Bloomer, 1980).
Apart from the primary colling of the DNA about the 
nucleosomes, the chromatin Is further folded back on itself 
several times. This colling has been cited as the basis of 
another possible mechanism for gene control (Wasylyk and Chambon, 
1979). A gene that is tightly folded would be inaccessible to RNA 
polymerase molecules and therefore "inactive", whilst a gene that 
is "active" and being transcribed would be in a more "open" 
chromatin configuration. However, it could be that the more open 
configuration is brought about by the transcription and not the 
more open structure allowing transcription to take place. In 
either case, such active genes should be more readily accessible 
to nucleases than those tightly folded and inactive sequences.
Several nucleases have been used to distinguish between the 
active and inactive sequences within a nucleus, the most widely 
used is DNase I although micrococcal nuclease and DNase II 
also achieve this purpose (Reeves and Jones, 1976; Bloom and 
Anderson, 1978; Wood and Felsenfeld, 1982; Larsen and Welntraub, 
1982). Welntraub and Groudine (1976) showed that DNase I could 
distinguish between transcribed and non-transcrlbed gene 
sequences. Chicken globln genes were preferentially digested in 
erythrocytes, but not in fibroblast or brain cells. This 
relationship was also shown for the chicken ovalbumin gene (Garel 
and Axel, 1976); those cells that normally synthesize ovalbumin 
showed Increased sensitivity to DNase I as compared to those
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cells that do not transcribe this gene. Since these initial 
experiments, this facet of DNase I sensitivity has been extended 
to many more gene systems, and further levels of sensitivity have 
been described. For the most part, a gene that is being 
transcribed or is potentially able to be transcribed, is more 
sensitive than the same gene sequence that is not going to be 
transcribed. The sensitive domain encompasses the transcribed 
region, but may also extend for several kb either side of the 
gene. However, the area about the transcribed region, although 
more sensitive than the surrounding bulk DNA tends to be less 
sensitive than the actual transcribed sequences (Stadler et 
al, 1980)
Also associated with transcribed genes are ultra- sensitive 
spots of DNase 1 sensitive chromatin. These may be only a few 
bases long, or extend for up to 50 bp. They are normally only 
found in the flanking regions of transcribing genes, but a few 
exceptions occur in both cases. For example, there are DNase 1 
hypersensitive sites located 300 bp from the 5' end of the 
Drosophila heat-shock protein genes 83, 28, 23, 26, and 22 
whatever the transcriptional state of the genes (Wu e_t al, 
1979 b; Wu, 1980; Keenest al, 1981), although further sites 
appear when the cells are heat-shocked. One of the hypersensitive 
sites associated with the glue protein gene Sgs4 of 
Drosophila is located 30 bp within the transcribed sequence 
(Shermoen and Beckendorf, 1982), and there are two hypersensitive 
sites associated with the mouse/Jglobin gene (from erythroleukemla 
cells) located within the transcribed sequence (Hofer ¿t al, 
1982). All other hot spots appear to be outside the transcribed 
region, although not all are in such close proximity as those of
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the Drosophila heat-shock protein genes; for example the site 
associated with the chicken conalbuain gene is about 1 kb from 
the 3' end of the gene (Kuo ¿t al, 1979). At least In the 
Polyoma viral system, the location of the DNase 1 hypersensitive 
site Is not determined by the nucleotide sequence of the DNA at 
the hypersensitive site (Herbomel e£ al, 1981), but perhaps 
by a DNA sequence upstream from this site.
The hypersensitive sites about the 5' flanking region of the 
Drosophila glue protein gene Sgs4 at -330, -405 and -480 
(Shermoen and Beckendorf, 1982) seem to be associated with 
sequences that are necessary for transcription of the gene in 
vivo (Shermoen and Beckendorf, 1982; Muskavitch and Hogness, 
1982). These sites are well removed from the 'typical' RNA 
polymerase II transcription signals at -25 to -30 (-TATA-) and 
-80 bp (-CAAT-). One of the hypersensitive sites within the mouse 
/3 globin gene (Hofer e_t al, 1982) is in the vicinity of the 
cap site, and is more prominent in chromatin from induced cells.
The cause of the different chromatin structure in 
untranscribed and transcribed genes is not clear. The HMG 
proteins 14 and 17 (Goodwin ¿t al, 1973) are associated 
exclusively with transcribed sequences (Levy et al, 1979; 
Weisbrod et al, 1980; Weisbrod and Uelntraub, 1981), but it 
is unlikely that these actually cause the chromatin 
conformational change (Gazit et al, 1980), although they may 
be responsible for fixing or maintaining the new chromatin 
structure. Some Drosophila heat-shock protein genes seem to 
have their chromatin structure modified in some indeterminate way 
by a protein (Cralne and Kornberg, 1981).
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Methylatlon and demethylatlon has also been called upon as a 
trigger for gene activation. In some Instances the correlation 
between the activity of a given gene and the degree to which the 
cytosine residues are methylated Is quite clear (McGhee and 
Cinder, 1979; Shen and Manlatls, 1980; Compere and Palmlter, 
1981). However, lack of methylation per se Is not a 
prerequisite for gene transcription. That Is, transcription may 
still occur If a sequence Is methylated (McKeon ej. al, 1982). 
The rRNA genes of Xenopus laevls are a case In point. In 
somatic cell nuclei, although most of the gene repeat Is heavily 
methylated there are two sites of undermethylatlon in the 
non-transcrlbed spacer region (Bird and Southern, 1978). The 
extra extrachromosomal rDNA in oocytes Is also of this pattern, 
whilst the chromosomal rDNA of oocyte and sperm nuclei are 
heavily methylated (Bird et al, 1981). It would appear that 
early in development at or preceding the point at which rRNA 
transcription recommences, these sites within the non-transcrlbed 
spacer become demethylated. The rDNA In the closely related 
species X.borealis Is undermethylated at these sites 
throughout its life cycle (Macleod and Bird; 1982). In laevls x 
borealis hybrids the methylation state at the swimming tadpole 
stage Is the same in both maternal and paternal rDNA sequences, 
but only the laevls rDNA is DNase I sensitive and only these 
sequences are transcribed. So although demethylatlon of the gene 
sequence to be transcribed, or a site near to It may be a 
prerequisite for transcription to occur, It probably Is not the 
signal for that gene to be transcribed.
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Methods for Studying the Control of Transcription.
A good transcription system designed to look at 
transcriptional control should be as close as possible to the 
in vivo conditions, whilst being relatively simple in its 
components. The control of transcription during oogenesis and 
early embryogenesls of Xenopus laevls is, with the exception 
of 5S RNA genes, still largely unexplained. Most transcription 
assays contain recombinant DNA as the template; this has the 
definite advantage that the system is very simple, but the 
disadvantage that the DNA is not in the natural chromatin form. 
In isolated cell culture nuclei, although the genes are 
associated with the chromatin proteins, they are actively 
transcribing a whole range of genes, many of which are also 
transcribed during oogenesis and embryogenesis. The erythrocytes 
of X.laevls are nucleated, but the chromatin is highly 
condensed and very little transcription occurs (Maclean eji 
al, 1973; Hentschell and Tata, 1978). It therefore makes a very 
useful tool to study ribosomal RNA transcription since it is a 
near-natural source of Inactive ribosomal genes.
It is not clear whether rRNA transcription is controlled by 
an inhibitor (Yamana and Shiokawa, 1966; Shlokawa and Yamana, 
1967; Uada et al, 1968), or an activator (Crampton and 
Woodland, 1979a, b) molecule. Although the use of erythrocyte 
nuclei will not detect an inhibitor molecule, it might at least 
detect any activator. Erythrocyte nuclei can be Induced to 
transcribe RNA above their normal rate by injection into 
Xenopus oocytes (Korn and Gurdon, 1981), and to divide when
injected Into Xenopus eggs (Brun, 1978), although in this case 
the "embryo" never proceeds further than the early gastrula
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atage. However, these particular systems have disadvantages when 
trying to distinguish the active component and therefore 
incubation with oocyte protein extracts is the preferred method 
of assay« The development and use of this system is the subject 
of this thesis.
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CHAPTER II; MATERIALS AND METHODS.
1. Materials.
Moat reagents used were AnalaR grade from BDH. Exceptions 
and their origins are listed below.
Agar Aids.
Gluteraldehyde, electron microscopy grade.
Amershaa International.
15— H^] uridine 5' triphosphate, ammonium salt, 10-30 Ci/mmol. 
deoxy[5-^H] cytidine S' triphosphate, ammonium salt,
15-30 Ci/mmol.
L-f^S] methionine, 600 Ci/mmol.
deoxy 5'-[or^P] triphosphate, triethylammonlum salt,
2000-3000 Ci/mmol.
Boehrlnger Mannheim, 
or-amanitin
proteinase K EC 3.4.21.14 
polytd(A-T) ]
Kornberg DNA polymerase I EC 2.7.7.7 
ATP, CTP, GTP, UTP.
Bio.Rad Laboratories Ltd.
Acrylamide
Flsons Scientific App. Ltd.
Bromophenol Blue (BPB)
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Kodak.
N,N'-methylene bisacrylamide 
Milllpore Corporation.
1.4 cm diameter nitrocellulose filters, pore size 0.4S pm.
New England Biolabs, Inc.
Restriction Enzymes Bam HI, Eco RI, Hind III.
The reaction conditions used were those Included by Biolabs 
with each batch of enzyme.
Pharmacia Fine Chemicals AB.
Sephadex G100 
Ficoll 400
Schlelder and Schull.
Nitrocellulose filters, pore size 0.45 urn.
Schwarz/Mann, Inc.
RNase-free Sucrose
Sigma London Chemical Company Ltd.
Agarose Type II 
Trypsin
Trypsin Inhibitor 
Dlthiothreltol (DTT)
RNase A EC 3.1.27.5 
TI RNase EC 3.1.27.3 
Actlnomycln D
Bovine Serum Albumin (BSA)
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Cytochrome c 
Blue Dextran 
Ovalbumin 
Yeast tRNA
dATP, dCTP, dGTP, dTTP 
Polyvinylpyrrolidone (PVP)
DNase I from bovine pancreas EC 3.1.21.1 
Dithiothreltol (DTT)
Ethyl-m-amlnobenzoate (MS222)
Lysozyme EC 3.2.1.17
South African Snake Farm, Fish Hoek, South Africa.
Mature Xenopus laevls
These and their progeny were reared as described by Gurdon and 
Woodland (1975).
Whatman Chemical Separation Ltd.
DEAE Cellulose 
Filter paper No 54
Worthington Biochemical Corp.
RNase-free DNase 1 EC 3.1.21.1
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Plasmld
pXHOl
pXlrl08
pXlr212
pXlrlA
Cl 3
PCX1H4U1
pXlo31
DNA
A gift from Dr A. Colman. It contains a single copy of 
the X.laevls ribosomal RNA gene repeat (10.75 kb 
Hind III fragment) Inserted Into pMB9. As constructed 
by Dr R. Reeder. See Figure 6.1.
A gift from Dr A. Colman. It contains the 6.27 kb Eco 
RI fragment of the X.laevls rDNA repeat Inserted 
Into pCRl (Boseley e£ al, 1978). See Figures 6.1 
and 7.10.
A gift from Dr A. Colman. It contains the 4.48 kb Eco 
RI fragment of the X.laevls rDNA repeat Inserted 
into pCRl (Boseley £t al, 1979). See Figure 7.10.
A gift from Dr A. Colman. It is a subclone of pXlrl08 
containing the 1.57 kb Pst I fragment. As constructed 
by Dr B.E.H. Maden. See Figure 7.10.
A gift from Dr R.W. Old. It contains about 300 bp of 
X. laevls globin cDNA inserted Into pCRl.
A gift from Dr P.C. Turner. It contains 382 bp of X. 
laevls histone H4 cDNA inserted into pAT153 (Turner 
and Woodland, 1982).
A gift from Dr A. Colman. It contains a single 660 bp 
repeat of the X.laevls 5Sooc RNA gene, pseudogene 
and spacer, Inserted Into pMB9 (Federoff and Brown, 
1978).
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>*210 A gift fro« Dr A. Colman. It contains two copies of
tRNA-Metl, and a single copy of the tRNA genes for 
phenylalanine, asparagine, alanine, leucine, lysine, 
and tyrosine. This is a 3.18 kb genomic DNA fragment 
inserted into A598 vector (Clarkson et al, 1978; 
Bryan at al, 1981).
C13, pcXIHAWl, pXlo31, pXlrl4 andlt210 were received as DNA 
preparations. pXHOl, pXlrl08 and pXlr212 were received as 
plasmid-containing bacteria. These were grown and the plasmid DNA 
extracted as described in the Methods section.
Semlpurifled X.laevls RNA polymerases were prepared by Prof. 
H.R. Woodland following the method of Boeder (1974), being a 40Z 
ammonium sulphate precipitate from whole Xenopus laevis 
ovary, kinase labelled^P-18S and 28S rRNAs were also prepared by 
Prof H.R. Woodland. 2.5 fig 18S and 28S rRNA purified from a 
sucrose gradient were heat denatured (80*C, 3 minutes) and kinase
labelled with 27 pCi^P-ATP. This gave2P-18S rRNA at 8.5xlC? cpm/pg 
an JV-28S rRNA at 6.4xl(^ cpm/pg.
The rDNA fragment L-108 (2.18kb cut from pXlrl08 by a Bam HI x 
ECO RI double digest) wa6 a gift from Dr. P. Boseley.
r
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2. Methods.
Preparation of Erythrocyte Nuclei from Xenopus laevls. 
Homogenization Buffer (H buffer).
0.3 M sucrose (RNase-free), 2 mM Magnesium Acetate, 3 mM Calcium 
chloride, 10 nH Trls-HCl pH 8.0, 0.1? Trlton-X100, 0.5 mM
Dithiothreitol.
Centrifugation Buffer (C buffer).
2 M sucrose (RNase-free), 5 mM magnesium acetate, 10 mM Tris-HCl 
pH 8.0, 0.5 mM dithiothreitol.
Resuspension Buffer (RB).
25? glycerol, 5 mM magnesium acetate, 50 mM Trls-HCl pH 8.0, 0.1
mM EDTA, 5 nM DTT.
Calcium and Magnesium-free Barth-X.
Modified Barth solution containing 58 mM NaCl, 1 raM KC1, 24 mM 
NaHCQp 15 mM HEPES.
Nuclei were prepared according to the method of Marzluff 
et al (1973). A large female Xenopus laevls was 
anaesthetized using 0.1? ethyl-m-aminobenzoate (MS222) and the 
blood collected by cardiac puncture using a heparin rinsed 
syringe and diluted into Ca/Mg-free Barth-X plus 0.1 mg/ml 
heparin. The erythrocytes were washed several times in Ca/Mg-free 
Barth-X by centrifugation (MSE 6L, 8 x 50 ml rotor, 2,000 rpm for 
10 minutes at 4*C) and resuspension to remove all the plasma and 
white blood cells. The clean erythrocyte pellet was taken up in H 
buffer and left on ice for 5 minutes before being homogenized in 
a loose fitting Teflon-glass homogenlzer so that all the cells
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were lysed» An equal volume of C buffer was added and mixed well« 
5 ml aliquots of this nuclear suspension were layered over 8 ml 
of C buffer in a 15 ml Corex tube. After centrifugation (MSE 6L, 
8 x 50 ml rotor, 3,500 rpm for 60 minutes at 4*C ) the sucrose 
solutions were removed carefully and the pelleted nuclei gently 
resuspended in RB to a final concentration of 2 x 10^  nuclei/ml. 
The nuclei were stored in small aliquots at - 70*C.
Preparation of Liver Nuclei from Xenopus laevls.
Homogenization Medium (IM).
10 mM Trls-HCl pH 7.4, 10 mM sodium chloride, 1.5 mM magnesium 
chloride, 502 glycerol (w/v).
The procedure used was a modification of that of Schribler 
and Weber (1974), the liver from a mature Xenopus laevls 
female was roughly chopped and washed in HM. The pieces were 
homogenized in a Teflon-glass homogenizer in 4 volumes of HM 
buffer plus 0.1Z Triton-XlOO on ice. The homogenate was strained 
through sterile muslin, briefly spun (MSE 6L, 8 x 50 ml rotor, 
2000 rpm for 5 minutes at 4*C) to pellet the nuclei and any 
unlysed cells. This pellet was rehomogenized on ice in HM plus 
0.1Z Triton-XlOO and centrifuged again. The pellet was further 
washed 3 times with IM only, and after the final spin the nuclei 
were taken up in the standard resuspension buffer and stored at 
-70*C. Although this leaves the nuclei slightly contaminated with 
pigment granules, further cleaning spins were not carried out to 
prevent loss of transcriptional activity.
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The basic 100 pi assay contained 50 pi of erythrocyte nuclei 
In RB plus KC1, MnCl and ribonucleotide-triphosphates at optimal 
concentrations (Chapter III), such that the final mix was; 1C^  
nuclei In 12.5? glycerol, 2.5 nM magnesium acetate, 25 oM 
Trls-HCl pH 8.0, 2.5 nM DTT, 0.05 nM EDTA, 120 nM KC1, 1 oM MnCl2 
, 0.4 irti ATP, CTP and GTP, 0.02 nM UTP and 4 pCl3H-UTP (10-30
Cl/mmole). The nuclei were Incubated at 25*C and duplicate 10 pi 
or 20 pi samples spotted onto 2 cm pieces of Whatman 54 filter 
paper at the required times. The filters were dropped into 
Ice-cold 5Z TCA, 1Z tetrasodlum pyrophosphate. Filters pooled In 
this way were washed three times in TCA/pyrophosphate on Ice, 
twice with ethanol and once with acetone before being dried and 
the TCA precipltable cpm determined (Toluene-PPO-POPOP 
scintillant, Packard scintillation counter). These were expressed 
as pmoles UMP incorporated per l(f nuclei.
To preincubate the nuclei with an oocyte, egg or embryo 
extract, the standard 100 pi assay contained; 10® nuclei, 40 pi 
extract, 0.5 x RB, 50 mM KC1, 1 cM MnCl2 , and 0.02 oM ATP, CTP, 
CTP and UTP. The nuclei were Incubated for 60 minutes, then 
either spun down gently (Eppendorf Microfuge, for the minimum 
possible time) and taken up In the basic assay mix, or 
supplemented to bring the salt concentrations etc to those of the 
standard assay. The nuclei were Incubated again at 25*C for 30 
minutes, samples taken and processed as above.
Nuclear Tranacrlptlon Assay.
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Identical conditions to the nuclear transcription assay were 
used, but the template was poly(d(A-T)]. A standard SO pi assay 
contained 20 pi of the extract to be tested, 2 pg poly[d(A-T)], 
0.5 x RB, 120 otft KC1, 1 bM M n C ^ , 0.4 nil ATP, CTP, and GTP, 0.02 
bM UTP and 2 pCi3H-UTP (10-30 Ci/mmole).
RNA Transcription Assay.
Preparation of Oocyte, Egg and Embryo Protein Extracts.
Washing and Homogenizing Buffer (W-H Buffer).
50 nil Trls-HCl pH 8.0, 0.5 mM DTT, 0.05 mM EDTA.
Eggs and embryos were dejellied In 1Z cysteine hydrochloride 
pH 8.0. Small pieces of ovary or dejellied eggs or embryos were 
washed in several changes of W-H buffer and then homogenized in a 
half volume of W-H buffer In a Teflon-glass homogenizer on ice. 
The resultant homogenate was given a clearing spin (MSE 6L, 8 x 
50 ml rotor, at 2500 rpm for 30 minutes at 4*C) before the 
supernatant was centrifuged further (MSE HS18, 8 x 5 ml rotor, at 
12600 rpm for 30 minutes at 4*C).The extracts were collected free 
from lipid, yolk and pigment and stored at -70*0 in 100 fil 
aliquots. Alternatively, if the original crude extract volume was 
small, the homogenate was given a single spin in an Eppendorf 
mlcrofuge (3 minutes at 4*C). Protein content was determined 
using the method of Lowry cst al (1951) and adjusted to 30 
mg/ml.
Protein extracts centrifuged at 100,000g were spun in a 3x6.5ml 
rotor, MSE 6L, 3 hrs at 4*C before being stored as above.
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Preparation of^%-oocyte Extract.
About 200 vitellogenic oocytes were incubated in 250 pi 
modified Barth-X with 200 pCi^-methlonine for 24 hours. After 
this time the oocytes were washed thoroughly in WH buffer and a 
soluble protein extract made as described above.
Column Chromatography.
Column Buffer
10 oM Tris-HCl pH 8.0, 0.05 mM EDTA, 0.5 nM DTT.
Sephadex G100 was swollen in column buffer overnight and 
de-fined. A column (height 23 cm, diameter 2 cm) was packed and 
washed through with column buffer at 4*C. The column was 
calibrated with cytochrome c, ovalbumin and blue dextran as 
markers. 50 pi glycerol was added to the 200 pi protein extracts 
before loading on the column. The resulting eluate was collected 
as 30 drop fractions.
Preswollen DEAE cellulose was packed (column size; height
2.5 cm, diameter 2 cm) and washed with column buffer. 200 pi 
samples of crude protein extracts or 3 ml volumes of G100 column 
fractions were loaded and further column buffer run through until 
the Ol^of the eluate was zero. A NaCl gradient was run through 
the washed column (0-0.45 M NaCl in column buffer) and 30 drop 
fractions collected.
All columns were run at 4*C, and the resulting column 
fractions stored at -20*C.
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Acrylamlde Gel Electrophoresis.
Running Buffer
50 mti Tris-HCl pH 8.0, 380 oH glycine, 0.1 Z SDS.
Sample Buffer
50 n*i Tris-HCl pH 6.8, 10Z glycerol, 2Z SDS, 5Zp-mercaptoethanol, 
0.001Z BPB.
18Z low bis acrylamide gels were run (18Z acrylamide, .09Z 
bis-acrylamide, 37 oM Tris-HCl pH 8.8, 0.5Z SDS), with a 3Z
acrylamide stacking gel (3Z acrylamide, 24 mM Tris-HCl pH 6.8, 
0.1Z SDS). The resulting gels were either stained with Coooassle 
Blue or Silver stained (Switzer et al, 1979)
Coomassie Blue Staining.
Stain and Fix
45Z ethanol, 10Z glacial acetic acid, 0.1Z coomassie blue.
Destain I.
45Z ethanol, 10Z glacial acetic acid.
Destaln 11.
5Z Isopropanol, 10Z glacial acetic acid, 0.005Z Coomassie blue. 
Gels were stained for a minimum of 3 hours, followed by 2
hours in each destaln.
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Sllver staining.
The original method of Switzer £t al (1979) was used. 
Fluorography
The fixed gels were treated with DMSO (two washes) and then 
DMSO plus PPO, before being dried down and exposed to X-ray film 
(Fuji RX).
Extraction of RNA 
a. From Whole Cells.
Modified Kirby (1968) Extraction Buffer.
10 oM EDTA, 6% 4 amino sallcycllc acid, IX NaCl, 0.1 M Tris-HCl 
pH 9.0, 2Z SDS, 6Z phenol.
The cells (eg. tissue culture cells, Xenopus laevls 
oocytes) were homogenized In an equal volume of extraction 
buffer, and extracted with two volumes of phenol-chloroform (1:1) 
until the Interface was clear. The aqueous phase was extracted 
twice more with chloroform-lsoamylalcohol (1:24) made 0.4 M L1C1 
and precipitated with 2.5 volumes of ethanol at -20*C overnight. 
The precipitated nuclei acids were redissolved In 5 ntf 10
nM Trls-HCl pH 7.5 and Incubated on Ice with 100 pg/ml DNase I 
for 10 minutes. This was phenol extracted and precipitated after 
the DNase treatment. The resulting RNA precipitate was 
reprecipitated at least once more before being stored at -20*C as 
the precipitate until required.
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Modified Kirby (1968) Extraction Buffer.
1Z tri-isopropyl-naphthalene, 5Z phenol, 6Z 4-amino-salicyclic 
acid, 50 oM Trls-HCl pH 8.2.
An equal volume of 2 x extraction buffer was mixed well with 
the transcription assay. The procedure for extraction was the 
same as for a whole cell RNA extraction, except that the volumes 
were much smaller (about 1 ml) and therefore the extractions were 
carried out In Eppendorf Fllptop 1.5 ml vials and using an 
Eppendorf benchtop microfuge.
b. From Transcription Assays.
Preparation of Plasmid DNAs.
The bacteria were grown In 1,-Broth until they reached on 0 ^  
of 0.8 to 1.0. At this point chloramphenicol was added to 50 
pg/ml and the bacteria kept at 37SC for 20 hours. The bacteria 
were pelleted (MSE HS18, 6x250 ml rotor, 15 minutes at 4*C) and 
taken up In 25Z sucrose, 50 oM Trls-HCl pH 8.0. The bacteria were 
lysed with 5 mg/ml Lysozyme on Ice for 5 minutes, followed by the 
addition of 0.2 volumes of 0.25 mM EDTA, 50 mM Trls-HCl pH 8.0 
and 2 volumes 0.25 nM EDTA, 50 oM Tris-HCl pH 8.0, 0.5Z
Trlton-XlOO for 20 minutes. After lysis the bacterial mix was 
spun at 18,000 rpm In the MSE HS18 centrifuge (8x50 ml rotor) and 
the supernatant stored at 4*C.
The plasmid DNA was purified from the cleared lysate by the 
method of Col man et al (1978) and stored as precipitated DNA 
at -20*C until required.
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Loadlng DNA onto Nitrocellulose Filters.
DNA in lxSSC was denatured by incubating the DNA in 0.5 M 
NaOH for 45 minutes at room temperature. The Milllpore filters 
(Type HA, pore size 0.45 pm) were washed with distilled water and 
6xSSC before the denatured DNA was neutralized with HC1 and 
loaded onto the filter under slight negative pressure. The 
filters were washed once more with 6xSSC before being baked at 
80*C for 2 hours and stored at -20*C.
RNA-DNA Hybridizations.
The Milllpore filters loaded with the appropriate DNA were 
dampened with 3xSSC, 50Z formamlde and carefully placed at the 
bottom of a plastic scintillation vial Insert. The RNA sample to 
be hybridized was taken up in 3xSSC, 50Z formamide pH 7.0 and 
added to the filters. These were Incubated submerged in a 37*C 
water bath for 24 hours. The hybridized filters were pooled in a 
large volume of 0.2Z SDS, 2xSSC and shaken gently while being 
washed (4x30 minute washes). The dried filters were counted in a 
Packard Scintillation Counter with PPO-POPOP-Toluene scintillant.
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Agarose slab gel electrophoresis.
Trls-Acetate Running Buffer.
40 oM Tris, 20 nM sodium acetate, 2 mM EDTA, adjusted to pH 8.3 
with glacial acetic acid.
Sample Buffer.
0.5 x Running Buffer, 1Z SOS, 25Z glycerol, 2Z BPB.
Standardly 0.8Z agarose gels were poured Into a 15 cm x 20 
cm mould with slot former and used as soon as it had set. The 
gels were run submerged at 25 v overnight or until the marker dye 
had migrated two thirds of the way down the gel. Gels were 
stained In 50 pg/ml ethidlum bromide for 15 to 30 minutes, before 
being photographed under UV light. Gels that were to be Southern 
blotted were not stained or examined under UV light, Instead the 
marker tracks were cut away and these were stained whilst the 
rest of the gel was blotted.
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Transfer of DNA Fragments from Agarose Cels to Nitrocellulose 
Filters.
This was carried out using the procedure of Southern (1975); 
the agarose gels were soaked in 0.5 M NaOH, 1.5 M NaCl for 15 
minutes followed by 1 M Tris-HCl pH 5.0, 3 M NaCl for a further 
15 minutes. The treated gel was placed on dampened filter paper 
over a reservoir of 20xSSC with a nitrocellulose filter on top of 
the gel. Further dry filters and tissues were placed above this. 
The transfer was allowed to run for 24 hours before the filter 
was removed, washed in 2xSSC and baked at 80*C for 2 hours.
Separation of RNA Species using Sucrose Gradients.
Sucrose solutions (20Z and 5Z) and the RNA (at a maximum of 
100 ug per gradient) were in 50 mM Tris HC1 pH 7.5, 100 mM NaCl, 
0.5 mM EDTA. All solution used were OEPC treated and the sucrose 
was RNase-free grade. 12 ml linear 5-20 Z sucrose gradients were 
made and loaded with 100-200 pi RNA sample. These were 
centrifuged in a Beckman L8 centrifuge (SU40 rotor, 38,000 rpm, 
4*C, 4 hours) and fractionated into 0.4 ml fractions using a 
density gradient fractionator (1SCO, model 640).
-39-
DNA Extraction.
Extracted nuclei were taken up In 0.52 SDS, 12.5 oM EDTA and 
Incubated overnight with 50 mg/ml proteinase K. The resulting 
mixture was extracted with phenol-chloroform (1:1, equilibrated 
against 10 oM Tris-HCl pH 7.5, 1 oH EDTA ) until the Interface 
was clear, and twice with chloroform-isoamylalcohol (24:1). The 
aqueous phase was made 0.2 M sodium acetate and precipitated with
2.5 volumes of ethanol.
The precipitate was redlssolved In O.lxSSC, made 0.3 M 
sodium acetate and Incubated for 60 minutes at 37*C with 100 
pg/ml RNase A and 1,000 units T1 RNase. This was extracted with 
phenol-chloroform twice and chloroform-lsoamylalcohol once before 
being precipitated with 2.5 volumes of ethanol.
The DNA was redlssolved In 10 mM Trls-HCl pH 8.5, 1 sH EDTA 
and dialysed against this buffer for 24 hours, before being 
reprecipitated, redlssolved In water or the dialysis buffer and 
the concentration calculated. The DNA was stored at 4*C for 
Immediate use or as an ethanol precipitate at -20*C.
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DNase I Digestion.
RSB.
0.01 M Trls-HCl pH 7.4, 0.01 M NaCl, 3 nM MgC^.
Proteinase Buffer.
10 mM GDTA, 0.1Z SDS.
DNase I Stopping Solution.
6.7Z SDS, 167 mM EDTA
The method of Welntraub and Groudlne (1976) was used. 
Erythrocyte nuclei were gently centrifuged out of the 
prelncubatlon mix, or If this step had not been carried out, from 
RB, and taken up In RSB such that the final concentration was 1 
mg/ml DNA (1.67xlC? nuclel/ml). DNase I at 1 mg/ml was added to a 
final concentration of 20 pg/ml and the nuclei Incubated at 37*C 
for S minutes when S-10Z of the DNA had been released. The nuclei 
were gently spun out of the digestion buffer and resuspended In 
twice the volume of proteinase buffer. Proteinase K was added and 
the DNA extracted as outlined above.
In order to Investigate whether there were any sites of high 
DNase I sensitivity (Wu ¿t al, 1979a) present, the nuclei 
were DNased for a shorter time and the reaction was stopped by 
making the reaction 12.5 mM EDTA; 0.5Z SDS with the stopping 
solution. The DNA was extracted In the normal way.
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DNA-DNA Hybridization Conditions.
Hybridization buffer.
SOZ Formamlde pH 7.0, 3xSSC, 0.2Z BSA, Ficoll, PVP, 0.25 
mg/ml non-competing yeast RNA.
1. Dot Blots.
Nitrocellulose filters loaded with DNA were dampened with 
the hybridization buffer and placed in the bottom of a 
scintillation vial Insert or bijou. Hybridization buffer was 
added (a final volume of 100 pi buffer + probe per two duplicate 
filters) and the denatured nicktranslated DNA probe in O.lxSSC. 
The vials were capped and hybridized at 37*C for 24 hours. The 
filters were washed after the hybridization in three washes (30 
minutes each) of 2xSSC at room temperature.
2. Southern Blots.
The same basic method as that described above was used, but 
scaled up such that 5 ml buffer + probe was used for each filter. 
These were hybridized within a sealed plastic bag for 24 hours 
before being washed as above.
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Nlcktranalatlon of DNA
Nicktranalatlon Buffer.
50 an Tris-HCl pH 7.9, 10 nM MgCly 10 nM DTT, 50 mg/ml BSA.
For every y paoles hot dNTP 2y pmoles cold dNTPs were used, 
usually 50 pCi labelled dNTP was used, either 3H-dCTP (18-25 
Ci/mnol) or3^ P-dCTP (2000-3000 Cl/nusol). These were frozen in 
liquid nitrogen and desiccated Immediately before being taken up 
In nicktranslation buffer. DNA (from 100 ng to 1 pg per reaction) 
at a final concentration of 1 pg/100 ul and DNase I were added 
such that for every pg DNA 100 pg DNase I was used, and Incubated 
for 15 minutes at 37*C. 5 units Kornberg polymerase I were added 
and the reaction Incubated for 3 hours at 15*0. Carrier DNA was 
added to the reaction which was phenol extracted and desalted by 
running through a Sephadex G75 column. The fractions were counted 
and the first peak precipitated. The resulting probe was 
redissolved in O.lxSSC, and denatured by boiling and rapid 
cooling before being added to the hybridizations.
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CHAPTER III; TRANSCRIPTION IN ERYTHROCYTE NUCLEI AND THE EFFECT 
OF CELLULAR EXTRACTS.
A faithful transcription system consists of the template, 
enzyme, triphosphates and also the salts necessary to obtain 
optimal Incorporation of the triphosphates into the RNA product. 
A variety of templates have been used, extending from recombinant 
and total nuclear DNA to chromatin and intact nuclei. These have 
been transcribed by a range of added enzyme preparations; 
purified and semipurlfied RNA polymerases from the same source as 
the template or from E.coll, cellular extracts and the 
endogenous RNA polymerases that are in the nuclei or chromatin 
being assayed. Optimal activity is measured not only by overall 
incorporation of radioactivity, but also by assessing the amount 
of faithful transcription.
Whole nuclei have been used to study a number of genes, such 
as those encoding the Drosophila heat shock protein genes 
(Miller and Elgin, 1981) and mouse immunoglobulin kappa light 
chain genes (Smith and Huang, 1976). In several cases pure, 
cloned genes have been used as templates eg Xenopus 5S rRNA 
(Engelke et al, 1980), mouse rRNA (Grummt, 1981) and chicken 
conalbumin and ovalbumin (Wasylyk et al, 1980). Most of these 
types of assay system utilize homologous RNA polymerases, but 
whilst some success has been claimed using chromatin plus 
E.coll RNA polymerase to synthesize rabbit globln mRNA 
(Wilson et al, 1975), other workers (Zasloff and Felsenfeld, 
1977; Maryanka et al, 1979) have been unable to produce avian 
globln mRNA using the same sort of system.
While it is clearly Important to have an homologous template
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and RNA polymerases, it is also Important to have the correct 
salt concentrations to give the optimal transcription conditions. 
Most transcription systems have monovalent cations (either K* or 
Nl£) at a fairly high concentration (50-150 mM). These correspond 
to an extent on the normal isotonic environment of the nucleus In
the cell, for example In Amphibia It Is 110 nM. The necessary
2* 2*divalent cations (Mg and/or Mn ) are present at much lower 
concentrations (0-10 mM), (Marzluff ^t a_l, 1973; Crampton and 
Woodland, 1979a; Thomas e£ al, 1980; Miller and Elgin, 
1981).The activity of all three of the RNA polymerases found In 
Xenopus laevls depend on the concentration of magnesium or
manganese ions, and all have slightly differing salt optima
(Roeder, 1974a). Whilst all will function with 1-2 mM Mn? , RNA
polymerases II and III require less Mg^* (4 mM and 2 mM
respectively) than RNA polymerase I (6 mM). Some systems (Miller 
and Elgin, 1981) function without manganese and contain only 
magnesium as the divalent cation. Others (Crampton and Woodland, 
1979a) will function entirely on manganese.
There is also a balance to be maintained between a high 
radioactive Incorporation, and a reasonable absolute level of 
synthesis for initiation and elongation by the RNA polymerases. 
This will depend on various factors, such as the actual activity 
of the RNA polymerases on the particular template.
Preparation of Erythrocyte Nuclei.
The blood collected from one adult female Xenopus laevls 
(5-7 ml/animal) was diluted into calcium-magnesium free modified 
Barth's medium and washed free of contaminating white blood cells 
by gentle centrifugation and resuspension in the buffer at 4*C.

FIGURE 3.1
Nuclear Ly8is During Incubation.
Erythrocyte nuclei were Incubated In a standard Incubation 
mix at 10^ nuclel/125 pi. At times during the Incubation S pi 
samples were removed, diluted Into 20 pi 0.5 x Rb and counted In 
a haemocytometer.
TABLE 3.1
Transcriptional Activity of Stored Erythrocyte Nuclei.
Age of nuclei pmoles UMP incorp.
/10^nuclei/30 minutes
0 days 5.41
2 days 5.63
2 weeks 5.27
1 month 5.49
3 months 5.50
b months 5.39
Nuclei, at various times after preparation, vere assayed in 
a standard 50 pi transcription assay. Duplicate 10 pi samples
were taken at 0 and 30 minutes of the incubation.
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The cleaned erythrocytes were lysed on Ice by adding H-buffer, 
which contains both calcium and magnesium as well as 0.1Z Triton 
X100, followed by homogenization in a loose fitting Dounce 
homogenizer. The nuclear suspension, checked for 100Z lysis by 
phase microscopy, was made up to 1 M sucrose, layered over a 2 M 
sucrose pad and centrifuged at 4000g for one hour. This gives a 
soft clean pellet of nuclei. These were resuspended in RB and 
stored at -70*C for up to 6 months without significant loss in 
activity [TABLE 3.1].
As compared with other methods (eg Hllder and Maclean, 
1974), where nuclei are repeatedly spun for a short time at high 
speed to remove any contaminating cytoplasm, this method 
(modified from that of Marzluff e£ al, 1973 and Crampton and 
Woodland, 1979a) has the advantage that the nuclei are only spun 
and resuspended once, so minimising any loss of transcriptional 
activity. The nuclei are rendered free from cytoplasmic 
contamination by passage through the sucrose pad. Nuclei isolated 
using Triton X100 tended to clump, so all incubates were gently 
agitated during the assay to prevent this clumping and to ensure 
even distribution of the assay components. Loss by nuclear lysis 
was indétectable under these conditions, even after 2 hours of 
incubation [FIG 3.1].
Salt Optima for Erythrocyte Nuclear Transcription.
As a starting point, the conditions of Marzluff e_t al 
(1973) ware used, but with a lower UTP concentration (0.02 aM, 
instead of 0.05 m  UTP; in addition 4 jiC13H-UTP, at 10-30 
Ci/amole, were present in 100 pi assays). It was decided to 
optmize the nuclei for maximal incorporation of3H-UTP into TCA
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FIGURE 3.2
Salt Optima.
Throughout this series of assays the concentrations of ATPt 
GTP, and CTP were kept constant at 0.4 mM. The concentration of 
cold UTP was 0.02 mM with 2 uCi3H-UTP/50 pi assay.
3.2A; KC1 Optima. A series of 50 pi assays, containing
5xl0^nuclei in 0.5 x Rb with 2.5 mM MgCl and 1 mM 
MnCl, were set up with a range of KC1 concentrations 
between 0 and 420 mM. These were incubated at 25°C. 
Duplicate 10 pi samples were taken at 0 and 30
minutes.
3.2B; MnCl Optima. A series of 50 pi assays, containing 
5x105nuclei in 0.5xRb with 2.5 mM MgCl and 120 mM 
KC1, were set up with a range of MnCl concentrations 
between 0 and 10 mM. These were incubated at 25*C. 
Duplicate 10 pi samples were taken at 0 and 30
minutes.
3.2C; MgCl Optima.A series of 50 pi assays, containing 
5xl05nuclei in MgCl free 0.5xRB, 120 mM KC1 and 1 mM 
MnCl, were set up with a range of MgCl 
concentrations between 0 and 15 mM. These were 
incubated at 25®C. Duplicate 10 pi samples were 
taken at 0 and 30 minutes.
FIGURE 3.3
Specific Activity of3H-UTP In the Transcription Assay.
A series of 30 pi assays were set up (5x10^ nuclei, 0.5xRB, 
120 rt KC1, 1 mM MnCl, 0.4 mM ATP, CTP, GTP, and 2 pCl3H-UTP) 
with varying amounts of cold UTP from 0 to 0.4 mM. Duplicate 10 
pi samples were taken at 0 and 30 minutes.
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FIGURE 3.4
Triphosphate Optimum.
A series of standard 30 pi assays were set up but without 
ATP, CTP and GTP. These were added In varying concentrations 
between 0 and 0.4 mM. Duplicate 10 pi samples were taken at 0 and 
30 minutes.
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preclpltable counts without added cell extracts. All incubations 
were carried out at 25*C.
To determine which concentration of KC1 gave maximum 
Incorporation of^H-UTP into TCA insoluble material, the Mn^and 
concentrations were kept constant at 1.0 nM and 2.S nM 
respectively whilst the ^concentration was varied from 0 nM to 
420 mM. Figure 3.2A shows that the amount of incorporated was 
maximal at 120 mM KC1. This value was used in all subsequent 
assays. The optimum concentration of MnCl is 1 nM [FIG 3.2B], and 
that of Mg was demonstrated to be 2.5 nM [FIG 3.2C].
The optimal levels of radioactive and non-radioactlve 
nucleotide triphosphate concentrations were also determined. 
Firstly the amount of non-radioactive UTP was varied. The other 
three triphosphates were kept at 0.4 mM and the^H-UTP label at 2 
pCl/50 jil assay. Secondly, the concentration of ATP, CTP and GTP 
was varied while both cold and labelled UTP were kept constant.
At very low concentrations of cold UTP (less than 0.005 mM) 
although the radioactivity incorporated is high, the actual 
number of pmoles of IMP incorporated into RNA is very low [FIG 
3.3]. At the other extreme, 0.4 mM cold UTP, the opposite is 
true, and the resulting transcription by the erythrocyte nuclei 
cannot be accurately measured. A concentration of 0.02 oM was 
finally used in subsequent assays. Although this does not give 
maximum elongation and initiation by the RNA polymerase 
molecules, or the largest amount of radioactivity incorporated, 
it la a balance between the two. Figure 3.4 shows that there is 
no pool of triphosphates in the erythrocyte nuclei - adding no 
ATP, CTP and GTP results in no incorporation of label. After 0.3
FIGURE 3.5
Test for Degradation of RNA Product of Transcription by 
Erythrocyte Nuclei.
Two duplicate 200 ul assays (2xl0^nuclei) were Incubated at 
25*0. At Intervals two 10 pi samples were taken to determine the 
pmoles UMP incorporated/lO^nuclel at that time point. One assay
(o-- o) was left unchanged throughout the 90 minute Incubation,
The other (-<---+) had unlabelled UTP added after 30 minutes to a
final concentration of 0.5 mM
FIGURE 3.6
Number of Erythrocyte Nuclei In the Transcription Assay.
The number of erythrocyte nuclei in a standard 50 pi 
transcription assay was varied from 0 to 15x10*. Duplicate 10 pi 
samples were taken at 0 and 30 minutes.
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nM XTP, no further Increase In Incorporation Is seen, this agrees 
well with the UTP concentration curve [FIG 3.3]. Therefore a 
concentration of 0.4 nM was used for the unlabelled 
triphosphates.
RNA Polymerase Activity In Erythrocyte Nuclei.
If the transcription by erythrocyte nuclei In the system 
described above Is followed over 90 minutes [FIG 3.5], It can be 
seen that the Incorporation of UMP Into acid-insoluble material 
is linear for 30 minutes. After this time the reaction slows and 
gradually plateaus off, such that the maximal amount of IMP 
incorporated Is about 5.5 pmoles; that Is one erythrocyte nucleus 
synthesizes about 0.006 pg RNA In 30 minutes. The level of 
synthesis can therefore be calculated as 0.1 X of the DNA content.
If cold UTP Is added to a final concentration of 0.5 mM - an 
amount sufficient to arrest detectable incorporation- at 60 
minutes of the incubation, no decrease In the amount of ^H-UTP 
incorporated can be detected, as would have been the case If 
RNase had been present [FIG 3.5].
That the transcription observed is dependent upon the 
numbers of nuclei present In the assay is shown in Figure 3.6. 
The correspondence between nuclear numbers and the amount of 
^H-UTP Incorporated is linear up to 7.5xl0^nuclei/50 pi assay. At 
this value, the graph plateaus off. Also, at higher 
concentrations of nuclei, they become more likely to clump and 
perhaps for this reason the distribution of the assay components 
Is more uneven, causing the levelling off. An assay with no 
nuclei present Incorporates no radioactive precursor. In a
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FIGURE 3.7
Inhibition of Transcription in Erythrocyte Nuclei by 
oramanltln.
A series of 50 pi standard transclptlon assays were set up 
with Increasing amounts of the Inhibitor oramanitin. Duplicate 10 
pi samples were taken at 0 and 30 minutes and Incorporation was 
expressed as TCA-lnsoluble cpm/lC^ nuclei.
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FIGURE 3.8
Relative Levels of RNA Polymerases I, II, and lit In Erythrocyte 
Nuclei.
To duplicate 50 pi transcription assays was added
oc-amanitln, at either 1 or 100 pg/ml. Assays with no ocamanltln 
were also carried out. 10 pi samples were taken at 0 and 30 
minutes and the pmoles UMP lncorporated/10^ nuclei calculated for
each oramanltin concentration. This was expressed as the amount 
of transcription due to each of the three RNA poljmerases.
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standard assay of SO pi there were 5 * 1CT nuclei present (10 
nuclei/ml), which are enough to give a readily measurable 
incorporation without problems of clumping.
In order to investigate the relative activities of the three 
RNA polymerases in the erythrocyte nuclei, use was made of the 
inhibitor oramanitln (Jacob et al, 1970). At low 
concentrations (1 pg/ml) c*-amanitin specifically inhibits RNA 
polymerase II, which synthesizes hnRNA and mRNA. At higher 
concentrations (100 pg/ml) RNA polymerase III, responsible for SS 
and tRNA synthesis, is inhibited. The synthesis of rRNA by RNA 
polymerase I is not inhibited by or-amanitln. If the concentration 
of aramanitin is increased in the nuclear assay [FIG 3.7] it can 
be seen that the low concentrations of oramanltln (0.1-20 pg/ml) 
decrease the transcriptional activity to very low levels. On 
increasing the concentration further (above 30 pg/ml) all 
detectable transcription is inhibited. Thus, the relative 
activities of the three RNA polymerases can be calculated [FIG 
3.8].
Almost all the transcriptional activity seen is due to RNA 
polymerase II activity (86Z). There is some RNA polymerase III 
activity (14Z), but no ocamanitin resistant RNA polymerase I 
activity is detectable. These values agree well with the data of 
Hentschell and Tata (1978) who showed that the RNA polymerase 
activity seen in mature erythrocyte nuclei is due to the 
persisting, template-bound, inactive RNA polymerase II molecules, 
although they found a low level (3Z) of 1 pg/ml or-amanltin 
resistant RNA polymerase activity.
During the development of the mature erythrocyte from the
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basophilic erythroblast, at each successive division the cell 
volume gets progressively larger whilst the nucleus becomes more 
condensed. By the time the erythrocyte Is mature Its 
nucleus/cytoplasm ratio has dropped from 0.8 for the basophilic 
erythroblast to 0.35 (Thomas and Maclean, 1975). Whilst this Is 
taking place there Is a gradual cessation of RNA synthesis. Cells 
early in erythropoeisls are transcriptionally active, but as they 
undergo differentiation to the mature form, RNA polymerase I and 
then RNA polymerase 111 activity is lost (Hentschell and Tata, 
1978). This is due to these enzyme molecules being lost from the 
cell. In the mature erythrocyte there Is still some 
transcription, but this is due to the remaining RNA polymerase II 
molecules. These are locked onto the chromatin and the activity 
seen represents a slow elongation of the final transcript.
In avian erythrocytes, which undergo a similar development 
to that found In Xenopus (Williams, 1972), it has been found 
that RNA polymerase II molecules are tightly bound to the 5' ends 
of the globin genes (Gariglio ejt al, 1981). It would seem 
likely therefore, that the RNA polymerase II molecules in 
Xenopus erythrocytes are also to be found in similar 
transcriptional complexes on the globin genes. Thus the 
erythrocyte nuclei prepared and assayed by the methods discussed 
above would appear to conform to previously published data on 
erythrocyte transcription (Hentschell and Tata, 1978). Most of 
the synthesis seen Is RNA polymerase II activity, whilst the 
remainder, calculated from a figure not much above background, is 
due to RNA polymerase III transcription. This could be because of 
some late erythrochromatlc erythroblasts are present In the blood 
sample; the lack of any RNA polymerase I activity would argue
against any contamination by very early stage erythroblasts or
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white blood cells.
Effect of Oocyte and Egg Extracts on Erythrocyte Transcription.
As previously discussed, the transition from oocyte to egg 
brings about an abrupt reduction in transcriptional activity. The 
high level seen during oogenesis falls and no measurable rRNA 
synthesis is seen until the mid to late blastula stage of 
development (Shlokawa et al, 1981a, b). Considering a single
gene or gene fatally, the transition between the different 
activity states could be seen slmpllstlcally as resulting from an 
Inhibitor in the egg which is later inactivated or diluted out by 
the subsequent cell divisions of the developing embryo. 
Alternatively, there might be an activator in the oocyte which is 
lost or chemically modified in some way during the egg stage and 
reappears in the later stages of early development. The existence 
of a definite activating molecule has been shown in the case of 
the oogenetic 5S genes of Xenopus (Birkenmeier et al, 1978; 
Ng ££ *1» 1979; Engelke et al, 1980; Honda and Boeder,
1980). This activator is present in oocytes, but is absent from 
extracts of unfertilized eggs. While these experiments made use 
of naked recombinant DNA, the erythrocyte provides a good source 
of equally non-transcribing genes, but in their native chromatin 
form. This template will detect not only activating molecules 
which bind to the DNA Itself, as in the case of the 5S genes, but 
also those which Interact with the chromatin. However, although 
the transcriptionally Inactive erythrocyte nucleus is a 
potentially good tool for the study of activating molecules, the 
fact that it is so inactive means that it is not useful to detect
any inhibitors of transcription
FIGURE 3.9
Effect of Oocyte and Egg Extracts on Transcription by 
Erythrocyte Nuclei.
To 2xl06 nuclei was added 37.5 pi of an oocyte extract
(•-- •), an egg extract (■»--- +), the extracts contained 30 mg
proteln/ml. As a control the nuclei were Incubated with 30 mg/ml
BSA In column buffer (o-- o). Salts and triphosphates were added
to give the normal concentrations In a final volume of 200 yil. 
Duplicate 10 jil samples were taken from each vial at Intervals 
throughout the 120 minute Incubation.
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Extracts of both oocytes and dejellled eggs were prepared by 
homogenization followed by centrifugation to remove pigment, yolk 
and lipid from the soluble protein extract. The protein content 
was determined by the method of Lowry et al (1951) and 
adjusted to 30 mg/ml. This represents under normal assay 
conditions 600 pg extract protein/ 50 pi assay or 1.2 ng extract 
protein/ nucleus. In the case of nuclei treated with an oocyte 
extract, the soluble protein from 10 oocytes was Incubated with 
106 nuclei.
If an oocyte or egg extract Is added to erythrocyte nuclei 
and the incorporation of ^H-UTP into acld-lnsoluble material 
followed [FIG 3.9], It Is found that both extracts Increase the 
synthesis of ^H-RNA as compared with nuclei that have been 
incubated with the same amount of protein In the form of BSA, but 
the oocyte extract Increases It to a more marked degree. The 
addition of the egg extract Increases the Initial rate of 
synthesis by about 1.5 times, but the nuclei plateau at about the 
same time, albeit at a higher level, than the BSA-treated nuclei. 
The incubation of nuclei with an oocyte extract not only causes 
the Initial rate to Increase, but also delays the plateau by at 
least 60 minutes. Thus, the addition of an egg extract gives a
1.7 fold stimulation and that of an oocyte extract a 4.8 fold 
stimulation after 30 minutes of Incubation. These values are the 
mean results of several experiments, which showed little 
variation.
In order to Increase the amount of transcription, the nuclei 
war« preincubated at 25*C with low levels of all four 
triphosphates plus the relevant extract for one hour, before 
being gently spun down and resuspended In the standard assay
TABLE 3.2
Effect on Transcription In Erythrocyte Nuclei of Preincubation 
with Protein Extracts.
Nuclei preincubated pmoles UMP incorp. Stimulation
with; /l(f nuclei/30 minutes
buffer 5.49 1
egg extract 11.5 2.1
oocyte extract 33.1 6.3
5x10^ erythrocyte nuclei were preincubated with 20 ul of 
protein extract in a 50 pi volume at 25 C for 60 minutes. At the 
end of this time, the nuclei were gently spun out of the 
preincubation media and taken up in a standard 50 pi incubation 
mix. Duplicate 10 pi samples were taken at 0 and 30 minutes of 
the subsequent incubation.
FIGURE 3.10
Optimal Concentration of KC1 During Prelncubatlon.
A series of 50 pi assays (5x10^ nuclei, 20 pi protein
extract) were set up with either column buffer (o-- o), egg
extract (+-— +) or oocyte extract (e--•) present, and with
increasing amounts of KC1 from 0 to 120 mM. These were 
preincubated for 60 minutes, after which time the conditions were 
adjusted to those of an incubation assay, that is the KC1 
concentration was brought to 120 mM in all cases. 10 pi samples 
were taken at 0 and 30 minutes of the incubation.
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FIGURE 3.11 
Prelncubatlon Time.
5.1<? nuclei In SO pi volume were preincubated for increasing
lengths of time with either 20 pi of column buffer (o-- o) or
oocyte extract (•---a). The nuclei at the end of each
prelncubatlon were spun out and resuspended in SO pi of 
incubation mix. Samples (2x10 pi) vere taken at 0 and 30 minutes 
of the subsequent incubation.
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buffer containing^H-UTP, and assayed in the normal way. This 
slightly increases the ratio of extract to nuclei. By 
preincubating the nuclei in this way, the effect of the egg 
extract on the nuclei [TABLE 3.2] is increased slightly from a
1.7 fold stimulation to 2.1 fold. That of oocyte extract is also 
increased to 5.2 fold from 4.8 fold.
Thus whatever agent causes the Increases in transcription, 
must either associate with the nuclei during the prelncubatlon 
step, and remain with them during centrifugation and 
resuspension, or its effect must be exerted during preincubation 
in a stable way. To see if this prelncubatlon effect by the 
nuclei could be increased by altering the ionic strengths during 
the preincubation, the KC1 concentration was varied during the 
first stage and brought back to 120mM for the incubation stage. 
Figure 3.10 shows that at 50nM KC1 during the preincubation there 
is a marked increase in activity in oocyte-treated nuclei, such 
that a stimulation of 6.0 fold is observed over the control 
nuclei. This KC1 concentration during the preincubation has no 
detrimental effect on incorporation by the control or egg-treated 
nuclei, ie this Increase in stimulation is because the
oocyte-treated nuclei Incorporate more^H-UTP into 
TCA-preclpltable material, and not because control nuclei 
synthesize less^H-RNA.
The standard preincubation time of 60 minutes is the one 
that gives the best Increase in stimulation by the oocyte 
extract. A very ahort, 15 minute, prelncubatlon with oocyte 
extract will atill give a slight Increase in incorporation of 
^H-UTP [FIG 3.11], but with a 90 minute prelncubatlon the 
stimulation Is no longer increasing. Further the risk of
TABLE 3.3
Effect on Erythrocyte Nuclear Transcription of Preincubation
with Protein Extracts.
Nuclei preincubated pmoles UMP incorp. Stimulation
with; /10^nuclei/30 minutes
buffer 5.61 1
egg extract 11.8 2.1
oocyte extract 34.2 6.1
5x10^ nuclei were Incubated with 20 pi of protein extract in 
a 50 pi volume for 60 minutes. After this time, they were 
supplemented with salts etc to give standard incubation 
conditions. Duplicate 10 pi samples were taken at 0 and 30 
minutes of the incubation period.
TABLE 3.4
Effect of an Extract of Defolllculated Oocytes on Transcription 
by Erythrocyte Nuclei.
Nuclei preincubated pmoles UMP lncorp. Stimulation
with; /10^nuclei/30 minutes
buffer 5.61 1
egg extract 11.8 2.1
total ovary extract 34.2 6.1
separated oocyte extract 36.1 6.4
A protein extract was prepared in the standard way from 
separated and defolliculated oocytes and adjusted to 30 mg 
protein/ml. 20 jil of this extract was preincubated with 5x10^ 
nuclei in a 50 pi volume. After 60 minutes the salt
concentrations etc were raised to those of an incubation assay. 
10 pi samples were taken at 0 and 30 minutes of the following 
incubation. As controls, nuclei were preincubated in the same way 
with buffer, egg extract and the normal oocyte extract (»whole 
ovary extract).
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bacterial contamination increases with time, so a preincubation 
time of 60 minutes followed by an incubation of 30 minutes was 
standardly used. Nuclei remain transcriptionally active during an 
incubation of this time [FIG 3.9].
The method of spinning and resuspending the nuclei between 
the preincubation and Incubation steps does have the disadvantage 
of being cumbersome when more than 12 assays are being performed. 
In these cases, therefore, the preincubated nuclei were 
supplemented with salts, triphosphates etc to bring the 
concentrations up to those of the standard assay buffer. This 
variation yields the same Increase in Incorporation as seen with 
the spun and resuspended nuclei [TABLE 3.3].
Table 3.4 shows that if the oocyte extract is made from 
separated and defolliculated vitellogenic oocytes and not from 
the usual whole ovary preparation, only a slight increase is seen 
in Incorporation over that produced by the standard preparation. 
It would seem likely therefore, that whatever is causing this 
increase in incorporation is present in the oocytes themselves 
and not in the surrounding follicle cells, other non-oocyte 
ovarian tissue or in small, rather than vitellogenic oocytes. The 
slightly higher stimulation is presumably because more of this 
oocyte component is present per mg protein in the separated 
oocyte preparation.
Actinomycin D is a potent Inhibitor of RNA polymerases. At a 
concentration of 100 pg/ml it will inhibit all three of the RNA 
polymerases (Wldnell and Tata, 1966). It acts not by binding to 
the RNA polymerase molecule Itself, as oe-amanitln does (Jacob
TABLE 3.5
Inhibition of Transcription by Actlnomycln D.
pmoles I'MP incorporated/10^nuclei/30 mins. 
- Actlnomycln D + Actinomycin D
buffer 5.3 0.02
egg extract 10.7 0.01
oocyte extract 31.7 0.00
Nuclei «ere preincubated with the relevant protein extract 
and vdth or without 100 fjg/ml Actinomycin D. After 60 minutes the 
nuclei vere spun out and taken up in a standard incubation mix, 
with Actinomycin D valere appropriate. 10 jil samples «ere taken 
for processing at 0 and 30 minutes of the incubation.
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e£ «1, 1970), but by binding to the DNA (Uldnell and Tata, 
1966). It Is therefore possible to distinguish between 
transcription using a DNA template and that using endogenous RNA 
as template. The latter event has been reported for several In 
vitro transcription systems (Zasloff and Felsenfeld, 1977; 
Maryanka et al, 1979). These, however, were using E.coll 
RNA polymerase for transcription, rather than an homologous or 
endogenous enzyme and template. As Table 3.5 shows, Actlnomycln D 
at 100 pg/ml results In total Inhibition of transcription by 
erythrocyte nuclei, either assayed on their own, or with egg or 
oocyte extracts.
Therefore, the Incorporation of ^H-UTP seen Is not due to 
transcription from a RNA template but Is due to DNA-dependent RNA 
polymerase activity. Neither Is the increase In Incorporation 
seen In oocyte-treated nuclei merely the sticking of^H-UTP to the 
filter by the extra protein, since this Incorporation Is 
sensitive to Actlnomycln D.
RNA Polymerase Levels In Erythrocyte Nuclei Treated with Egg and 
Oocyte Extracts.
Although these basic mixing experiments demonstrate that a 
crude oocyte extract brings about an Increase In Incorporation of 
%-UTP Into acid-insoluble material, they do not give any insight 
into the relative activities of the three RNA polymerases. For 
this the specific Inhibitor cvamanitln has to be used to 
differentiate between two possibilities. Either the endogenous 
RNA polymerase II of the erythrocyte nuclei Is elongating 6 fold 
faster as a result of some component in the oocyte extract, or 
the other RNA polymerases In the extracts have Initiated and
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FIGURE 3.12
Relative Levels of the Three RNA Pol>merases la Extract-Treated 
Erythrocyte Nuclei.
Erythrocyte nuclei were preincubated (5x10^nuclei In 5U pi 
assay) with buffer, egg extract or oocyte extract and with 
cramanitln at 0, 1 or 100 pg/ml. These assays were supplemented 
after 60 minutes to Incubation concentrations and Incubated for a 
further 30 minutes. Duplicate 10 pi samples were taken at 0 and 
30 minutes of this incubation.
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started to transcribe fro« the erythrocyte chromatin, those in 
the oocyte extract doing so more than those in the egg extract.
The levels of all three RNA polymerases in nuclei treated 
with both oocyte and egg extracts were determined using 
or-amanitin and compared to the levels found in untreated nuclei 
[FIG 3.12]. As can be seen, preincubation with an egg extract 
results in an increase in both RNA polymerase II and III activity 
(to 7.15 and 3.59 pmoles UMP incorporated/^ nuclel/30 minutes 
respectively) There is also some ar-amanitln insensitive RNA 
polymerase 1 activity detectable (0.26 pmoles UMP lncorporated/10^ 
nuclel/30 minutes), but this is at a level barely above 
background. If, on the other hand, the nuclei are preincubated 
with an oocyte extract, then all three RNA polymerases show 
Increased activity. In the case of RNA polymerase II it is to the 
same level as is shown by egg-treated nuclei, whilst RNA 
polymerase III shows an increase in activity (to 9.01 pmoles UMP 
incorporated/10^ nuclei /30 minutes) above that given by 
egg-treated nuclei. However, these Increases in the activities of 
RNA polymerases II and III do not account for more than 49.9 Z of 
the transcription in oocyte-treated nuclei, the remaining 50.1Z 
is due to RNA polymerase I activity. Since there is no detectable 
RNA polymerase I activity in the erythrocyte nuclei when assayed 
alone, it is reasonable to assume that the RNA polymerase I 
molecules came from the oocyte extract and that the transcription 
seen is as a result of the initiation of new RNA chains on the 
erythrocyte chromatin. That this is so can be shown in two ways. 
Firstly by using an inhibitor of RNA polymerase initiation it 
should be possible to inhibit all RNA polymerase I activity in 
the oocyte-treated nuclei; secondly by demonstrating that there 
are Indeed no RNA polymerase I molecules present in the
no Rifamycin plus Rifamycin
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FIGURE. 3.13
Inhibition of Transcription by Erythrocyte Nuclei by Rifampin
with 20 pi of column buffer or oocyte extract,with and without 50 
pg/ml Rifamjcin AF/01J, and 0, 1 or 100 pg/ml oramanltln. The 
assays were supplemented to produce the standard Incubation 
conditions after 60 minutes preincubation and duplicate 10 pi 
samples taken at 0 and 30 minutes of the following incubation.
Nuclei ♦ buffer oocyte buffer oocyte
Af/013.
Erythrocyte nuclei (2xl0^nuclel In 50 pi) were preincubated
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erythrocyte nuclei. These latter would have to be bound very 
tightly to the chromatin, so that under normal assay conditions 
no elongation occurs. Some component of the oocyte extract would 
therefore have to weaken this binding to allow transcription to 
proceed.
Whilst the Rlfamycln Is a potent Inhibitor of bacterial RNA 
polymerase (Hartmann £t al, 1967), It has no effect on 
eukaryotic RNA polymerases (Jacob et al, 1968). However, 
several of Its synthetic derivatives do inhibit these enzymes. In 
particular, the Rlfamycln SV derivative AF/013 has been shown 
(Meilhac et al, 1972) to Inhibit RNA polymerases I and II at 
initiation, whilst not Inhibiting already initiated and 
elongating RNA polymerase molecules. If this Inhibitor Is added 
to erythrocyte nuclei with or without oocyte extract [FIG 3.13] 
it can be seen that RNA polymerase II activity Is not altered 
either in untreated or oocyte-treated nuclei. RNA polymerase I 
activity, on the other hand, is completely inhibited in 
oocyte-treated nuclei. This again shows that the RNA polymerase 
II activity seen in erythrocyte nuclei is due to elongation of a 
preinitiated nascent RNA molecule. The stimulation in RNA 
polymerase II seen on the addition of an oocyte or egg extract is 
due to an increase in the rate of elongation of the final RNA 
transcript and not reinitiation or new initiation by the RNA 
polymerase II molecules from the protein extracts. About 48Z of 
the RNA polymerase III transcription seen in oocyte- treated 
nuclei is due to previously initiated molecules, which show an 
increased rate of elongation, whilst the remainder is due to 
newly initiated molecules. The RNA polymerase I activity seen in 
oocyte-treated nuclei, however, is completely sensitive to 
Rlfaaycln AF/013 inhibition. This would indicate that it is due
80
FIGURE 3.14
Effect of Sarkosyl on Transcription by Erythrocyte Nuclei.
Three 150 pi transcription assays were set up (1. 5xl(?
nuclel/assay) with nuclei alone (o-- o), nuclei wltn IZ Sarkosyl
(i---+) or nuclei with 1Z Sarkosyl and 100 pg/ml oramanltln
(•-- •). Duplicate 10 ul samples were taken at Intervals
throughout the tlmecourse.
TABLE 3.6
Preincubation conditions pmoles UMP incorporated
Extract oramanitin /1U^  nuclei/30 mins.
- oramanitin + oramanitin
buffer none 5.7 0.00
egg none 11.3 0.23
oocyte none 35.1 17.6
oocyte 1 yig/ml 34.9 17.4
oocyte 100 pg/ml 36.3 18.2
oocyte none, no 27.2 13.7
added XTP
Erythrocyte nuclei were preincubated with protein extracts,
oramanitin and triphosphates as above, for 60 minutes. After this
time the nuclei were spun out and resuspended in a standard
Incubation mix with or without 100 yg/ml oramanitin to determine 
the RNA polymerase I activity. Samples were taken at 0 and 30 
minutes of the Incubation.
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excluslvely Co iniciación by RNA polymerase I molecules from Che 
oocyCe extract.
The anionic detergent, Sarkosyl, acCs Co remove nearly all 
Che chromadn-assoclaCed proCelns from DNA, excepC for iniClaCed 
RNA polymerases (Green £t al, 1975). Ics effecC is Co block 
new Iniciación, buC Co facillCaCe Che run off of pre-exisdng 
cranscrlpCion complexes. When 1Z Sarkosyl was added Co 
eryChrocyCe nuclei Chere was an Increase in cranscrlpdonal 
acdviCy [FIG 3.U] but Chis was all due Co run off by RNA 
polymerases II and III. Ic did noC resulc in any measurable RNA 
polymerase I activity. Thus it would seem that Che RNA polymerase 
acdvlCy in chese eryChrocyte nuclei is due Co already iniCiaCed 
RNA polymerase II and III molecules whose elongación is inhibited 
by Sarkosyl-sensiCive proteins, as described by Hentschell and 
Tata (1978). Further, there seem Co be no RNA polymerase I 
molecules. The removal of almost all of Che proteins associated 
with Che chromatin does not resulc in Che reacCivation of any 
silent population of RNA polymerase I molecules.
By preincubating che nuclei with an oocyCe extract plus a 
high (100 pg/ml) or a low (1 yg/ml) level of ot-amanitln it is 
possible Co determine whether Che RNA polymerase I activity is 
dependent on either RNA polymerase II and/or RNA polymerase III 
molecules being acCive during che preincubation stage. As Table
3.6 shows, neither RNA polymerase II nor RNA polymerase III 
activity during Che preincubation is necessary for subsequent RNA 
polymerase I activity during the assay. If on Che ocher hand, all 
of Che crlphosphaCes are left out of Che preincubation mix, buC 
added later, this does have a small effecC on Che Cranscrlpdonal 
activity of oocyte-created eryChrocyte nuclei. There is still a
-58-
stimulation observed over the%-UTP incorporated by untreated or 
egg-treated nuclei [TABLE 3.6], but this is slightly less than 
that seen in oocyte-treated nuclei preincubated with the 
triphosphates.
Thus the RNA polymerase I activity observed in 
oocyte-treated nuclei is not dependent on prior RNA polymerase II 
or III activity, neither is it totally dependent on added 
triphosphates during the low salt preincubation stage. This 
effect might be small because there is a triphosphate pool in the 
oocyte extract Itself. The likely explanation of the higher 
synthesis with added triphosphates is that they permit the 
loading of many RNA polymerase I molecules on to the activated 
ribosomal genes.
RNA Polymerase Levels in Oocyte and Egg Extracts.
It could be argued that the stimulation observed when 
erythrocyte nuclei are incubated with an oocyte extract is Just a 
reflection of the RNA polymerases present in the extract. An egg 
extract might give a lower stimulation because it contains no RNA 
polymerase I. Roeder (1974b) has shown that the levels of the 
three RNA polymerases remain constant not only during the change 
from oocyte to egg, but also during the early development of the 
embryo. It is only at embryonic stage 30-33 that the relative 
amounts alter. During this time, the actual transcription by the 
RNA polymerases on embryonic nuclei varies significantly, from a 
high level of transcriptional activity during oogenesis, to no 
transcription at all in the unfertilized egg and early cleavage 
embryo. Non-rRNA synthesis has been detected as early as the 
blastula stage (Newport and Klrschner, 1982a), whilst the first
FIGURE 3.15
RNA Polymerase Activity In an Oocyte Extract.
12.5 pi of oocyte extract was incubated in a 50 pi assay 
under the same conditions as a nuclear transcription assay, but 
instead of nuclei, the template was increasing amounts of
polyl d( A-T) J (o-- o) or purified X.laevis DNA O --- +).
Duplicate 10 fil samples were taken at 0 and 30 minutes of the
assay.
TABLE 3.7
RNA Polymerase Levels in Oocyte and Egg Extracts.
Extract Template pmoles UMP incorporated
/100 pi assay/30 mins.
buffer norte 0.00
egg none 0.00
oocyte none 0.00
egg 4 pg poly(d(A-T)J| 120.0
oocyte 4 pg polyld(A-T)j| 167.7
The extracts were incubated in a standard incubation mix, 
but without nuclei, 4 pg polytd(A-T)]/100 pi assay was added as 
required. Duplicate 10 pi samples were taken at 0 and 30 minutes
of the incubation period.
RNA Polymerase; I II  HI I I I  I I I
Oocyte Egg
FIGURE 3.1b
RNA Polymerase Levels In Oocyte and Egg Extracts.
50 pi transcription assays were set up containing 
polyt d(A-T)], 20 pi oocyte or egg extract and 0, 1 or 100
ocamanltln. These were incubated for 30 minutes, samples 
pi) being taken at the beginning and end of this period.
2 pg 
pg/ml
(2x10
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rRNA synthesis has been noted in mid to late blastula stage 
embryos (Shiokawa £t al, 1981a, b). RNA polymerase assays 
were performed to check that the relative levels of the three RNA 
polymerases were identical in both oocyte and egg extracts. 
Exactly the same conditions were used as for the nuclear 
transcription assays, thus ensuring that the measurements taken 
accurately reflected the levels of the RNA polymerases that were 
active under the normal assay conditions. However, Instead of 
using X.laevls DNA as the template for the RNA polymerases, 
the synthetic template poly[d(A-T)] was used. This gave a better 
incorporation of^H-UTP into acid-insoluble material (FIG 3.15). A 
concentration of 40 |jg/ml poly[d(A-T)] was used standardly in all 
the following assays. The values obtained from these assays for 
the levels of the three RNA polymerases might be different from 
those determined by Roeder (1974a, b) since the extraction 
procedure and subsequent assay conditions are not the same.
As Table 3.7 shows, neither egg nor oocyte extract Incubated 
in an assay system without a template results in any 
transcription. When poly[d(A-T)j is added, both extracts show 
high total RNA polymerase activity, but the egg is only 70Z as 
active as that of the oocyte. However, the relative amounts of 
the three RNA polymerases are similar in both extracts (FIG 
3.16]. Thus in both egg and oocyte extracts, 67Z of the total RNA 
polymerase activity observed with poly(d(A-T)] as template is as 
a result of RNA polymerase III, a further 25Z is due to RNA 
polymerase I and the remaining 8Z as a result of RNA polymerase 
II activity. The RNA polymerase activity seen in oocyte-treated 
nuclei cannot therefore be a simple reflection of the RNA 
polymerase levels in the extract. RNA polymerase I represents 
only 25Z of the active RNA polymerases in the oocyte extract
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♦FIGURE 3.17
Transcription on Erythrocyte Chromatin or poly(d(A-T) I Produced 
by Added. Seml-purlfled RNA Polymerases.
Pairs of 50 fil transcription assays were set up with either
5xl05 nuclei (o-- o) or 2 fig poly(d(A-T)] (H--- ♦) and Increasing
amounts of a semlpurlfled RNA polymerase preparation. 100 fig/ml 
or-amanltln was Included In all the assays, such that only RNA 
polymerase I activity is seen. Duplicate 10 fil samples were taken 
at 0 and 30 minutes of the transcription assay.
FIGURE 3.18
Effect of Increasing the Concentration of Oocyte Extract In the 
Transcription Assay.
Increasing concentrations of oocyte extract (from 5 to 60 mg 
proteln/ml) were Incubated for 30 minutes In a 30 pi assay with
either 5xl05nuclel (o-- o) or 2 pg polyld(A-T)] (+-- ■*■). 2x10 pi
samples were taken at 0 and 30 minutes of the Incubation.
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under these assay conditions, but transcribes 50Z of the RNA made 
by erythrocyte nuclei added to this extract. Since all three RNA 
polymerases are present in the egg extract, It is not lack of RNA 
polymerase I which causes the lack of stimulation seen In 
egg-treated nuclei, but rather the lack of some other component 
of the oocyte extract or possibly the presence of an Inhibitor, 
which affects its activity on nuclei but not on poly[d(A-T) ].
Effect of RNA Polymerase I on Erythrocyte Nuclear 
Transcription.
Another indication that the Increased activity seen in 
oocyte-treated nuclei is not a reflection of the mere presence of 
RNA polymerase I, is given by the addition of a crude RNA 
polymerase preparation to the nuclei. As can be seen from Figure 
3.17, increasing the amount of RNA polymerase 1 has no effect on 
nuclear transcription at all, whereas with poly[d(A-T)] as 
template there is a corresponding Increase in incorporation of 
^H-UTP into acid-insoluble material. If, however, the amount of 
oocyte extract is increased in a nuclear assay, an Increase in 
incorporation can be observed [FIG 3.18]. Starting with a 
concentrated oocyte extract and diluting it with column buffer, 
it can be seen that decreasing the amount of oocyte extract 
results in a decrease in transcription by the nuclei. Above 40 
mg/ml of protein, however, the extract does not elicit any 
further response, and above SO mg/ml protein, addition of the 
extract shows a decreased response. If the nuclei are replaced by 
poly[d(A-T)] in this assay, [FIG 3.18], the system becomes 
saturated above 40 mg/ml of protein, but shows no decreased 
response above this concentration.
RNA Fblymerase; I I I  I I I  I  I I  III
Extraction; standard ♦ glycerol
FIGURE 3.19
RNA Pol>mera3e Levels In Oocyte Extracts.
12.5 pi of a standard oocyte extract, or one extracted using 
a gljcerol-rich buffer were Incubated with 2 pg polytd(A-T)) in a 
50 pi assay with 0, 1 or 100 pg/ml or-amanitin. These were
Incubated for 30 minutes with 2x10 pi samples being taken at 0
and 30 minutes.
buffer oocyte extract
standard ♦ glycerol
FIGURE 3.20
RNA Polymerase Levels In Erythrocyte Nuclei Treated with Oocyte 
Extracts.
20 pi of column buffer, a standard oocyte extract, or one 
extracted using a gljcerol-rlch buffer were preincubated for 60 
minutes with 5xl0^nuclel In a 30 pi assay with 0, 1 or 100 pg/ml 
oramanltln. After salt supplementation, the nuclei were Incubated 
for a further 30 minutes, duplicate 1U pi samples were taken at 0 
and 30 minutes of the Incubation stage.
Iß
I
Ö 2 4 6 8 ÏO
RNA Polymerase ( jjI ) — —
FIGURt 3.21
Addition of Extra RNA Polymerase 1 to Erythrocyte Nuclei 
Supplemented with Oocyte Extract.
To 50 i^l assays containing Sxll^nuclel, 10 i^l oocyte extract 
and 100 pg/ml a-amanltln were added Increasing amounts of the 
crude RNA poljmerase preparation. These were incubated for 60 
minutes, supplemented to give the usual final Incubation 
conditions, and then incubated for 30 minutes. Samples (2x10 
pil) were taken at 0 and 30 minutes of this Incubation.
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To see whether the amount of RNA polymerase I In the oocyte 
extract Is in any way rate-limiting, two oocyte extracts were 
made in parallel. Both started with the same number of oocytes 
and finished with the same volume; one was made using the 
standard extraction process, the other using a glycerol-rich 
extraction buffer thus maximising the RNA polymerase content. 
This second extraction procedure results in a higher level of RNA 
polymerase activity [FIG 3.19], but it does not result in an 
increase in the amount of RNA polymerase I activity seen when 
this extract is added to erythrocyte nuclei [FIG 3.20]. Extra RNA 
polymerases can also be added in the form of a semi purified RNA 
polymerase preparation. By adding increasing amounts of this in 
the presence of the inhibitor oc-amanltin, such that only RNA 
polymerase I activity is possible, it can be shorn [FIG 3.21] 
that excess, semipurlfled RNA polymerase I has no effect.
Although the response of nuclei is dependent on the amount 
of extract added, this effect is not changed by adding extra RNA 
polymerases. Thus some other part of the oocyte extract must 
always be rate limiting. It would seem likely, therefore, that 
there is a component of the oocyte extract that induces RNA 
polymerase I activity in erythrocyte nuclel.lt is distinct from 
the RNA polymerase I molecule itself, since incubation of the 
nuclei with extra RNA polymerases does not elevate RNA synthesis 
by RNA polymerase I. This component has not been detected in egg 
extracts.
If this explanation, in terms of an activator present in 
oocytes, but not eggs, is correct, it should be possible to 
dilute the oocyte extract with an egg extract and achieve the 
same amount of transcription as if a neutral agent like a column
FIGURE 3.22
Dilution of Oocyte Extract by Column Butfer and Egg Extract.
SxlO^nuclel In a 50 pi assay were preincubated with 20 pi ot 
oocyte extract diluted with either column buffer (o- o) or an 
egg extract (+—— +), and 100 pg/ml ocamanltin. Alter this the 
assays were supplemented with salts etc and incubated for 30 
minutes. Samples (2x10 pi) were taken at the beginning and end of 
this incubation period.
FIGURE 3.23
Effect of Calcium and EGTA on Transcription by Erythrocyte 
Nuclei.
5xl05nuclel In a 50 pi assay were Incubated with 12.5 pi of
buffer (o o), egg extract (+ *) or oocyte extract (•-- •) and
Increasing amounts of CaCl or EGTA (0 to 5 mM). These were 
Incubated for 30 minutes, samples (2x10 pi) being taken at 0 and
30 minutes.
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buffer had been used. If, on Che other hand, there is an excess 
of an Inhibitor present in the egg extract, as well as the oocyte 
activator-molecule, the egg extract would produce a greater 
decrease than that shown on dilution by buffer. As previously 
mentioned, a simple assay with erythrocyte nuclei will only 
detect an activator. Figure 3.22 shows that the dilutions of 
oocyte extract with either buffer or egg extract produce 
identical results on erythrocyte nuclei. Therefore there can be 
no excess of Inhibitor in the egg extract.
Calcium and Transcription by Erythrocyte Nuclei.
Calcium is known to be Involved in the regulation of many 
cellular processes, Including key events of early development 
(Stelnhart £t al, 1977; Cuthbertson et al, 1981). So the 
difference between the oocyte and egg extract could be due to the 
presence and absence of calcium. Calcium has a detrimental effect 
on transcription by erythrocyte nuclei [FIG 3.23]. EGTA, which 
specifically binds to calcium, has no effect on transcription. 
Neither of the two extracts overcome this inhibition by calcium, 
and EGTA does not increase or decrease the amount of
transcription in the treated nuclei. Calcium, therefore, does not 
appear to be the cause of the difference between the effect of 
oocyte and egg extracts on erythrocyte nuclear transcription.
Change in Size of Erythrocyte Nuclei by Oocyte Extract.
The mature erythrocyte nucleus is small compared with nuclei 
from earlier stages of erythropoelsls or other more
transcriptionally active nuclei. Its 6 pg of DNA become tightly 
packaged and condensed during its development into the plcnotlc
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FIGURE 3.24
Change In Dimensions of Erythrocyte Nuclei on Incubation with 
Oocyte Extract.
Erythrocyte nuclei (5x10^nuclei/5u pi) were Incubated with 
12.3 pi of buffer, egg extract or oocyte extract. After 90 
minutes for the buffer and egg extract incubates, and 15, 45 and 
90 minutes for the oocyte extract, a 5 pi sample was removed, 
diluted into fresh Rb and the dimensions of 25 nuclei determined. 
Nuclei were also preincubated with butfer or oocyte extract (5xUT 
nuclei, 20 pi extract/50 pi), spun out after f>0 minutes and 
resuspended in RB before being measured. The dimensions quoted 
are for the long axis and are micrometer units where 1 micrometer 
unit ■ 2.5 ^ im.
Extract Time (minutes)
A buffer 0
B buffer 90
C egg 90
D oocyte 15
E oocyte 45
F oocyte 90
G buffer bO (preincubation)
h oocyte 60 (preincubation)
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nucleus found in the mature erythrocyte. It might be supposed 
that for transcription to occur, the DNA must be in a more 
dispersed state to allow the RNA polymerases free access to the 
relevant gene sequences. This opening up of the chromatin can be 
seen when somatic cell nuclei are Injected into oocytes (Gurdon, 
1976; Gurdon £t al, 1976; Korn and Gurdon, 1981), these 
undergo a several hundred fold increase in size that is 
correlated with an Increase in transcription. To see whether the 
erythrocyte nuclei incubated Ui vitro in these assays with an 
oocyte extract also show an increase in nuclear size, their size 
was determined under phase microscopy. Erythrocyte nuclei 
incubated without any extract did not alter their size (of 10 x 7 
ps) over a 90 minute Incubation period [FIG 3.24]. Nuclei 
incubated with an oocyte extract though, even after a short space 
of time (13 minutes), show an increase in size. A maximum size of 
11 x 8 pm is reached after 45 minutes and is not Increased 
thereafter. If the nuclei are preincubated for 60 minutes, spun 
and resuspended in extract-free incubation buffer, the mean size 
remains the same during the Incubation. Nuclei treated with an 
egg extract do not show an increase in size [FIG 3.24] when 
measured in the same way as oocyte-treated nuclei. Thus the 
oocyte extract brings about an Increase of about 39Z in the mean 
volume of the nuclei. Furthermore, there appears to be a shift in 
the size of all of the nuclei, and not a small population. This 
increase in size does not need the continued presence of the bulk 
oocyte extract for its maintenance, although presumably some 
molecules pass into the nuclei from the oocyte extract to bring
about this size Increase.
100t
FIGURE 3.25
Transcription by Xenopus laevls Liver Nuclei.
Liver nuclei were assayed for transcriptional activity In a 
standard Incubation assay (1.5x10^ nuclel/151) jil). Duplicate 10 i^l 
samples were taken at intervals throughout the tlmecourse
(o-- o). An indentlcal tlmecourse with erythrocyte nuclei has
also carried out in parallel (+-— +).
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FIGURE 3.26
Relative Levels of the Three RNA Polynerases In Liver Nuclei.
To 50 pi assays containing 5xl(i liver nuclei, were added, 
either 0, 1 or 100 pg/al ot-amanitin. These uere incubated for 30 
minutes and duplicate 10 pi samples taken at the beginning and
end of the incubation.
TAbLE 3. b
Transcription by Liver Nuclei Incubated with Protein Extracts, 
pmoles UMP incorporated 
/10^nuclei/30 mins.
Nuclei + buffer 6b.6
egg extract 6b.0
oocyte extract 69.4
Liver nuclei were incubated in the above extracts in a 
standard incubation assay. Duplicate 10 jal samples were taken at 
0 and 30 minutes of the incubation period.
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Transcription In Liver Nuclei.
Whereas transcription In the nuclei of Intact erythrocytes 
Is confined to the slow elongation of the final RNA transcripts, 
the liver transcribes a great variety of RNA species at a high 
rate using all three RNA polymerases. As a consequence, [FIGS 
3.25, 3.26] untreated, isolated liver nuclei are about 12 to 14
times as active in RNA synthesis as erythrocyte nuclei, 30.12 of 
this being due to RNA polymerase I, 53.22 RNA polymerase II and 
16.72 RNA polymerase III. The liver nuclei were used to study the 
effect of oocyte extract on rRNA genes that were already active. 
This contrasts with the situation in erythrocyte nuclei, where 
the extract must activate the genes. Oocyte and egg extracts were 
added to liver nuclei, after a 60 minute prelncubatlon period the 
nuclei were spun out and resuspended in the standard incubation 
buffer. Incorporation of^H-UTP into acid-insoluble material was 
measured after 30 minutes. As Table 3.8 shows, neither extract 
brings about any change in the transcription by liver nuclei. The 
oocyte extract component that brings about transcription by RNA 
polymerase I on an inactive genome, has no effect on actively 
transcribed ribosomal genes and their accompanying RNA polymerase 
I molecules. This component therefore, would not seem to affect 
either the rate of elongation of the ribosomal 40S precursor 
molecule being transcribed or the rate of initiation of the RNA 
polymerase I molecules on the rDNA of liver nuclei. It could be 
that liver nuclei already have an excess of the relevant 
component, or this component acts on the inactive gene itself to 
make it accessible in some way to the RNA polymerase I molecules 
such that transcription can commence.
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The erythrocyte nuclei of Xenopus laevla are 
transcriptionally Inactive, in that when they are placed In a 
transcription system that has been adjusted to give the maximum 
Incorporation of iH-UTP into acid Insoluble material, they only 
incorporate 5<5 pmoles UMP/10 nuclei/30 minutes. Most of this 
transcription is due to elongation by RNA polymerase II, although 
some RNA polymerase III activity is detectable. When the nuclei 
are preincubated vlth a protein extract from oocytes or eggs 
under lower KC1 and XTP concentrations, prior to the 
transcription assay itself, the total amount of UMP incorporated 
increases two-fold in the case of the egg extract and six-fold 
with the oocyte extract. With both extracts the rate of 
elongation of RNA polymerases II and III is Increased, some new 
initiation by both of these polymerases is also seen. However, by 
far the largest contribution to the RNA polymerase activity in 
the oocyte-treated nuclei, is newly initiated RNA polymerase I. 
This transcription is from a DNA template, not from the RNA that 
is present in the extract, nor is it mobilization of a 
sequestered population of RNA polymerase I molecules within the 
nuclei. Since both oocyte and egg extracts contain the same 
relative amounts of each of the three RNA polymerases, the lack 
of RNA polymerase I activity seen in egg-treated nuclei is  not a 
reflection of a lack of this polymerase in the egg extract. 
Transcription on an erythrocyte nuclear template is not effected 
by semlpurifled RNA polymerase I. An oocyte extract has no effect 
on transcription by liver nuclei that do transcribe their rRNA
genes.
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It would therefore appear that there la an activator 
molecule or molecules present In Xenopus laevls oocytes, that 
brings about transcription by RNA polymerase I on Inactive rDNA. 
Either this molecule(s) Is not present In unfertilized eggs, or 
it is not extracted under these conditions.
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CHAPTER IV: LOCATION AND OCCURRENCE OF THE RIBOSOMAL ACTIVATOR 
DURING OOGENESIS AND EARLY EMBRYOCENESIS
RNA Transcription during Oogenesis.
The oocyte, as previously discussed (Chapter I) contains all 
the RNA and certain proteins necessary for the early development 
of the embryo. During oogenesis therefore, a great deal of energy 
has to be expended In order to synthesize these molecules. Enough 
ribosomes have been synthesized to last until the swimming 
tadpole stage - as seen by the continued survival of the 
anucleolar mutants to this stage without further rRNA synthesis 
(Brown and Gurdon, 1964; Knowland and Miller, 1970; Miller and 
Knowland, 1970). Ribosome production Involves not only the 
transcription of the 18S and 28S rRNA species, but also that of 
the 5S rRNA. The necessary tRNAs must also be transcribed to deal 
with the large amount of protein synthesis that Is carried out 
from fertilization onwards. Finally, the mRNAs for Important 
structural proteins, such as the histones and actlns necessary 
for cell division to take place, have to be transcribed.
In order to produce this quantity of RNA, the oocyte goes 
through a series of stages of differing RNA synthesis. The 
pre-vltellogenlc oocyte sytheslzes hnRNA, 4S (tRNA) and 5S RNA, 
but very little, If any, 40S rRNA (Ford, 1971; Mairy and Denis, 
1972; Thomas, 1974). The 5S RNA is synthesized to such a degree 
that there la a 100 fold excess of 5S RNA over 18S and 28S RNA at 
this stage (Ford, 1971). The synthesis of these latter rRNA 
species from the extrachromosomal ribosomal DNA does not begin In 
earnest until early In vitellogenesis, and reaches a peak In 
mld-vitellogenesls (Ford, 1971). Although the rate of synthesis
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Chereafter slows down slightly, some rRNA synthesis occurs until 
oocyte maturation (Ford, 1971; LaMarca e_t aj^ , 1973, 1975;
Anderson and Smith, 1977) and the final melotlc division, when 
the amplified rDNA becomes dispersed and all RNA synthesis comes 
to a halt. 4S and 5S synthesis occurs throughout vitellogenesis, 
the finished molecules being stored In 7S and 42S 
rlbonucleoproteln particles until they are needed (Ford, 1971; 
Picard £t al, 1980). Presumably, In ribosome synthesis, the 
5S DNA is the rate limiting component, and In order to have a 
sufficient supply of 5S rRNA for the vast numbers of ribosomes 
made during vitellogenesis the 5S genes have to be transcribed 
for a longer period (Malry and Denis, 1972). There are 20,000 
5Sooc RNA genes/haploid genome (Brown et al, 1971) as 
compared to the 1.5 to 2.5 million copies of the rRNA genes
(Dawld et al, 1970). Messenger RNA species can be detected in
all stages of oogenesis. Histone mRNA can be detected In
pre-vltellogenlc oocytes at levels comparable to those seen In
vitellogenic oocytes, both by cell-free translation assays 
(Ruderman and Pardue, 1977) and by hybridization to cloned 
histone DNA sequences (van Dongen ejt al, 1981). Similarly the 
poly-A* RNA species do not alter from those seen In the 
pre-vltellogenlc oocyte (Rosbash and Ford, 1974; Darnborough and 
Ford, 1976; Golden et al, 1980). This is despite the fact 
that the lampbrush chromosomes do not appear until early 
vitellogenesis and are transcribed at a high rate (Anderson and 
Smith, 1978). Either this transcription does not go towards the 
maternsl mRNA pool and Is degraded, or serves some other 
undefined purpose, or the mRNA synthesized during early oogenesis 
has s limited half life and the lampbrush transcription serves to 
maintain the levels of the mRNA pool.
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Throughout oogenesis, the relative activities of the three 
RNA polymerases remains constant (Roeder, 1974b) although in very 
early pre-vitellogenlc oocytes, about the pachytene stage when 
rlbosomal gene amplification Is occurlng (Perkowska et al, 
1968; Gall, 1968; Kalt and Gall, 1974), the actual quantity of 
RNA polymerase is small. Between this stage and the mature oocyte 
there is a 500-fold increase in the amount of RNA polymerase 
(Roeder, 1974b). These unchanging relative levels of the three 
RNA polymerases are maintained even though each RNA polymerase 
has a different transcriptional activity at different stages of 
oogenesis. For instance, in pre-vitellogenic oocytes there are 
almost equal quantities of RNA polymerases I and III, but only 
the RNA polymerase III molecules are transcribing the oocyte 
chromatin, to produce 4S and 5S RNA. The RNA polymerase I 
molecules are idle, but it is not through lack of ribosomal 
genes. To the 48,000 5S genes available to the RNA polymerase III 
molecules (Brown et al, 1971), there are between 1.5 and 2.5 
million copies of the rlbosomal genes in the amplified rDNA 
(Perkowska ej: al, 1968). The lag between the appearance of 
the amplified rDNA (MacGregor, 1968; Gall, 1969; Kalt and Gall, 
1974) and the onset of its transcription (Ford, 1971), even 
though RNA polymerase I is present in the oocyte (Roeder, 1974b), 
and the gradual increase in the transcription of these amplified 
genes to the maximal transcription of mid-vitellogenesis 
(MacGregor, 1968; Scheer, 1973), could be said to indicate the 
presence and gradual accumulation of some component within the 
developing oocyte. This component would be necessary for 
ribosomal gene transcription to occur and be quite separate and 
distinguishable from the RNA polymerase I molecules.
It was shorn in Chapter III that a total ovary homogenate -
FIGURE 4.1
Relative Amounts of the Three RNA Polymerases During Oogenesis.
An ovary was stripped of Its oocytes, which were sized 
before being washed In WH buffer. Protein extracts were prepared 
in the standard way from the various size classes and adjusted to 
30 mg/ml. These extracts were assayed In the RNA polymerase assay 
using polyld(A-T)] as template and the Inhibitor ocamanltln to 
distinguish between the RNA polymerases (at 0, 1 and 100 pg/ml). 
Duplicate 10 pi samples were taken from the SO ul assay at 0 and
30 minutes.
TABLE 4 . 1
RNA Polyaerase Activity in Extracts of Oocytes of Different
Stages.
Oogenetic Stage: pmoles UMP incorp. pmoles UMP incorp.
/1.2 mg protein/30 mins. /oocyte/30 mins.
I+1I 12.3 0.0616
111 23.3 0.232
IV 22.7 0.76
V 20.4 1.36
The left hand column shows the results normalised to the 
amount of protein in the added extract, and the right hand column 
the results normalised to the number of oocytes from which the 
extract came. 50 pi assays containing 2 pg/ml poly[ d(A-T)], 20 pi 
oocyte extract from different stage oocyte extracts plus all the 
normal salts etc were incubated for 30 minutes. 2x10 pi samples 
were taken at the beginning and end of the incubation.
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which will contain oocytes of all stages - contains a component 
that brings about an increase in transcription by RNA polymerase 
I of the inactive ribosomal RNA genes in erythrocyte nuclei. 
Since oocytes may be separated, according to size, it should be 
possible to see whether this component is present at all stages 
of oogenesis or only at a few.
RNA Polymerase Levels During Oogenesis.
When the relative levels of the three RNA polymerases were 
determined using the poly[d(A-T)] transcription assay, it was 
seen [FIG 4.1] that, although the percentage of the total 
activity for each RNA polymerase remained constant, the total 
amount of RNA polymerase activity increased during oogenesis, the 
pre-vitellogenlc oocytes having 60Z of the activity per mg 
protein seen in the full-grown oocytes. As these extracts were 
assayed on the basis of protein content and not oocyte numbers, 
it should be noted that more pre-vitellogenic oocytes went into 
the making of that extract than was the case with the mature 
oocytes. Therefore, if this is taken into account [TABLE 4.1], 
there is an increase (of 22-fold) in the total amount of RNA 
polymerase activity during oogenesis, le the pre-vitellogenic 
oocytes (Stages X+II) contain only 4.5Z of the RNA polymerase 
activity of the stage V vitellogenic oocytes. At all stages, in 
these extracts, RNA polymerase 1 constitutes about 2SZ of the 
total RNA polymerase activity.
Presence of the Ribosomal Gene Activator During Oogenesis.
If these oocyte extracts, derived from oocytes at different
stages in their growth, are added to erythrocyte nuclei and
FIGURE 4.2
Effect of Oocyte Extracts from Different Stages of Oogenesis on 
RNA Polymerase I Transcription In Erythrocyte Nuclei.
The oocyte extracts described in Figure 4.1 were assayed 
with erythrocyte nuclei in a 50 pi preincubation assay with 100 
pg/ml oramanitin present such that only transcription by RNA 
polymerase 1 was possible. Duplicate 10 pi samples were taken at 
0 and 30 minutes of the incubation.
FIGURE 4.2
Effect of Oocyte Extracts from Different Stages of Oogenesis on 
RNA Polymerase I Transcription In Erythrocyte Nuclei.
The oocyte extracts described in Figure 4.1 were assayed 
with erythrocyte nuclei in a SO pi preincubation assay with 100 
pg/ml oramanltin present such that only transcription by RNA 
polymerase I was possible. Duplicate 10 pi samples were taken at 
0 and 30 minutes of the incubation.
TAbLE 4.2
Erythrocyte nuclei plus; pooles UMP incorp.
/10^ nuclei/30 mins.
RNA Polymerase I Activity in Erythrocyte Nuclei Preincubated
with a Pre-vltellogenic Oocyte Extract.
buffer 0
egg extract 0.4
Stage l+II oocyte extract 7.6
Stage 1+11 oocyte extract plus buffer 3.9
Stage 1+11 oocyte extract plus egg extract 4.0
Total oocyte extract 16.3
Erythrocyte nuclei were preincubated in a 30 pi assay with 
either buffer, egg extract, oocyte extract or a pre-vitellogenic 
oocyte (stage 1+11) extract. Since the latter contains very 
little RNA polymerase 1, two further assays were carried out; 
erythrocyte nuclei were preincubated with 10 pi stage 1+11 oocyte 
extract and 10 pi egg extract to provide the RNA polymerase I, or 
10 pi of buffer. All preincubations and incubations were carried 
out with 100 pg/ml or-amanltln so that only RNA polymerase I 
transcription was seen. Duplicate 10 pi samples were taken at 0 
and 30 minutes of the incubation.
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assayed for RNA polymerase I activity, It can be seen [FIG 4.2] 
that all extracts elicit some activity. In the case of the 
vitellogenic oocyte extracts, the amount of &NA polymerase I 
activity is comparable to that seen In nuclei treated with an 
extract of whole ovary, and varies little between the smallest 
vitellogenic oocyte and mature oocyte extracts. Pre-vitellogenic 
oocyte extracts, on the other hand, although eliciting RNA 
polymerase I activity at a level above that seen In nuclei 
treated with an egg extract, do not show as high a response as 
when a vitellogenic oocyte extract was used. This could be a 
reflection of the small amount of RNA polymerase I molecules in 
the extract. To get round this problem, excess RNA polymerase 
molecules were added to the assay in the form of an egg extract. 
An egg extract has as much RNA polymerase activity as an oocyte 
extract, but does not stimulate RNA polymerase I activity In 
erythrocyte nuclei [FIG 3.12]. As Table 4.2 demonstrates, the 
addition of the extra RNA polymerases has no effect on the RNA 
polymerase I activity seen In erythrocyte nuclei preincubated 
with a pre-vitellogenic oocyte extract. The lower amount of 
transcription by RNA polymerase 1 in these nuclei, therefore, is 
not due to the lack of RNA polymerase I Itself, but rather to the 
lack of the oocyte specific component necessary for rlbosomal RNA 
gene transcription. Since it is difficult to separate out 
different stages of pre-vitellogenic oocytes it is not possible 
to say whether this component is present in small amounts in all 
pre-vitellogenic ocytes or only present in those oocytes 
approaching vitellogenesis. The amount of extract (1.20 mg) from 
stage V oocytes Incubated with l(í nuclei represents the soluble 
protein from about 15 oocytes, whilst the same amount of protein 
from a pre-vitellogenic oocyte extract represents about 200 
oocytes. So there is actually very little stimulatory activity in
T AULE 4.3 10
RNA Polyaerase I Activity in Erythrocyte Nuclei Prelncubated
with Extracts from Oocytes of Different Stages.
Oogenetic Stage: pmoles UMP incorp. pmoles UMP incorp.
/10^ nuclei/30 mins. /It/ nuclei/30 mins
/1.2 mg protein /10 oocytes
1+11 7.6 0.19
111 17.6 0.8b
IV 19.0 3.1
V lb.2 10.5
10 erythrocyte nuclei were preincubated with either 1.2 mg 
oocyte extract/lOO^ jl assay (left hand column) or with the soluble 
protein from 10 oocytes (right hand column), and with 100 pg/ml 
oramanitin. After a 60 minute preincubation the nuclei were 
supplemented with salts to the conditions of an incubation assay 
and Incubated for a further 30 minutes.
FIGURE 4.3
Effect of Different Stage Oocyte Extracts on RNA Polynerase II 
and III Transcription In Erythrocyte Nuclei.
The oocyte extracts decribed in Figure 4.1 were assajed with
erythrocyte nuclei in a 50 pi preincubation assay with and
without oramanitln present. Duplicate 10 pi samples were taken at
0 and 30 minutes of the Incubation period. From these the pmoles
6UMP Incorporated/10 nuclel/30 minutes as a result of RNA 
polyaerase II (o--o) and III (+-— -f) transcription were
calculated
R N A  Polymerase; I I I  III 
Oocyte; totnl
I II I I I  I I I  in
cytoplasm germinal
vesicle
FIGURE 4.4
Relative Amounts of the Three RNA Polymerases in the Germinal 
Vesicle and Cytoplasm of the Oocyte.
Protein extracts from separated oocytes, enucleated oocytes 
and germinal vesicles were prepared in the standard way. The 
protein content of the oocyte and enucleated oocyte extracts were 
adjusted to 30 mg/ml and the final volume of the germinal vesicle 
extract made the same as that of the enucleated oocyte extract. 
These were assayed In a 50 jil assay with polytd(A-T)] as template 
and aramanitln to distinguish between the three RNA polymerases. 
Duplicate 10 pi samples were taken at 0 and 30 minutes of the
Incubation
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each pre-vitellogenic oocyte [TABLE 4.3]. If erythrocyte nuclei 
are preincubated with the soluble proteins from 10 oocytes [TABLE 
4.3], It can be seen that there Is a jump in the amount of the 
component/oocyte between stages III and IV. The concentration 
still rises though In later stages of oogenesis.
Different oocyte stage extracts have little effect on the 
RNA polymerase II or III activity [FIG 4.3].The amount of 
transcription for both remains more or less constant. The high 
degree of RNA polymerase III activity seen in pre-vitellogenlc 
oocytes relative to RNA polymerase I activity Is not reflected In 
increased amounts of RNA polymerase III activity In erythrocyte 
nuclei treated with a pre-vltellogenic oocyte extract.
Location of the Rlbosomal Gene Activator within the Oocyte.
This component which activates the rlbosomal genes is 
present in vitellogenic oocytes which synthesize mostly rlbosomal 
RNA, and is present In low levels In pre-vitellogenic oocytes 
where some ribosomal RNA synthesis occurs, but most of the RNAs 
transcribed are 4S and 5S species. The synthesis of rRNA in the 
oocyte Itself, could also be affected by the location within the 
cell of regulatory molecules. The oocyte can be divided Into the 
cytoplasm and the nucleus or germinal vesicle (GV). This Is the 
site of transcription, not only from the 4C chromosomal DNA, but 
also the extrachromosomal rDNA.
In Xenopua It Is easy to prepare cytoplasm-free CVs by 
manual techniques, leaving an Intact enucleated oocyte. When the 
resulting extracts are assayed for RNA polymerase activity It is 
found [FIG 4.4] that almost all of the total transcriptional
TABLE 4.4
pmoles UMP incorp. 
/10^ nuclei/30 mins.
RNA Polymerase Activity In Erythrocyte Nuclei Preincubated With
Extracts of Oocyte GVs and Cytoplasms.
column buffer 5.4
egg extract 10.3
oocyte extract 35.4
CV extract 23.9
enucleated oocyte extract 5.0
enucleated oocyte extract 8.5
plus egg extract
The protein extracts from oocyte GVs and cytoplasm as 
described in Figure 4.4 were incubated with 5xl(£ nuclei in a 
standard 50 pi preincubation assay. After 60 minutes the assays 
were supplemented with salts etc to give standard incubation 
conditions; 2x10 pi samples were taken at 0 and 30 minutes of the 
subsequent incubation. Nuclei were also preincubated with 10 pi 
of egg extract and 10 pi of enucleated oocyte extract instead of 
the normal 20 pi extract/assay. As controls, nuclei were 
preincubated with 20 pi of column buffer, egg extract and oocyte
extract.
20</>c■g
Om
\
5u
2
° o
\
5<3c.
§■
10-
>/>
<u
R N A  Polymerase;
I II HI
O o c y t e ;  total
I II  III 
GV
I II  in
cytoplasm
I II ID 
cytoplasm
♦egg
I U III 
egg only
F IG U R E  4 . 5
R e l a t i v e  A m ounts  o f  RNA P o l y m e r a s e s  I ,  I I  a n d  I I I  A c t i v i t i e s  I n  
E r y t h r o c y t e  N u c l e i  T r e a t e d  w i t h  E x t r a c t s  f r o m  E n u c l e a t e d  O o c y t e s  
a n d  G e r m i n a l  V e s i c l e s .
Erythrocyte nuclei were preincubated with the oocyte 
extracts described In Figure 4.4 and oramanitln at 0, 1 and 100 
pg/ml. Nuclei were also preincubated with an egg extract, and egg 
extract plus the enucleated oocyte extract. After the 60 minute 
preincubation the assays were supplemented with salts, 
triphosphates and^ H-UTP, and Incubated for a further 30 minutes. 
Duplicate 10 pi samples were taken at 0 and 30 minutes of this 
incubation.
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act 1 vi ty (91Z) is located in the germinal vesicle. The little 
(9Z) activity that is found in the cytoplasmic extract is 
probably due to a small amount of leakage during the preparation 
of the germinal vesicles. When added to erythrocyte nuclei, the 
enucleated oocyte extract elicits no response of Increased 
transcriptional activity, indeed this extract is slightly 
inhibitory [TABLE 4.4]. This is not surprising, as detection of 
the oocyte component depends upon the presence of RNA polymerase 
I, which is present only in the nuclear extract. However, even on 
the addition of an egg extract to act as a source of RNA 
polymerases, no RNA polymerase I activity is seen above the 
control [TABLE 4.4; FIG 4.5]. An extract made from the purified 
germinal vesicles does result in Increased transcription by 
erythrocyte nuclei [TABLE 4.4], and as can be seen, the relative 
levels of the three RNA polymerases active in the treated nuclei 
[FIG 4.5] are the same as are found in whole oocyte-treated 
nuclei. The oocyte component responsible for stimulating 
transcription by RNA polymerase on erythrocyte chromatin is 
therefore located exclusively in the oocyte nucleus, as might be 
expected since this is where all the transcription occurs.
Presence of Ribosomal Gene Activator during Early 
Embryogenesis.
By its presence and location during oogenesis, the activity 
that stimulated RNA polymerase I mirrors the transcription of the 
amplified ribosomal RNA genes during oocyte development. The RNA 
produced during oogenesis is required, at least in some cases, to 
last through the early development of the embryo. So whilst 
translation of the stored mRNA continues throughout the early
FIGURE 4.6
Levels of the Three RNA polymerases During Early Embryogenes Is.
Protein extracts were prepared iron oocytes, and from 
dejellled eggs and embryos at various stages of development, 
I . between stages 5 and 33. These were adjusted to 30 mg/ml protein
and assayed for transcriptional activity using poly(d(A-T)] as 
template with oc-amanltln at 0, 1, or 100 pg/ml. Duplicate 10 Pi 
samples were taken from the 30 pi assays at 0 and 30 minutes of
the Incubation, (o-- o) RNA polymerase l; (+-— +) RNA polymerase
II; (•---a) RNA polymerase III.
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embryonic cleavages (Wasserman eit al, 1982), no further RNA 
la transcribed until later. One explanation of this could be that 
transcription and rapid replication of the DNA are not mutually 
compatable. While It Is possible to demonstrate the transcription 
of small RNA species (AS and 5S RNA) during mitosis (Zylber and 
Penman, 1971), the synthesis of larger RNA molecules Is not seen 
in cultured cells, possibly due to the structural constraints of 
the condensed chromatin during mitosis. While the cells of the 
embryo are not mitotic for all of the time during the early 
stages of development, they are in S-phase for the remainder of 
the time. Whatever the reason for the lack of RNA synthesis seen 
during the early stages of embryogenesls, it is not until the 
early blastula stage of development that the first transcription 
can again be observed, and it is only when the embryo reaches 
late to mid blastula stage that newly synthesized ribosomal RNA 
(Shiokawa et al, 1981a, b) and nucleolar formation can be 
observed. The rRNA synthesis seen in embryos is transcribed from 
the chromosomal genes, the extrachromosoma 1 copies are dispersed 
during oocyte maturation, are not replicated in the subsequent 
cell divisions and remain detectable until the early gastrula 
embryo (Busby and Reeder, 1982).
RNA Polymerase Levels during Embryogenesls.
Extracts made from embryos at different stages of 
development yield the levels of the three RNA polymerases shown 
in Figure 4.6, when assayed with poly[d(A-T)] as template. The 
relative amounts (per mg protein) of RNA polymerases I and II 
remain relatively stable during the development of the embryo 
from early cleavage to neurula. These levels are the same as 
found in egg and oocyte extracts. RNA polymerase III, on the
19
FIGURE 4.7
Effect on Erythrocyte Nuclear Transcription of Extracts from 
Different Stage Embryos.
The embryo extracts described In Figure 4.b were 
preincubated In a 50 pi assay with erythrocyte nuclei, 
supplemented with salts etc to bring the conditions to those of a 
standard incubation and Incubated for a further 30 minutes. 
Duplicate 10 pi samples were taken at 0 and 30 minutes of the
incubation.
20
FIGURE 4.8
Relative Levels of the Three RNA Polymerases In Erythrocyte 
Nuclei Prelncubated with Embryo Extracts.
The conditions were the same as for Figure 4.7 except that 
or-amanltln was Included In the assay at 0, 1 and 1U0 i^g/ml. This 
gives values for the transcription of each of the RNA polymerase
types; (o-- o) RNA polymerase I, (+-— ♦) RNA polymerase 11,
(•-- e) RNA polymerase III.
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other hand, exhibits an Increase, which peaks at stage 5 - 11. In 
contrast Roeder (1974b) showed that the relative levels of the 
three RNA polymerases varied very little during the development 
of the embryo to the swimming tadpole stage, and that there are 
about equal quantities of the three RNA polymerases. However, la 
the assays I performed on these extracts, RNA polymerase III was 
the most abundant, at least until stage 14. These differences In 
amounts of the RNA polymerases and the varying amount of RNA 
polymerase III between different embryonic extracts is probably a 
reflection of the different assay conditions and of the 
extraction procedure which was not optimized to conserve the 
maximum amount of RNA polymerase activity. The drop in the 
activity or amount of RNA polymerase III activity after stage 11, 
could be brought about by the loss of chromatin associated RNA 
polymerase III, since the amount of tRNA synthesized per gene 
becomes maximal at stage 10 (Brown and Llttna, 1964b;1966).
Presence of the Rlbosomal Gene Activator during Embryogenesls.
The addition of an extract made from early cleavage embryos 
has only a slight effect on transcription by erythrocyte nuclei 
compared with similar treatment with an egg extract [FIG 4.7]. 
Extracts from later stage embryos yielded increasing amounts of 
^H-UTP incorporated into acid-insoluble material by the 
erythrocyte nuclei until a peak was reached with the addition of 
a neurula extract. A slightly lower, but constant level of RNA 
polymerase activity was maintained when extracts from later stage 
embryos were used. Using the specific RNA polymerase inhibitor, 
or-amanitln, the levels of all three RNA polymerases were 
determined for each extract on its addition to erythrocyte 
nuclei. As Figure 4.8 shows, RNA polymerase II activity in
FIGURE 4.9
RNA Polymerase I Activity In Erythrocyte Nuclei Treated with 
Embryo Extracts.
The embryo extracts decscribed la Figure 4.6 tere assayed
with 100 pg/ml oramanltln and either polyld(A-T)) (o-- o) or
erythrocyte nuclei (i---+), such that only transcription by RNA
polymerase I was possible. Experimental details as In Figures 4.7 
and 4.8. The data are expressed as pmoles UMP Incorporated/\&
nuclei for the erythrocyte nuclear assay, or pmoles UMP
Incorporated/100 pi assay for when poly[d(A-T)] was used as
template.
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treated nuclei varies little between oocyte, egg and early 
cleavage extracts, it shows a slight Increase in activity in 
blastula and gastrula extracts and then declines slowly. A slight 
peak of activity, albeit only 1.2 fold higher than in nuclei 
treated with egg extract, is seen in nuclei treated with a 
gastrula extract. RNA polymerase 111 activity follows a similar 
pattern, but delayed slightly, such that a peak of activity is 
seen in neurula-treated nuclei, at 2.9 fold above the level in 
egg-treated nuclei. The activity thereafter drops to a level 
similar to that seen in nuclei prelncubated with an egg or an 
early cleavage extract. The peak in RNA polymerase III 
transcription in the extract-treated nuclei is not related to the 
levels of RNA polymerase III molecules seen in the extracts 
themselves, since these are at their highest at the earlier 
stages of development and are declining when the RNA polymerase 
III activity in embryo-treated nuclei is Increasing [FIG 4.6]. 
The activity of RNA polymerase I in these embyro-treated nuclei 
also varies little between egg and early cleavage embryo 
extracts. In both cases it is low, at a level well below that 
seen in oocyte-treated nuclei. After this stage, the activity 
Increases until in nuclei treated by a neurula extract, about a 
third of the transcription is due to RNA polymerase I activity. 
This activity continues to Increase until stage 22 when it 
reaches a level equivalent to that seen in oocyte-treated nuclei 
and accounts for about S6Z of the total RNA synthesis. As Figure
4.9 demonstrates, although the activity of RNA polymerase I in 
the erythrocyte nuclei varies between different developmental 
stages, mimicking endogenous embryonic nuclei, the actual amount 
of RNA polymerase I activity in whole embryos remains constant.
So it could be proposed that the molecule(s) present in the
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oocyte that are responsible for bringing about ribosomal gene 
transcription in treated erythrocyte nuclei is absent in the egg 
and early cleavage stage embryos. The same molecule, or one that 
achieves the same effect would appear later on during embryonic 
development. Its absence in the egg would account for the low 
level of rRNA synthesis seen at this stage. It would then build 
up slowly through the early stages of development from blastula 
onwards so that by stage 22 it is at its maximum concentration. 
This build up could occur in either of two extreme ways, or as a 
mixture of the two, to account for the intermediate values 
between blastula and neurula stage embryos. All cells might 
gradually accumulate the component during development, either by 
synthesizing these molecules anew or by reactivating a store of 
them, for example by phosphorylation, so that all cells have an 
identical amount of this component; or, some cells of the embryo 
might contain high, or maximal levels of the component and others 
contain very low amounts, or none at all. During development 
therefore, more cells would switch from containing no active 
ribosomal component to containing a high level. In the earlier 
stages a disparity might be expected in the ribosomal RNA 
synthesizing ability of different cells, which would disappear as 
development progressed. It has been shown (Woodland and Gurdon, 
1968; Misumi £t al, 1980) that there are Indeed at least two 
distinct cell populations in neurulae with respect to both their 
ribosomal RNA synthesis and their eventual differentiation. 
Endoderm cells from these embryos synthesize little rRNA, whilst 
the remaining embryonic cells do so. This disparity between the 
ability of theses cells to synthesize rRNA is not seen in later 
stage embryos (Woodland and Gurdon, 1968; Misumi ¿t al. 
1980). Although the first explanation cannot be completely ruled 
out, it would seem likely that the second poasibility could
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explain In part 
component during
the graduel accumulation of the atlmulatory 
embryonic development.
TABLE 5.1
Effect of Increasing Centrifuge Speed on Oocyte and Egg
Extracts.
Extract RCF(xg) pmoles UMP incorp. Stimulation
/10^nuclei/30 mins.
buffer — 5.9 1
egg 8,000 11.9 2.02
egg 20,000 11.6 1.97
egg 100,000 10.7 1.81
oocyte 8,000 36.1 6.12
oocyte 20,000 35.6 6.03
oocyte 100,000 38.7 6.56
Dejellied eggs or oocytes were homogenized in WH buffer and 
spun at 8,000g, 20,000g or 100,000g. The resulting soluble 
protein extracts were adjusted to 30 mg protein/ml and tested In 
a normal 50 pi preincubation plus Incubation assay for total
transcriptional activity.
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CHAPTER V; PURIFICATION BY COLUMN CHROMATOGRAPHY OF THE COMPONENT 
OF OOCYTES WHICH STIMULATES RNA POLYMERASE I.
All of the extracts studied in the preceding chapters are 
very crude preparations. They are mixtures of all the proteins, 
nucleic acids and constitutive Ions that are left when the lipids 
and Insoluble proteins are removed. This Is achieved by a series 
of centrifugation steps. These Increasing centrifuge speeds do 
not result In any loss of activity [TABLE 5.1]; even a I00,000g 
spin, that removes most of the ribosomes in the sample, has 
little effect on its stimulation of RNA synthesis. Neither does 
it cause an egg extract to show this activity, as might be 
expected if a sedimentable inhibitor was causing the different 
effects of oocyte and egg extracts. It will be noticed, that the 
specific activity increases during the centrifugation process. 
This is because a number of non-stimulating proteins are lost at 
each step. If the extracts are standardized according to the 
number of oocytes in the starting material, rather than according 
to the mass of protein, this effect is not seen. The observation 
that oocyte extracts prepared using a 100,000g spin can still 
stimulate RNA polymerase I activity in erythrocyte nuclei means 
that the molecule(s) responsible is not tightly bound to a 
subcellular structure that remains intact during the 
homogenization and subsequent centrifuge steps, and sediments at 
the same speed or faster than ribosomes.
Sephadex GIOO Column Chromatography of Oocyte Extracts.
From the study of crude extracts, it is not possible to say 
whether the relevant oocyte component is a single molecule, or 
several working in concert. Nor is it possible to say whether the
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FIGURE 5.1
Fractionation by Sephadex G100 of an Oocyte Extract.
A 200 pi aliquot of oocyte extract was loaded onto a G100 
column (2 cm diameter by 23 cm), the 30 drop fractions were 
collected and stored at -20°C. These were assayed with 
erythrocyte nuclei, but no additional polymerase or egg extract, 
In 50 pi preincubation and Incubations (20 pi column fraction, 5 x 
lO^nuclel), two 10 pi samples were taken at 0 and 30 minutes of
the incubation.
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actlvlty seen la auclel treated with a neurula extract la brought 
about by the same or different molecules from those In the oocyte 
extract. I have atteapted to explore these possibilities by 
fractlonating neurula and oocyte extracts oa Sephadex and DEAE 
cellulose columns. Of course, two disimilar proteins might still 
co-elute after these chromatographic steps, and the existence of 
a single stimulatory column fraction does not mean there la only 
a single protein species responsible.
The OD profile of an oocyte extract after passage through a
Sephadex C100 column Is shown In Figure S.l. The first peak
contains the largest of the protein molecules and the high
molecular weight nucleic acids. The second, smaller, peak
contains the smallest molecules, eg free triphosphates and
mineral ions, whose passage have been most Impeded through the 
small
column due to their/size. The column was calibrated with 
molecular weight marker proteins.
When the column fractions were assayed with erythrocyte 
nuclei in a standard preincubation assay, no Increase In
transcription was seen on the addition of any of these fractions 
[FIG 5.1]. This means that even the endogenous RNA polymerase II 
was not affected by these fractions. In the case of RNA 
polymerase I an effect could hardly be expected, since the nuclei 
contain no RNA polymerase I [FIG 3.8] and none was present and 
active In the column fractions (see later). This deficiency was 
rectified by adding egg extract as the polymerase source; this Is 
possible because the egg extract Itself does not affect RNA 
polymerase I transcription of the rlbosomal genes [FIG 3.12]. The 
approach Is analogous to the studies of Engelks et al (1980) 
on 5S genes. Under these assay conditions, a peak of stimulated
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FIGURE 5.2
Oocyte G100 Column Assay with Erythrocyte Nuclei and Egg 
Extract.
The column fractions described in Figure 5.1 were assayed 
using an egg extract as the RNA polymerase source such that a 50 
pi preincubation contained 10 pi column fraction, 10 pi egg
» extract and 5 x lC?nuclei (o---o). These were supplemented with
salts etc to a final volume of 63 pi after 60 minutes, and 
duplicate 10 pi samples taken at 0 and 30 minutes of the 
subsequent incubation. A parallel column assay was also carried 
out, but with 100 pg/ml or-amanltln present to prevent all but RNA 
polymerase I activity (+---h).
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tranacrlptlonal activity Is seen [FIG 5.2]. It elutes slightly 
before cytochrome c and has an estimated molecular weight of 
19500 - 21000 daltons. The single peak of activity Is constant 
between different columns and different oocyte extracts, the 
active component(s) of this peak was designated Fr-18.
In order to determine which of the three RNA polymerases 
present in the egg extract is responsible for this Increase In 
transcription, the column assay was repeated using ot-amanitln. As 
previously mentioned, Fr-18 has no effect on transcription by the 
endogenous RNA polymerases in erythrocyte nuclei. Figure 5.2 
demonstrates that the stimulation of transcription brought about 
by fractions 17-19 Is resistant to high (100 pg/ml) levels of 
oramanitin. The transcription Is therefore a result of RNA 
polymerase I activity. No further peaks of transcriptional 
activity can be seen on adding of-amanltln. Small peaks might have 
been masked by the amount of variation seen in fractions away 
from the main peak; indeed the amount of variation seen about the 
control value Is decreased by adding the Inhibitor.
The amount of stimulation observed In nuclei treated with 
Fr-18 Is comparable with nuclei treated with oocyte extract, 
despite a 20-fold dilution by the column procedure. This 
Increase In activity by dilution may be produced by loss of some 
inhibitor of transcription, or the loss of any RNases that are 
present In the oocyte extract.
The Sephadex results show that the stimulation of RNA 
polymerase I transcription In nuclei plus egg extract Is produced 
either by a single protein species or by multiple protein species 
of the same molecular weight. Although the stimulation seen In
FIGURE 5.3
Oocyte C100 Column Assay with Erythrocyte Nuclei, Egg Extract 
and Fr-ltf.
The column fractions described in Figure 5.1 were assayed 
using erythrocyte nuclei (5 x lO^nuclel/assay), 7 pi egg extract,
7 pi Fr-18 and 7 pi column fraction in a final 50 pi volume.
These were preincubated for 60 minutes, supplemented with salts
etc and Incubated for a further 30 minutes. Samples were taken at *
0 and 30 minutes of the incubation
FIGURE 5.4
Oocyte G100 Column Assay with Erythrocyte Nuclei and 
Semi purified RNA Polymerases. 10
10 pi aliquots of the oocyte C100 column fractions were 
preincubated with 5 x 10^erythrocyte nuclei, 100 pg/ml of-amanltln 
plus semlpurifled RNA polymerases In a final volume of 50 pi. 
After 60 minutes the assays were supplemented with salts etc and 
incubated for 30 minutes. 2x10 pi samples were taken at 0 and 30 
minutes of the Incubation to determine the RNA polymerase I
activity.
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nuclel treated with oocyte extract la more than accounted for by 
this peak, It Is still possible that there Is a second oocyte 
component which depends not only on the presence of RNA 
polymerase 1, but also on the presence of Fr-18. Therefore, the 
column assay was repeated, this time having both egg extract and 
fraction 18 within the assay mix [FIG 5.3]. No other regions 
within the column yielded any Increase In activity, the only peak 
in transcription observed being that around fraction 18. It 
appears, therefore, that only Fr-18 is required for RNA 
polymerase I transcription of erythrocyte rRNA genes, or, If 
something else is necessary, it is present In the egg extract.
In order to test If there was anything In the egg extract 
that was necessary to see a peak at fractions 17-19 apart from 
the RNA polymerases, the egg extract was substituted by a crude 
RNA polymerase preparation. The resulting assay [FIG 5.4] showed 
a similar peak of activity In fractions 17-19 to that obtained 
with an egg extract. It is resistant to 100 pg/ml or-amanitin 
Indicating that it is RNA polymerase I that is required. The RNA 
polymerase preparation was crude, being only a 10-40X (NH^Jj SO^ 
precipitate of an oocyte extract, so it is possible that it 
contains another essential substance, that is also present in the 
egg extracts.
There remains the possibility that Fr-18 does not have a 
specific effect on the transcription of the ribosomal genes by 
RNA polymerase I. (That the ribosomal genes are Involved will be 
shown in Chapters VI and VII). Two possibilities for this 
non-specific function are that the fraction contains further RNA 
polymerase and the presence of a DNA nicking enzyme. These can be 
ruled out. Although excess RNA polymerase I has no effect on
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FIGURE 5.5
Oocyte Cl00 Column Assay with poIy[d(A-T)].
The oocyte C100 column fractions were tested for RNA 
polymerase activity by Incubating 20 pi aliquots of the fractions
with 2 pg poly[d(A-T)] In 50 pi assays for 30 minutes (o---o). A
parallel series of assays were carried out on 10 pi aliquots of 
the column fractions with 10 pi egg extract and 5 x 10^  nuclei
(+---►). These were preincubated for 60 minutes, supplemented and
incubated for a further 30 minutes. In both cases 2x10 pi samples 
were taken at 0 and 30 minutes of the Incubation.
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erythrocyte nuclei and the molecular weight of an RNA polymerase 
would ensure that It would pass through the column In the void 
fraction, It could be argued that Fr-18 contains some kind of RNA 
polymerase activity. However, as Figure S.S shows, when the 
column fractions are assayed using poly[d(A-T)] as template no 
activity is seen In any of the fractions, including fraction 18.
It is a little surprising that the early fractions contain no RNA 
polymerase activity. However the fractions were stored at -20® C 
without glycerol or any other stabilizing chemical, which 
together with the relatively small amount of RNA polymerase 
activity in the original extract and the 20-fold dilution may 
explain the lack of subsequent RNA polymerase activity in the 
column fractions.
It is known that both RNA polymerases I and II 
preferentially initiate transcription at single stranded sites 
within the double stranded DNA template (Selfart, 1971). Thus if 
fraction 18 contained a nicking enzyme, its stimulatory activity 
could be a reflection of its ability to produce unspecific breaks 
in the erythrocyte DNA. This does not, however, explain why only 
stimulation of RNA polymerase I is seen, since RNA polymerase II v
is also present in the egg extract. The column fractions were 
again assayed, but this time using the supercolled plasmid pXlrl4 
in place of the nuclei. In this way, by incubating the plasmid in 
Identical salt conditions to the nuclear assay followed by 
Isolating the DNA and running it out on an agarose gel, it was 
possible to detect nicking by the disappearance of supercolls.lt 
is known that an oocyte extract contains a variety of enzymes, 
including nlcklng-closing enzymes, that would cause a supercolled 
plasmid to become relaxed.None of these are associated with 
fractions 17-19; rather they are found at fractions 10-13 [FIC
10 15 2 c T
Fraction Number
FIGURE 5.6
DNA Nicking Activity In the Oocyte G100 Column Fractions.
0.3 pg samples of plasmid pXlrlA were incubated in a 
standard Incubation mix with 10 pi each column fraction at 25#C 
in a series of 25 pi assays. After 90 minutes 0.1 pg pXUOl was 
added as carrier, the samples were extracted once with 
phenol-chloroform (1:1), once with chloroform, made 0.3 M sodium 
acetate and ethanol precipitated. The precipitated DNA was taken 
up in sample buffer and run on a 0.8Z agarose gel overnight. The 
gel was stained with ethidium bromide and photographed under UV 
light.
FIGURE 5.7
Heat Inactivation of Fr-18.
50 pi samples of oocyte C100 column fractions 10-27 were 
boiled for 10 minutes and cooled before 10 pi of each was added
to a standard 50 pi column assay (+---1-; 5xl(? nuclei, 10 pi egg
extract). A parallel assay was carried out using unboiled column
fractions (o---o). The assays were preincubated for 60 minutes,
supplemented and Incubated for a further 30 minutes. Duplicate 10 
pi samples were taken at the beginning and end of the Incubation.
i
TABLE 5.2
Trypsin Inactivation of Fr-18.
Preincubation Ingredients; pmoles UMP incorp.
/10^nuclei/30 mins.
Nuclei + buffer 7.6
oocyte extract 23.7
boiled oocyte extract 7.9
trypsin x oocyte extract 7.3
Fr-18 24.7
trypsin x Fr-18 7.9
trypsin-trypsin inhibitor x oocyte extract 19.5
trypsin-trypsin inhibitor x Fr-18 22.7
100 pi samples of an oocyte extract and Fr-18 were incubated 
with trypsin or trypsin plus trypsin inhibitor for 30 minutes. 
Trypsin inhibitor was added to the trypsin digestions at the end 
of this time. A 50 pi sample of oocyte extract was also boiled 
for 10 minutes. These samples (10 pi) were preincubated with 5xl(? 
nuclei and 10 pi egg extract for 60 minutes before being 
supplemented with salts etc and incubated for a further 30 
minutes. As controls, nuclei were preincubated with 10 pi of 
column buffer or 10 pi oocyte extract and 10 pi egg extract. 
Protein samples were incubated with trypsin at 500 pg/ml for 15 
■inutes at 37*C prior to the addition of trypsin inhibitor (500 
fig/ml) and assay.
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5.6]. This does not rule out a nicking enzyme being a functional 
component in the stimulation by Fr-18, since these would be 
present in the egg extract, and possibly in the RNA polymerase 
preparation as well. However, since neither of these on their own 
have any effect on transcription of erythrocyte chromatin by RNA 
polymerase I, some other component of the oocyte must still be 
necessary to stimulate RNA polymerase I.
It can be shown that the active component of fraction 18 is, 
or includes, a protein by demonstrating its sensitivity to 
trypsin treatment and boiling. As Figure 5.7 shows, boiling the 
column fractions results in the loss of the peak, at fractions 
17-19. Other components of the oocyte extract are also heat 
degradable [TABLE 5.2], eg RNA polymerases, and extra have to be 
supplied, in this case as egg extract. After trypsin treatment 
both the oocyte extract and Fr-18 lose their ability to stimulate 
RNA polymerase I activity [TABLE 5.2]. Egg extract was also added 
to these assays as the RNA polymerase I source. If trypsin 
inhibitor is added at the same time as the trypsin, Instead of 
before the transcription assay, the oocyte extract and Fr-18 do 
not lose any potency. Therefore it is likely that that whatever 
is bringing about this effect is a protein.
Sephadex G100 Column Chromatography of Germinal Vesicle and 
Enucleated Oocyte Extracts.
It has been demonstrated previously (Chapter IV) that the 
protein responsible for bringing about transcription by RNA 
polymerase I is located within the germinal vesicle of the 
oocyte. An enucleated oocyte extract has no effect on erythrocyte 
nuclear transcription, even when excess RNA polymerases are
FIGURE 5.8
Fractionation by Sephadex GLOO of an Enucleated Oocyte Extract.
150 pi of an enucleated oocyte extract was loaded onto a 
Sephadex C100 column (2 cm diameter x 23 cm) and the resulting 30 
drop fractions collected and stored at -20®C. 10 pi aliquots of 
these fractions were added to 50 pi column assays (5xlC? nuclei, 
10 pi egg extract), preincubated for 60 minutes, supplemented and 
Incubated for 30 minutes. 2x10 pi samples were taken at 0 and 30 
minutes of the incubation.
FIGURE 5.9
Fractionation by Sephadex G100 of an Oocyte Germinal Vesicle 
Extract.
100 pi of an oocyte germinal vesicle extract was loaded onto 
a Sephadex G100 column (2 cm diameter x 23 cm), 30 drop fractions 
were collected and stored at -20*C. 10 pi aliquots of fractions 
10 to 27 were preincubated with 5xl0^nuclel and 10 pi egg extract
with (H--- 0  or without (o-- o) 100 pg/ml oramanltln. After a 60
minute prelncubatlon period the assays were supplemented and
Incubated for 30 minutes.
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present. Sephadex G100 columns were run of both oocyte components 
- the germinal vesicle and the remaining cytoplasm. When assayed, 
using an egg extract as the RNA polymerase source, the enucleated 
oocyte column [FIG 5.8] yielded no peaks of higher 
transcriptional activity. None of the resulting column fractions 
had any effect on transcription. The germinal vesicle column gave 
one peak of heightened transcriptional activity - fractions 17-19 
[FIG 5.9]. This corresponds In Its location to the peak seen when 
an extract of whole oocytes Is fractionated. The activity has an 
estimated molecular weight of 19750 to 21250 daltons. The level 
of transcription seen in this peak is somewhat lower, which is to 
be expected since only 50 germinal vesicles were loaded onto this 
column, as compared with 100 whole oocytes that were normally 
used. As expected, or-amanltln shows that the Increased 
transcription In the nuclei Incubated with fractions 17-19 is a 
result of RNA polymerase I [FIG 5.9]. Therefore the active 
component found In the oocyte extract G100 column fractions is 
located in the oocyte nucleus.
Sephadex G100 Column Chromatography of Egg Extract.
In terms of transcription by RNA polymerase I, an egg 
extract elicits no response when Incubated with erythrocyte 
nuclei, despite containing that RNA polymerase. This does not 
necessarily mean that the stimulatory protein found In the oocyte 
extracts is absent from the egg extract, although this Is the 
simplest explanation. It could be chemically modified eg 
glycosylated or phosphorylsted, or perhaps be tightly bound to or 
In equimolar amounts with an Inhibitor. An egg extract was run 
through a Sephadex G100 column and the resulting fractions 
assayed In the standard way. As Figure 5.10 shows, there is no
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FIGURE 5.10
Fractionation by Sephadex G100 of an Egg Extract.
A 200 pi aliquot of egg extract was loaded onto a G100 (2 cm 
diameter x 23 cm) and the resulting 30 drop fractions collected 
and stored at -20*C. Three column assays using these fractions 
were carried out, 5x10^nuclei were preincubated with 20 pi column
fraction (o-- o), 10 pi column fraction plus 10 pi egg extract
(H---+) or 10 pi column fraction, 10 pi egg extract and 100 pg/ml
or-amanltln (•-- a). These were preincubated for 60 minutes,
supplemented and Incubated for 30 minutes.
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FIGURE 5.II
Eg g GI00 Column Assay with Erythrocyte Nuclei and Semlpurlfted 
RNA Polymerases.
15 pi of egg C100 column fractions 9 to 28 were added to 
5xl0^nuclei and semipurified RNA polymerase with oeamanitin at 
100 pg/ml in a final volume of 50 pi, such that only RNA 
polymerase I transcription was possible. These were preincubated 
for 60 minutes, supplemented and Incubated for a further 30 
minutes. Samples (2x10 pi) were taken at 0 and 30 minutes of the 
incubation period.
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FIGURE 5.12
Fractionation by Sephadex C100 of an Early Cleavage Extract.
100 pi of an early cleavage embryo extract was loaded onto a 
G100 column (2 cm diameter x 23 cm) and the resulting 30 drop 
fractions collected and stored at -20aC prior to being assayed. 
Three column assays were carried out, 5x10^ nuclei were
preincubated with 20 pi column extract (o-- o), 10 pi column
fraction and 10 pi egg extract (+— -+) or 10 pi column fraction,
10 pi egg extract and 100 pg/ml oramanltln (•-- a ) . These were
preincubated for 60 minutes, supplemented and Incubated for 30
minutes.
FICURE 5.13
Fractionation by Sephadex C10Q of a Gastrula Extract.
100 ul of a gastrula extract was loaded onto a C100 column 
(2 cm diameter x 23 cm) and the resulting 30 drop fractions 
collected and stored at -20*C. Three column assays were carried 
out, 5x10^ nuclei were preincubated with 20 pi column fraction
(o-- o), 10 pi column fraction plus 10 pi egg extract (+---►) or
10 pi column fraction, 10 pi egg extract and 100 pg/ml a-amanltln 
(•-- •). These were preincubated for 60 minutes, supplemented and
Incubated for 30 minutes.
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FIGURE 5.14
Fractionation by Sephadex GI00 of a Heurula Extract.
100 pi of a neurula extract was loaded onto a G100 column (2 
cm diameter x 23 cm) and the resulting 30 drop fractions 
collected and stored at -20*C. Three column assays were carried 
out, 5x10'’ nuclei were preincubated with 20 pi column fraction
(o-- o), 10 pi column fraction and 10 pi egg extract (+---►) or
10 pi column fraction, 10 pi egg extract and 100 pg/ml a-amanltln 
(•-- •). These were preincubated for 60 minutes, supplemented and
Incubated for 30 minutes.
-84-
peak of activity In any of the column fractions. This assay used 
egg extract as the RNA polymerase source, but the same result was 
obtained using the crude RNA polymerase preparation [FIG 5.11]. 
Even with Increased sensitivity found by inhibiting RNA 
polymerases II and III with ocamanitin, no peak could be seen. 
Therefore there is no free activator protein as found in the 
oocyte extract. This kind of analysis shows only that the 
activity is absent, the protein could nevertheless be present in 
an inactive form.
Sephadex G100 Column Chromatography of Embryo Extracts.
Similar columns to those described above were run using a 
series of embryo extracts from early cleavage, gastrula and 
neurula stage embryos.They were assayed with or without 
cr-amanltin using an egg extract as the RNA polymerase source. 
That from early cleavage embryos showed no peak of activity [FIG 
5.12]. This lack of any stimulatory peak, similar to an egg 
column assay, is not surprising since the early cleavage extract 
has no effect on transcription in erythrocyte nuclei (Chapter 
IV). There would appear to be a slight peak of Increased 
transcription in the fractions collected from a gastrula G100 
column [FIG 5.13]. Although this activity appears to correspond 
to where the oocyte activating protein, Fr-18 would be and the 
transcription that results is resistant to ce-amanitin, the amount 
of transcription is scarcely above background. In the neurula 
column fractions, however, a definite peak is seen [FIG 5.14]. 
Since the transcription seen is resistant to ocamanitln it is due 
to RNA polymerase I. The three sets of column fractions were also 
assayed using the crude RNA polymerase preparation Instead of an
egg extract. As Figures 5.15, 5.16 and 5.17 show, the results are
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FIGURE 5.15
Early Cleavage G100 Column Assay with Erythrocyte Nuclei and 
Semlpurlfled RNA Polymerases.
15 pi of the early cleavage G1Û0 column fractions 9 to 27 
were added to 5xl0^nuclei and semlpurlfled RNA polymerases with 
100 pg/ml oramanitin in a final volume of 50 pi such that only 
transcription by RNA polymerase I was possible. These were
preincubated for 60 minutes, supplemented and incubated for a 
further 30 minutes.
FIGURE 5.16
Gastrula G100 Column Assay with Erythrocyte Nuclei and 
Semlpurlfled RNA Polymerases.
15 pi of the gastrula G100 column fractions 9 to 27 were
added to 5x10^ nuclei and semipurified RNA polymerases with 100 
pg/ml or-amanitin in a final volume of 50 pi such that only 
transcription by RNA polymerase I was possible. These were
preincubated for 60 minutes, supplemented and incubated for a 
further 30 minutes.
FICURE 5.17
Neurula G100 Column Assay with Erythrocyte Nuclei and 
Semlpurlfled RNA Polymerases.
15 pi of the neurula G100 column fractions 9 to 27 were
added to 5x10^ nuclei in a 50 pi assay with semipurified RNA 
polymerases and 100 pg/ml oramanitin so that only RNA polymerase 
I transcription was possible. There were preincubated for 60 
minutes, supplemented and Incubated for a further 30 minutes.
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FIGURE 5.18
Heat Inactivation of "Fr-18" from Neurula G100 Column.
50 jil of neurula G100 column fractions 9-27 were boiled for 
10 minutes and cooled before 10 pi of each was added to a
standard 50 |il column assay (+---*■; 5x10^ nuclei, 10 pi egg
extract). A parallel assay was carried out using unboiled column
fractions (o---o). The assays were preincubated for 60 minutes,
supplemented and incubated for a further 30 minutes. Duplicate 10 
pi samples were taken at the beginning and end of the incubation.
TABLE 5.3
Trypsin Inactivation of Active Component from a Neurula G100 
Column.
Prelncubatlon Ingredients; pmoles UMP lncorp.
/10^nuclei/30 mins.
Nuclei + buffer 7.7
neurula G100 peak 15.1
boiled neurula G100 peak 7.6
trypsin x neurula G100 peak 7.2
trypsin-trypsin inhibitor x neurula G100 peak 14.9
100 jil samples of neurula G100 fraction 18 were either 
boiled for 10 minutes, incubated with trypsin or incubated with 
trypsin and trypsin inhibitor. Trypsin inhibitor was added to the 
trypsin digestion after the 30 minute incubation. Erythrocyte 
nuclei were preincubated with 10 jjl aliquots of the above samples 
and 10 pi egg extract. After the 60 minute prelncubatlon the 
assays were supplemented with salts etc and incubated for a 
further 30 minutes.
Trypsin digestions were carried out a6 detailed In Table 5.2.
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FIGURE 5.19
Fractionation by Sephadex G100 of a Combined Oocyte and Neurula 
Extract.
100 pi of an oocyte and a neurula extract were combined and 
loaded onto a Sephadex C100 column (2 cm diameter x 23 cm ), the 
30 drop fractions were collected and stored at -20*C. These were 
assayed In two standard column assays (10 pi column fraction, 10 
pi egg extract, SxlO^nuclel In a final volume of 50 pi) with
(+---+) or without (o-- o) 100 pg/ml or-amanltln. After a 60
minute prelncubatlon the assays were supplemented and Incubated 
for a further 30 minutes.
a
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the same, indicating that the lack of any stimulatory proteins in 
early cleavage embryos is not an artefact from using an egg 
extract as the RNA polymerase source. As Figure 5.18 shows, the 
peak of transcriptional activity seen in fractions 17-19 of the 
neurula column are heat inactivated. Similarly, the peak's 
ability to permit RNA polymerase I transcription of erythrocyte 
chromatin is lost by trypsin digestion [TABLE 5.3]. Since this 
protein would appear to run in a corresponding place to Fr-18 
isolated from an oocyte G100 column, the two proteins would 
appear to be very similar if not the same, in terms of molecular 
weight.
On combining an oocyte extract with a neurula extract, 
running the resulting mixture through a Sephadex G100 column and 
assaying in the normal manner, only one peak is found in 
fractions 17-19 [FIG 5.19]. It is no broader than that observed 
in oocyte or neurula unmixed columns, neither is there any 
evidence for a shoulder to this peak. Therefore, if these two 
proteins are not the same, then their molecular weights are very 
similar. The appearance of this protein, its lack in both egg and 
early cleavage extracts, its possible presence in the gastrula 
extract and its definite presence in neurula and oocyte extracts 
parallels the ability of the crude extracts to bring about RNA 
polymerase I activity on erythrocyte chromatin. Also it 
more-or-less mirrors the appearance of rRNA synthesis during 
embryonic development, although some workers (Shiokawa e_t al, 
1981a, b) would set the beginning of rRNA synthesis earlier in 
mid to late blastula stage embryos. This apparent lag could be a 
reflection of the small amount of starting material in the case 
of the blastula embryo extract. Although de novo rRNA 
synthesis can be seen in these embryos, only a small percentage
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FIGURE 5.20
Effect of NaCl on Transcription by Erythrocyte Nuclei.
To a series of 50 pl incubations (5xlC^ nuclei, 0.5xRB, 1 mM 
MnCl , 120 mM KC1, 0.4 mM ATP, CTP, GTP, 0.02 mM v’TP and 2 pCi 
^H-UTP) was added increasing amounts of NaCl from 0 to 90 mM. 
These were Incubated for 30 minutes, duplicate 10 pi samples 
being taken at 0 and 30 minutes.
(o-- o) nuclei alone; (+---0  nuclei plus egg extract.
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(Shiokawa et al, 1981a, b) of the embryonic cells are 
actually transcribing rRNA sequences. More cells start to 
synthesize rRNA as development proceeds (Woodland and Gurdon, 
1968; Mlsumi £t al, 1980; Shlokawa jit _al, 1981a, b).
Although a protein that affects RNA polymerase I activity In 
erythrocyte nuclei can be Identified on an oocyte or neurula G100 
column, no fraction was found that affected RNA polymerases II 
and III. So whilst incubation with an oocyte or a neurula extract 
brings about an Increase in the activity of all the RNA 
polymerases, no protein was isolated that affected RNA 
polymerases II or III from these columns. The observed 
stimulation of these RNA polymerases by oocyte and neurula 
extracts could be produced by agents also present In the egg and 
RNA polymerase preparation.
DEAE Cellulose Chromatography of Oocyte Extracts.
A Sephadex G100 column will only separate proteins on the 
basis of their size. In order to determine whether there Is one 
or more active protein types in Fr-18 and whether this Is the 
same as that found In the neurula column fractions at the same 
place, another method of column chromatography was used, that of 
DEAE cellulose, which depends on charge.
An oocyte extract was loaded on a DEAE cellulose column and 
all the non-binding proteins washed off before a NaCl gradient 
was applied. Figure 5.20 demonstrates that increasing the Na 
concentration has little or no effect on transcription by 
erythrocyte nuclei with or without an egg extract present. This
Is somewhat surprising since the monovalent cation Included In
FIGURE 5.21
Fractionation by DEAE cellulose of an Oocyte Extract.
A 300 pi sample of an oocyte extract was loaded onto a DEAE 
cellulose column (2 cm diameter x 2.5 cm )which was washed 
through with column buffer until the OD of the eluate was zero. A 
0-0.45 NaCl gradient was passed through the column, 30 drop 
fractions collected and stored at -20*C. These were assayed in a 
standard 50 pi column assay with either erythrocyte nuclei alone
(o-- o), erythrocyte nuclei plus egg extract (+— -+) or
erythrocyte nuclei, egg extract and 100 pg/ml a-amanitin (e-- e).
The assays were preincubated for 60 minutes, supplemented and 
Incubated for 30 minutes.
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FIGURE 5.22
Heat Inactivation of the Active Component Separated on a DEAL 
cellulose Column.
50 pi samples of oocyte DEAE cellulose column fractions 8-32 
were boiled for 10 minutes and cooled before 10 pi of each was 
added to a standard 50 pi column assay (5xl(? nuclei, 10 pi egg
extract; -I--- »■). A parallel assay was carried out using unboiled
column fractions (o---o). Both assays were preincubated for 60
minutes, supplemented and Incubated for a further 30 minutes.
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FIGURE 5.23
Oocyte DEAE cellulose Column Assay with Erythrocyte Nuclei and 
Semlpurlfled RNA Polymerases.
15 pi of fractions 8-32 from an oocyte DEAE cellulose column 
were added to 5x10^ nuclei, semlpurlfled RNA polymerases and 
ot-amanltln at 100 pg/ml in a final volume of 50 pi. Only 
transcription by RIJA polymerase I was possible. These were 
preincubated for 60 minutes, supplemented and Incubated for a 
further 30 minutes.
TABLE 5.4
Inactivation of Active Component from an Oocyte DEAE Column. 
Preincubation Conditions; pinoles UMP incorp.
/ 1 nuclei/30 mins.
Nuclei + buffer 7.8
oocyte DEAE peak 19.5
boiled oocyte DEAE peak 7.6
trypsin x oocyte DEAE peak 6.9
trypsin-trypsin inhibitor x oocyte DEAE peak 20.1
100 pi samples of pooled fractions 18 and 19 from an oocyte 
DEAE column [FIG 5.21] were either boiled for 10 minutes, 
incubated with trypsin or trypsin plus trypsin inhibitor. Trypsin 
inhibitor was added to the trypsin digestion after the 30 minute 
incubation. Erythrocyte nuclei were preincubated with 10 pi 
aliquots of the above samples , or untreated DEAE pooled 
fractions 18-19, and 10 pi ega extract. After the 60 minute 
prelncubatlon, the assays were supplemented with salts etc and 
incubated for a further 30 minutes.
Trypsin digestions were carried out as detailed In Table 5.2.
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FIGURE 5.24
Fractionation by DEAE cellulose of Fr-I8.
A 3 ml sample of pooled fractions 17-19 from an oocyte G100 
column were loaded onto a DEAE cellulose column (2 cm diameter x
2.5 cm). The column was washed with column buffer before the NaCl 
gradient was applied and the resulting 30 drop fractions 
collected and stored at -20°C. 10 pi samples of these fractions 
were added to 50 ul column assays (5xltr* nuclei, 10 pi egg
extract) either without (o-- o) or with (+---b) ocamanltin at 100
pg/ml. the assays were preincubated for 60 minutes before being 
supplemented and incubated for a further 30 minutes.
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the basic transcription recipe, potassium, has a sharp optimal 
concentration (FIG 3.2A), and sodium Ions are not normally 
Included. The column fractions from the DEAE column were assayed 
using an egg extract as the polymerase source (FIG 5.21). Only a 
single peak of Increased transcription was seen, it was eluted 
from the column by 190 mM NaCl just after the majority of the 
bound oocyte proteins have been eluted. By the addition of 
aramanitln to the column assay it can be shown that the Increased 
transcription Is due to RNA polymerase I [FIG 5.21]. There is no 
sign of any increase in the activity of the other two RNA 
polymerases, and Incubating the column fractions with erythrocyte 
nuclei alone has no effect on transcription [FIG 5.21]. To check 
that the Increased transcriptional activity is not an artefact of 
the salt concentration, the column fractions were dialysed 
against Na-free column buffer and then assayed in the normal way. 
As can be seen [FIG 5.22], the peak of increased, or-amanitln 
resistant, transcriptional activity is still present in fractions 
18 and 19. This peak is still present if the egg extract is 
replaced by the crude RNA polymerase preparation [FIG 5.23]. 
Table 5.4 shows that the active component of fractions 18 and 19 
of the DEAE salt gradient is a protein, since is it is heat 
degradable and trypsin sensitive.
To determine whether the oocyte proteln(s) isolated from the 
G100 column is the same as that Isolated from the DEAE column, a 
sample of pooled fractions 17-19 from the G100 column was loaded 
onto a DEAE column and salt eluted. Only one peak, eluted by 190 
mM NaCl, was shown by the transcription assay [FIG 5.24]. It is 
eluted from the column by the same concentration of NaCl as the 
protein from the total oocyte extract. The amount of stimulation
observed on incubating these column fractions (fractions 17-18)
FICURE 5.25
Fractionation by DEAE cellulose of an Egg Extract.
A 300 pi sample of an egg extract was loaded onto a DEAE 
cellulose column (2 cm diameter x 2.5 cm). The column was washed 
with column buffer before the NaCl gradient was applied and the 
resulting 30 drop fractions collected and stored at -20*C. 10 pi 
samples of these fractions were added to 50 ul column assays
(5x10^ nuclei, 10 pi egg extract; o-- o). The assays were
preincubated for 60 minutes, supplemented and Incubated for 30
minutes
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FIGURE 5.26
Fractionation by DEAE cellulose of Pooled Fractions 17-19 from 
an Egg G100 Column.
3 ml of the pooled egg G100 column fractions were loaded 
onto a DEAE cellulose column (2 cm diameter x 2.5 cm). The column 
was washed with column buffer before the NaCl gradient was 
applied and the resulting 30 drop fractions collected and stored 
at -20*C. 10 pi samples of the fractions were added to a standard 
column assay (10 pi column fraction, 10 pi egg extract, 5xl(i 
nuclei In a final volume of 50 pi). These were preincubated for 
60 minutes, supplemented and Incubated for 30 minutes.
i05l
NqCI]
M
(------- )
0 25
FIGURE 5.27
Fractionation by DEAE cellulose of a Neurula Extract.
A 150 pi sample of a neurula extract was loaded onto a DEAE 
cellulose column (2 cm diameter x 2.5 cm). This was washed with 
column buffer before the NaCl gradient was applied, the resulting 
30 drop fractions were collected and stored at -20*C. 10 pi 
samples of these fractions were added to a standard column assay 
(5x10^ nuclei, 10 pi column fraction, 10 pi egg extract) with
(+---*■) or without (o-- o) or-amanitln at 100 pg/ml. These were
preincubated for 60 minutes, supplemented and Incubated for 30
minutes.
FIGURE 5.28
Fractionation by DEAE cellulose of Fractions 17-19 from a 
Neurula G100 Column.
A 3 ml sample of the pooled fractions was loaded onto a DEAE 
cellulose column (2 cm diameter x 2.5 cm) which was washed with 
column buffer before the NaCl gradient was applied. 30 drop 
fractions were collected and stored at -20*C. 10 pi of these 
fractions were added to a standard column assay (5xl(? nuclei, 10 
pi egg extract, 10 pi column fraction) with (+— -+) or without
(o---o) 100 pg/ml oramanitln. These were preincubated for 60
minutes, supplemented and Incubated for 30 minutes.
-88-
with erythrocyte nuclei Is less than that seen with Fr-18, or 
fractions 18-19 from a total oocyte DEAE column. However, this 
can be explained by the two-fold dilution that has taken place on 
running the column. By these purification criteria It would 
appear that only a single protein Is responsible for Inducing RNA 
polymerase I transcription on erythrocyte chromatin.
DEAE Cellulose Salt Elution of Egg and Neurula Extracts.
The peak of transcriptional activity seen In oocyte extracts 
fractionated on DEAE cellulose [FIG 5.21] was absent If the same 
experiment was carried out using an egg extract [FIG 5.25]. This 
agrees well with the data from the G100 column . Neither Is a 
peak of transcriptional activity seen If fractions 17-19 from an 
egg G100 column were fractionated on a DEAE column [FIG 5.26]. 
Thus If an Inhibitor is present in the egg extract and coupled in 
some way with the activator molecule, it must either remain bound 
to It during Sephadex and DEAE chromatography or must co-elute 
with the stimulatory agent In both procedures.
As expected, the neurula extract which yields a stimulatory 
peak on passage through Sephadex G100 also yields a stimulatory 
peak on salt elution from DEAE cellulose [FIG 5.27]. Like Fr-18 
from oocyte extracts, this Is eluted by 190 mM NaCl. The neurula 
G100 fractions 17-19 when salt eluted from DEAE cellulose also 
show a single peak of transcriptional activity at 190 oM NaCl 
[FIG 5.28]; the smaller stimulation was due to dilution effects 
and the small amount of starting material. Both transcription 
peaks, from crude neurula extract or the semlpurlfled G100 
fractions, are a result of RNA polymerase I activity as judged by 
their resistance to 100 pg/ml or-amanitln [FIGS 5.26, 5.27].
Fraction Number;
10 15 20 25

FIGURE 5.29
Acrylamide Gel Analysis of Oocyte G100 Column Fractions.
200 pi of each column fraction was dried down before being 
taken up in 10 pi sample buffer and loaded onto a 18% low bis 
acrylamide gel. This was run overnight until the marker dye had 
migrated to the bottom of the gel. The gel was fixed, silver 
stained (Switzer al, 1979) and photographed. The data for
the column assay is that from Figure 5.2.
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FIGURE 5.30
Acrylamide Gel Analysis of Proteins In Fractions 17-19 of 
Oocyte, Egg and Neurula G100 Columns.
200 yl of pooled fraction 17-19 from an oocyte, egg and 
neurula G100 column were freeze dried before being taken up in 10 
yl sample buffer and loaded onto a 182 low bis acrylamide gel. 
This was run and stained as in Figure 5.29. The data for the RNA 
polymerase I activity in erythrocyte nuclei preincubated with an 
egg extract and these column fractions are those from Figures
5.2, 5.10 and 5.18.
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Visuallzatlon on Acrylamide Gels of the Oocyte Stimulatory 
Protein, Fr-18.
It Is possible that the protein responsible for the RNA 
polymerase 1 transcription Is a minor one within the oocyte 
extract. For Instance, if there was one of these protein 
molecules (of molecular weight 20,000 daltons) for each of the 
1.5-2.5 million rlbosomal genes (Perkowska e£ a_l, 1968) 
present In the oocyte, this would only amount to 0.07 pg of 
Fr-18/oocyte. This is, however, a minimum estimate since It Is 
likely that there Is more than one Fr-18 molecule per ribosomal 
RNA gene in the cell. For maximum sensitivity, the silver 
staining technique of Switzer et al, (1979) was used on 
oocyte G100 column fractions that had been analysed on acrylamide 
gels. Oocyte extracts contain a multitude of different sized 
proteins, several of which are present in fraction 18 [FIG 5.29]. 
It is likely that Fr-18 is present In oocyte and neurula 
extracts, but absent from egg extracts. Only one protein that Is 
abundant in fraction 18 shows this distribution [FIG 5.30]. From 
the mobility of marker proteins, this protein has a molecular 
weight of 21,000-22,500 daltons.
The evidence for this protein seen on the stained acrylamide 
gels being Fr-18 is clrcumstanclal and not rigorous. Silver 
staining of all column fractions from an oocyte DEAE cellulose 
column was attempted but no proteins at all were visible from 
fraction 15 onwards, and the high concentration of salt coupled 
with the low concentration of protein made analysis difficult.


FIGURE 5.31
Migration of Oocyte Proteins Into Erythrocyte Nuclei.
Erythrocyte nuclei in a standard 50 pi assay (5x10^ nuclei) 
were preincubated with either 20 i^l of a^S-oocyte extract (Track 
D), or 20 |il of Fr-18 (Track E) from a ^ S-oocyte G100 column. 
After a 60 minute preincubation the nuclei were spun out of the 
buffer washed twice with 100 jil of RB, and taken up in sample 
buffer. These were loaded onto a 18% low bis acrylamide gel which 
was run in the normal manner, fixed and stained with Coomassie 
blue and fluorographed before exposure to an X-ray film. 20 jil 
^S-oocyte extract was also preincubated with no nuclei (Track C), 
but spun, washed and loaded onto the gel in the same way. Also 
loaded were samples of the^S-oocyte extract (Track A) and 
separated germinal vesicles (Track B).
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Migratlon of Fr-18 Into Erythrocyte Nuclei.
For Fr-18 to bring about transcription by RNA polymerase I 
either it must pass Into the erythrocyte nuclei or It must exert 
its effect on the RNA polymerase 1 molecules themselves before 
they enter the erythrocyte nuclei. If the latter is the case, 
this modification is lost relatively easily, since partially 
purified RNA polymerase I molecules from the ovary do not 
transcribe erythrocyte chromatin. In the former case, it is 
possible that the protein acts either on the RNA polymerase I 
molecules, eg by loosely binding to them, or on the ribosomal 
genes, perhaps by altering their configuration to allow 
transcription to take place.
An^S-labelled oocyte extract was made by Incubating 
vitellogenic oocytes ii?^S-methionine and processing them in the 
usual way. Nuclei were preincubated with the'’s-oocyte extract in 
a standard preincubation buffer for 60 minutes, the nuclei were 
then isolated and washed to remove any proteins that might have 
stuck unspeciflcally to the nuclei. If this procedure was carried 
out with only tfaft -oocyte extract present and no nuclei, only 
0.002Z of the available counts were left. The proteins extracted 
from the nuclei were run out on an acrylamide gel, fluorographed 
and exposed to an X-ray film. About 28Z of the available counts 
in the oocyte extract become associated with the erythrocyte 
nuclei and these counts represent a number of proteins of 
differing molecular weights [FIG 5.31]. The^S-oocyte extract was 
fractionated on G100 Sephadex, and nuclei preincubated with each 
fraction in th e  same way as with the total extract. A certain 
amount of the radioactivity from the main column peak becomes
associated with the erythrocyte nuclei [FIG 5.32], but this
cpm
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FIGURE 5.32
Migration of Oocyte Proteins Into Erythrocyte Nuclei.
A 200 pi sample of the \-oocyte extract was loaded onto a 
G100 column (2 cm diameter x 23 cm) and the 30 drop fractions 
collected and stored at -20*0. 20 pi samples of these fractions 
were preincubated with 5x10^ nuclei In a standard 50 pi column 
assay. After the 60 minute prelncubatlon the nuclei were spun 
down, washed twice with RB and taken up In 20 pi RB. Duplicate 10
pi samples from each were counted (+-- +), as were 10 pi samples
of each column fraction (o-- o).
-91-
represents only 5.6X of the counts available. When nuclei were 
incubated with the fraction corresponding to fraction 18 of the 
original oocyte G100 columns, 2IX of the counts available 
associate with the nuclei [FIG 5.32] as compared with about 6Z in 
the surrounding fractions. It would appear therefore, that a 
protein (or proteins) present in fraction 18, becomes associated 
with the erythrocyte nuclei during the prelncubatlon stage of the 
transcription assay and remains there.
The proteins extracted from nuclei preincubated in this way 
were analysed on acrylamide gels as before. Nuclei preincubated 
with ^V-fraction 18 proteins only retain a single protein [FIG 
5.31], this band is seen when nuclei are preincubated with total 
S-oocyte extract. From marker proteins run on the gels, this 
protein has a molecular weight of 21,000-22,500 daltons. Its 
migration through the acrylamide gel corresponds to that of the 
protein, present in oocytes and neurula embryos but not eggs, 
suggested by silver staining [FIG 5.30]. This protein was 
labelled by Incubation of large oocytes with^S-methlonine and 
therefore must be synthesized during late oogenesis insplte of 
the fact that the amplified rDNA is activated at mid-oogenesis. 
So It might be that Fr-18 has a relatively short half life as 
compared to the time taken to transcribe the oogenetic rRNA and 
the protein is required throughout this stage.
Effect of Fr-18 on Transcription by Erythrocyte Nuclei.
Incubation of erythrocyte nuclei with an oocyte extract 
brings about newly initiated DNA-dependent RNA polymerase I 
transcription. It will be shown in Chapter VI that the product of 
this transcription is rlbosomal RNA. The effect of Fr-18 is
TABLE 5.5
Effect of Rifamycin AF/013 and Actinomycin D on Transcription by 
Erythrocyte Nuclei Preincubated with Egg Extract and Fr-18. 
Preincubation Conditions pinoles UMP lncorp.
/lCPnuclei/30 mins.
Nuclei + buffer 5.7
egg extract 12.6
oocyte extract 33.6
Fr-18 5.5
egg extract + Fr-18 23.7
egg extract, Fr-18 + Actinomycin D 0.02
egg extract, Fr-18 + Rifamycin AF/013 0.06
Erythrocyte nuclei (5x10^ nuclei/50 pi assay) were preincubated 
with 20 pi buffer, egg extract, oocyte extract or Fr-18. Similar 
preincubations were carried out with 10 pi egg extract, 10 pi 
Fr-18 and either 100 pg/ml Actinomycin D, 50 jig/ml Rifamycin 
AF/013 or neither. After the 60 minute preincubations the assays 
were supplemented and Incubated for a further 30 minutes.
20 -
R N A  Polymerase; I II III I I I  I I I  I II  I I I  I I I  I I I
Nuclei ♦ b u ffe r  egg extract oocyte eqg extract
e xtra c t ♦ Fr-18
FICURE 5.33
Relative Levels of the Three RNA Polymerases In Nuclei 
Preincubated with Egg Extract and Fr-18.
Duplicate 50 pi assays (5xlC? nuclei) were preincubated with 
20 pi buffer, egg extract or oocyte extract, or 10 pi egg extract 
and 10 pi Fr-18. with 0, 1 or 100 pg/ml of-amanltin. After 60 
minutes the assays were supplemented and Incubated for a further
30 minutes.
TABLE 5.6
Time of Addition of Fr-18.
Ingredients During; pmoles IMP incorp.
Preincubation Incubation /10^nuclei/30 mins.
egg extract + Fr-18 egg extract + Fr-18 23.0
buffer egg extract + Fr-18 19.6
Fr-18 egg extract + Fr-18 22.7
egg extract egg extract + Fr-18 18.8
egg extract egg extract 10.3
Fr-18 Fr-18 5.3
Fr-18 egg extract 22.9
5x10 nuclei were preincubated with buffer, Fr-18 and egg 
extract as in the table above in a final volume of 50 pi. After 
60 minutes the nuclei were spun down, washed in RB and taken up 
in an Incubation mix as outlined above. A 30 minute Incubation
followed
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identical to that seen when the total oocyte extract is used, 
provided, of course, that RNA polymerase I is also present. On 
being assayed with an egg extract and Fr-18, erythrocyte nuclei 
show a 6-fold stimulation in total transcription, 67 X of which, 
as judged by or-amanitin inhibition, is as a result of RNA 
polymerase I activity [FIG 5.33]. Incubation with just an egg 
extract or Fr-18 yields no such Increase in transcription [TABLE 
5.5]. The RNA polymerase I transcription is sensitive to both 
Rifamycin SV and actinoraycin D indicating that the RNA polymerase 
I is initiating new chains on a DNA template [TABLE 5.5]. 
However, unlike the oocyte extract, the addition of Fr-18 plus 
excess RNA polymerases has no effect on the activity of RNA 
polymerases II and III [FIG 5.33].
Although in a standard assay both RNA polymerase and Fr-18 
are present during an Incubation, it is not necessary for the RNA 
polymerase I molecules to be present during the prelncubatlon 
step [TABLE 5.6], only Fr-18. If the RNA polymerases are added at 
the end of the prelncubatlon the same stimulation is seen as when 
they were added at the beginning. However, when Fr-18 is added at 
the end of the preincubation, the amount of RNA polymerase I 
transcription is as if there were no preincubation. The degree of 
RNA polymerase I transcription is therefore dependent on the time 
that the active component of Fr-18 is present with the nuclei. It 
therefore seems unlikely, especially as the copurifying band from 
the silver stained column fractions appears to become associated 
with the nuclei, that the active component is modifying the RNA 
polymerase I molecules before they enter the nuclei. It is more 
likely that it modifies the rlbosomal genes in some way.
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CHAPTER VI; FIDELITY OF TRANSCRIPTION BY RNA POLYMERASE I ON 
ERYTHROCYTE NUCLEAR CHROMATIN
In vivo RNA polymerase I transcribes the rlbosomal genes 
to produce a 40S precursor molecule, later cleaved to produce the 
18S, 28S and S.8S rRNA species. It does not transcribe any other 
sequence and Is located exclusively In the nucleoli of active 
cells (Roeder and Rutter, 1970). The remaining RNA transcription 
la carried out by RNA polymerase II to produce hnRNA and mRNA, 
and by RNA polymerase III which transcribes the AS (tRNA) and 5S 
gene sequences. So although the 40S and 5S RNA species are all 
ribosome components, the two RNA species are transcribed by 
different RNA polymerases and are under different control 
mechanisms. The protein described by Engelke et £l (1980) 
seems to be specific to SS gene transcription and to have no 
effect on other gene sequences.
However specific RNA polymerase I may be for the rlbosomal 
genes of Intact cells, Its specificity may not be maintained In 
an _ln vitro transcription system. Although the erythrocyte 
nuclear transcription assay could be considered to be nearer the 
In vivo situation than If a recombinant DNA clone was being 
used as template, It cannot be regarded as a true reflection of 
the 'in vivo system for a number of reasons. Erythrocyte 
nuclei do not normally meet oocyte cytoplasm in a frog, and more 
importantly, the mature erythrocyte does not have transcribing 
rlbosomal genes. Although RNA polymerase I has been shown 
(Grummt, 1981; Crummt et al, 1982) to transcribe recombinant 
rlbosomal genes accurately, It Is possible that In my system It 
Is transcribing unspeclflcally. Specificity can be shown by 
demonstrating that not only Is the RNA produced read from the
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correct strand, but also that Initiation and termination occurs 
at the correct points and that non-transcrlbed spacer regions 
between the genes are not transcribed.
The rlbosoaal genes In Xenopus laevls are tandemly
repeated 470-fold per haploid genome (Brown and Weber, 1968; 
MacGregor, 1968; Gall, 1969) and have a repeat length of about
11.43 kb. The repeat Itself consists of about 3.59 kb of 
non-transcrlbed spacer and 7.84 kb of transcribed sequence [FIG 
6.1] (Boseley et al, 1978; 1979) The actual 40S precursor RNA 
molecule contains the 18S and 28S rRNA molecules plus a small 
5.8S rRNA molecule and three regions of spacer sequence.
Initiation normally occurs at the beginning of the external 
transcribed spacer, although Rungger ^t al (1979) have shown
that some initiation occurs at the partially reduplicated
promoter region (Moss and Birnstiel, 1979) located within the 
non-transcrlbed spacer. The gene repeat therefore contains about 
68.6% transcribed DNA, of which 76Z (or 52X of the entire repeat) 
codes for the 18S and 28S rRNA molecules.
That the RNA made by the oocyte-treated nuclei is a correct 
rRNA transcript can be shown in a number of ways. The two chosen 
here are hybridization to a recombinant DNA probe and 
fractionation by sucrose gradients. Both of these have advantages 
and disadvantages when used with this system, a major problem 
that being the oocyte-treated nuclei synthesize only a very
little RNA. However, this can be maximized by incubating the
(15 (jCl JH-UTP/100 ul assay)
nuclei for longer and with Increase^amounts of^H-UTP present In 
the assay. There Is also a problem that cold rRNA la present In 
the oocyte extract; this can be minimized by using an extract 
prepared with a high speed spin (100,000g), and by spinning out
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FIGURE 6.1
Restriction Map of the Rlbosomal Gene Repeat of Xenopus
Data from Boseley jet al (1978, 1979)
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FIGURE 6.2
Optimal Time for RNA-DNA Hybridization.
Duplicate millipore filters loaded with 1 pg of pXHOl DNA 
were placed in the bottom of 14 scintillation vial Inserts and 
100 pi of hybridization buffer (50% deionized formamide, 3xSSC) 
and probe (^P-28S rRNA at 6.4xl0^cpm/pg, 8.6 ng/vlal) added. 
These were Incubated at 37*c for increasing times. Hybridized 
filters were washed in four washes of 2xSSC, dried and counted 
when all the filters had been processed.
TABLE 6.1 Presence of rP.NA Transcripts from Erythrocyte Nuclei
Preincubated with Various Extracts.
RNA Source Competing cpm Z Internal Standards
RNA binding Eff.32P-18S! RNA 32P-28S RNA
Nuclei + cpm Z Eff. cpm Z Eff
oocyte extract — 18510 16.36 524 19.9 397 20.1
oocyte extract 18S 11806 11.7 19 0.7 373 18.9
oocyte extract 28S 10103 10.2 507 19.25 7 0.35
oocyte extract 18S+28S 4255 4.2 12 0.46 9 0.46
neurula extract — 29377 17.9 530 20.1 369 18.7
neurula extract 18S 18828 11.5 9 0.34 391 19.8
neurula extract 28S 17662 10.8 511 19.4 3 0.15
neurula extract 18S+28S 7105 4.3 16 0.6 5 0.25
egg extract — 23619 19.6 561 21.3 401 20.3
+ Fr-18
egg extract 18S 15146 12.6 20 0.75 409 20.7
+ Fr-18
egg extract 28S 14173 11.8 531 20.2 9 0.46
+ Fr-18
egg extract 18S+28S 5670 4.7 17 0.65 7 0.35
+ Fr-18
1 pg aliquots of pXHOl DNA was loaded onto Mlllipore 
filters and hybridized to the^H-RNA samples listed above. The 
conditions were the same as outlined in Figure 6.2. Competing 18S 
and 28S rRNA was at a final concentration of 50 pg/mlt
t h i s  d e c re a se s  th e  h y b r id iz a t io n  o f the 18S and 28S P-rRNA to
l e s s  than 2X
TABLE 6.1 Presence of rRNA Transcripts from Erythrocyte Nuclei
Preincubated with Various Extracts.
RNA Source Competing cpm Z Internal Standards
Nuclei +
RNA binding Eff.32P-18S RNA 
cpm Z Eff.
3?P-28S
cpm
RNA 
Z Eff
oocyte extract — 18510 18.36 524 19.9 397 20.1
oocyte extract 18S 11806 11.7 19 0.7 373 18.9
oocyte extract 28S 10103 10.2 507 19.25 7 0.35
oocyte extract 18S+28S 4255 4.2 12 0.46 9 0.46
neurula extract — 29377 17.9 530 20.1 369 18.7
neurula extract 18S 18828 11.5 9 0.34 391 19.8
neurula extract 28S 17662 10.8 511 19.4 3 0.15
neurula extract 18S+28S 7105 4.3 16 0.6 5 0.25
egg extract — 23619 19.6 561 21.3 401 20.3
+ Fr-18
egg extract 18S 15146 12.6 20 0.75 409 20.7
+ Fr-18
egg extract 28S 14173 11.8 531 20.2 9 0.46
+ Fr-18
egg extract 18S+28S 5670 4.7 17 0.65 7 0.35
+ Fr-18
1 yg aliquots of pXHOl DNA was loaded onto Milllpore 
filters and hybridized to the^H-RNA samples listed above. The 
conditions were the same as outlined in Figure 6.2. Competing 18S 
and 28S rRNA was at a final concentration of 50 |ig/mlt
t h is  d e c re a se s  the h y b r id iz a t io n  of the 18S and 28S P-rRNA to
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the nuclei after the prelncubatlon and resuspending then In 
extract-free buffer for the Incubation. Sucrose gradients have 
high capacity, thus minimizing any over-loading problem, but 
their resolution is not as high as gel electrophoresis. 
Hybridization analysis has the dual advantages of high 
sensitivity and lack of dependence on the integrity of the 
molecules synthesized.The latter is important if ribonucléase is 
present or if elongation is inefficient. However, any cold rRNA 
present will decrease the efficiency of the hybridization.
H yb rid iz a t io n  to  the  Ribosomal RNA P robe , pXHOl.
The analyses were conducted on erythrocyte nuclei Incubated 
with oocyte extract, neurula extract and egg extract plus Fr-18. 
of-amanitin (100 pg/ml) was present to ensure that only RNA 
polymerase I was active. The three3H-RNA samples were hybridized 
to recombinant plasmid pXliOl which contains the entire ribosomal
gene repeat [FIG 6.1]. The hybridization conditions were
32optim lzed using kinase-labeled P-28S rRNA. The filter bound 
pXHOl and labelled rRNA were incubated for 24 hours to achieve
maximum hybridization [FIG 6.2]. After this time the efficiency
32dropped from 40X as the filters became more fragile. P-18S and 
28S rRNA were used as Internal standards in the subsequent 
hybridizations.
When the hybridizations are carried out [TABLE 6.1] using 
the^H-RNA transcribed by erythrocyte nuclei, the efficiency of 
the system is much less, as Judged by the hybridization of the 
3^-rRNA. This reflects the continuing presence of contasdnating
cold rRNA in the samples, but since the efficiency is still quite 
high (20Z), the amount of cold rRNA is small. In all cases, the
■
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TABLE 6.2
Amount of Transcription of the I6S and 28S Regions by Treated 
Erythrocyte Nuclei.
RRA Source % binding cpm binding to cpm not
nuclei + to rDNA 18S region 28S region competed off
oocyte extract 92.25 6704 8407 4255
neurula extract 89.1 10549 11715 7105
egg extract 
plus Fr-18
92.0 9446 8473 5670
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3H-RNA from the treated erythrocyte nuclei binds to the probe just 
as efficiently as the Internal standard ^ -rRNA. So at least 
92.25Z of the RNA produced by oocyte-treated erythrocyte nuclei 
assigned to RNA polymerase I Is transcribed from the ribosomal 
genes; the efficiency is 89.1Z In the case of neurula-treated 
nuclei and 92Z for egg plus Fr-18 treated nuclei. This degree of 
binding of the ^H-RNA from the nuclei to the ribosomal probe Is 
reduced by the addition of cold 18S and 28S rRNA. If these are 
added in amounts sufficient to reduce the binding of the internal 
standard to zero the binding of the H-RNA Is likewise reduced, 
but not to zero. In all three cases, some binding is still 
detectable. This (22.9Z in the case of the oocyte-treated nuclei 
RNA or 18.4Z of the pXllOl binding RNA) could reflect the 
presence of sequences transcribed from non-ribosomal DNA, the 
wrong strand of rDNA, or from its non-transcrlbed region, or as 
will be shown, the presence of transcribed spacer rRNA. The 
transcribed spacer accounts for 24Z of the 40S precursor, and 
will only be present in trace amounts in the competing 18S and 
28S rRNA. When competing 18S or 28S rRNAs are used alone, it can 
be seen that the 18S competes off slightly more and the 28S rRNA 
slightly less than might be expected from their size. The 18S 
rRNA sequence contributes 23.9Z and the 28S rRNA sequence 52Z of 
the precursor but they compete off 36.2Z and 45.4Z of the H-RNA 
from oocyte-treated nuclei respectively [TABLE 6.2]. For RNA 
isolated from nuclei preincubated with egg extract and Fr-18 the 
18S sequences contribute 40Z and the 28S sequences contribute 
35.9Z of the RNA synthesized leaving 24.1Z not competed off. For 
RNA from nuclei prelncubated with a neurula extract the values 
are 35.9Z 18S and 39.8Z 28S with 24.3Z not competed off by the 
cold rRNA. This would indicate the presence of unfinished 
transcripts in the^H-RNA from oocyte-treated nuclei.
-97-
For all three sources of the^H-RNA about 90X of this RNA 
binds to the entire rlbosomal gene repeat unit. This demonstrates 
that It Is Indeed the ribosomal genes that are being transcribed 
by the RNA polymerase I molecules. That 77Z of the^H-RNA binding 
to pXHOl can be successfully competed off by cold 18S and 28S 
rRNA indicates that not only Is the correct strand being 
transcribed but also that It Is mainly the transcribed regions 
that are being transcribed. The 23Z that Is not competed off can 
be accounted for by the transcribed spacer sequences. To show 
that this is the case, the recombinant plasmid pXlrl08 was used 
[FIG 6.1; 6.3]. This contains both the beginning and the end of
the 40S transcript plus the entire non-transcrlbed spacer.
Hybridization to Restriction Endonuclease Fragments of Rlbosomal 
Plasmid, pXlrl08.
Double restriction enzyme digests were carried out on 
pXlrl08; Bam HI + Eco RI and Bam HI + Hind III. The former digest 
yields four fragments, the three as shown [FIG 6.3] plus the 
plasmid vector. The second digest also gives four fragments, but 
since Hind III cuts within the plasmid vector, the 490 bp and 
3350 bp fragments shown are attached to plasmid DNA. Using these 
restrictions, two fragments from the non-transcrlbed spacer 
region were isolated as follows. The digested DNA was run on an 
agarose gel, blotted onto nitrocellulose (Southern, 1975) and the
resulting filter cut into small pieces to coincide with the gel
32tracks and DNA bands. These pieces were hybridized to P-pXllOl 
DNA to check on the location of the fragments before 
hybridization to ^H-RNA from oocyte-treated and egg plus Fr-18
treated nuclei
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Restriction Map of rDNA Plasmid pXlr!08.
Data from Boseley £t a^ (1979)
FIGURE 6.4
Transcription of the rDNA Non-Transcrlbed Spacer In Erythrocyte 
Nuclei Pretreated with an Oocyte Extract.
The method is as outlined In the text. 5 pg of digested DNA 
being loaded onto the gel to be Southern blotted. The 
nitrocellulose pieces containing the relevant DNA fragments were 
hybridized for 24 hours (50% formamide, 3xSSC) with ^H-RNA 
isolated from erythrocyte nuclei preincubated with a S100 oocyte 
extract (1) or S100 egg extract plus Fr-18 (11). After the 60
minute prelncubatlon the nuclei were spun down and resuspended in 
the normal incubation mix for a further 60 minutes. The cpm bound 
to each filter is represented as cpm H-RNA bound/bp rDNA in that 
fragment.
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There is little hybridization to the fragments containing 
only non-transcrlbed spacer DNA [FIG 6.3]. Some might perhaps 
have been seen at the reduplicated promoter region around the two 
Bam HI sites in the non-transcrlbed spacer (Moss and Birnstiel, 
1979), since some initiation at this site has been described in 
vivo (Rungger et al, 1979). However, the treated nuclei do 
not matte much use of these promoters and very little binding 
above background is seen to either fragment, 0.14 cpm/bp of these 
fragments compared to 0.03 cpm/bp of vector DNA and 4.35 cpm/bp 
of coding sequences. Most binding is seen to the large 3350 bp 
fragment containing the external transcribed spacer and the 
beginning of the 18S gene. There is also some binding to the 
small (490 bp) fragment of the end of the 28S gene but this is at 
a lower level. The small amount of hybridization seen to this 
fragment is not due to the low binding of such a small fragment 
to the nitrocellulose, since in the Hind III + Bam HI digest the 
490 bp are attached to several kb of plasmid and should therefore 
bind well to the filter. The lower than expected amount of 
binding is probably a reflection of the number of transcripts 
that do not complete their transcription, either by falling of 
the gene or by elongating so slowly that they never reach the end 
of the gene. Calculating from the hybridization data only 30Z of 
the transcripts reach full length. Those that do, do not continue 
on into the non-transcribed spacer since there is no binding to 
the 1690 bp Hind III + Bam HI fragment that Immediately follows 
the end of the 28S gene. Since there is not a convenient 
fragment, it cannot be said whether Initiation is correct. 
Certainly, there is very little transcription in the 1100 bp Bam 
HI fragment which is the nearest fragment to the start of the 
external transcribed spacer, and this could be due to false 
initiation of the reduplicated promoters. This problem should be

4 '5S  16$ 28 S 45
FIGURE 6.5
H^-RNA isolated from erythrocyte nuclei that had been 
preincubated with a S100 oocyte extract (A) or S100 egg extract 
and Fr-18 (B) was loaded onto 12 ml 5-20% sucrose gradients.
These were centrifuged for 4 hours at 38,000 rpm at 4°C in the 
SW40 rotor of a Beckman L8 centrifuge. 400 pi fractions were 
taken, TCA precipitated and counted in a Packard Scintillation 
Counter. Parallel gradients were run with 4/5S, 18S, 28S and 45S 
RNA as markers, 18S and 28S RNA was added to the H-RNA samples 
immediately prior to loading to act as internal markers. These 
were located by measuring the OD at 260 nm of each fraction.
Sucrose Gradient Fractionation of ^H-RNA Isolated from
Erythrocyte Nuclei Preincubated with an Oocyte Extract.
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further Investigated using SI mapping.
Thus both oocyte-treated nuclei and nuclei preincubated with 
egg with Fr-18 and egg extract as the RNA polymerase source, 
yield RNA that by these hybridization criteria can be termed 
ribosomal RNA.
Fractionation of the RNA on Sucrose Gradients.
THe ^ i-RNA produced by oocyte-treated nuclei does not yield a 
8ingle high molecular band when run on a sucrose gradient [FIG 
6.5], Instead a smear of radioactivity is seen throughout the 
gradient but with a sharp upper limit at about 41.5S. So a 
population of different sized H-RNA molecules are extracted from 
erythrocyte nuclei treated with an oocyte extract in the presence 
of or-amanitin, 92Z of which hybridize to the ribosomal gene 
probe, and whose maximum size is 38 - 41.5S. Nuclei Incubated 
with egg extract and Fr-18 plus 100 jig/ml of-amanitin on the other 
hand, produce ^H-RNA that has slightly less diversity in size, 
the upper limit is still the same but more of the RNA is of this 
size and less of the smaller size than the RNA from oocyte 
treated nuclei. Thus the RNA synthesized by both sorts of treated 
nuclei is of a variety of lengths. This variety is due to two 
factors; nucleases present in the protein extracts - oocyte 
extracts contain more of these and the RNA from oocyte-treated 
nuclei is of a more diverse size range - and to the slowness of 
elongation in this system. Under these conditions only 50.9Z of 
the transcripts reach full length. This is calculated from the 
RNA made by nuclei treated with an egg extact plus Fr-18. It will 
still be a slight under estimate since the egg extract is not
free from nucleases. The value for RNA isolated from nuclei
- 1 0 0 -
prelncubated with an oocyte extract la 31.91. No RNA transcripts 
were found above 41.5S which would Indicate that Initiation Is 
correct, at least to the accuracy that can be measured here. 
Since termination Is correct and the full length transcript Is of 
the correct length, then Initiation should occur at approximately 
the correct site as well.
The RNA polymerase I activity seen In erythrocyte nuclei 
treated with an oocyte extract Is not mere non-specific 
transcription, but accurate transcription of the ribosomal genes. 
The protein semlpurlfled from oocyte extracts by column 
chromatography also brings about accurate ribosomal RNA synthesis 
when added to an egg extract. A neurula extract has the same 
effect. In the erythrocyte nucleus, the oocyte component has an 
effect exclusively on the Inert ribosomal genes; transcription by 
the other two RNA polymerases Is not altered by Fr-18, It only 
permits accurate transcription by RNA polymerase I.
-101-
CHAPTER VII. THE DNASE I SENSITIVITY OF ERYTHROCYTE RIBOSGHAL 
DNA.
Since Che initial discovery Chat Che DNase I sensitivity of 
the globin genes in different cell types correlates with globln 
gene expression (Weintraub and Groudlne, 1976), this relationship 
has been shown to hold true for a variety of genes. For example, 
the ovalbumin, conalbumin genes, both the«andp globln genes of
chickens (Garel and Axel, 1976; Kuo et al, 1979; Stadler et
al, 1980; Bellard e£ al, 1980), a number of heatshock
protein genes in Drosophila (Wu, 1980; Keene et al,1981) 
and the r-chromatin of Tetrahymena (Borchsenlus et al,
1981) . Several viral systems also follow this rule (eg Her borne 1 
et al, 1981; Groudine et al, 1981). This sensitivity or 
resistance of a gene to DNase I has been taken as a reflection of 
the chromatin structure of that gene. It appears that an actively 
transcribed gene has a more open configuration, thus permitting 
easy access of DNase I molecules. A similar sensitivity is 
sometimes seen when micrococcal nuclease or DNase II are used 
(Reeves and Jones, 1976; Bloom and Anderson, 1978; Bellard et 
al, 1982; Larsen and Weintraub, 1982; Wood and Felsenfeld,
1982) , although these enzymes probably recognise different facets 
of the same structure and subsequent digestion is also different.
The area of nuclease sensitivity encompasses not only the 
the active gene itself, but may extend for several kb beyond. The 
DNase I sensitivity of the globln genes of chicken extends for 
6-7 kb from the 5' end of the gene cluster and 8 kb from the 3' 
end (Stadler et al, 1980). Weisbrod and Weintraub (1981) have 
estimated the overall size of the DNase I sensitive region, or 
domain, to be 30-100 kb long, but within this large DNase I
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sensitive domain are smaller domains of more acute DNase 1 
sensitivity, corresponding to the region transcribed. The change 
from sensitive domain to resistant DNA is quite abrupt, and can 
be mapped (Weintraub et al, 1981). In several genes, the 
presence of sites exquisitely sensitive to DNase I have been 
shown (Kuo et al, 1979; Wu e£ al, 1979b; Wu, 1980; Keene
et al, 1981). These do not normally occur within a gene, but 
are at a fixed location beside it. The distance between gene and 
DNase I 'hot spot' depends upon the system, it varies from 1 kb 
from the 5' end of the conalbumin gene (Kuo et ¿1, 1979) to 
300 bp upstream from the 5' end of many of the heat shock protein 
genes of Drosophila (Wu £t al, 1979b; Wu, 1980; Keene et 
al. 1981). In some systems hypersensitive sites are present
whatever the transcriptional state of the gene; for example the 
heat shock protein genes in Drosophila (Wu et al, 1979b;
Wu, 1980; Keene et al, 1981) and the chicken conalbumin gene 
(Kuo ej: al, 1979) but in other cases these sites are only 
present in nuclei expressing these genes, eg the chicken
embryonic<* and U globin genes, certain of the sites associated 
with the Drosophila heat shock genes and the a andf> globin genes 
(Stadler et al, 1980; Weintraub et al, 1981); the rat 
preproinsulln also conforms to this pattern (Wu and Gilbert, 
1981).
It has been suggested (Weintraub and Groudine, 1976; Young 
et al, 1978) that the change in chromatin configuration 
visualized by DNase I sensitivity of the gene, initially set up 
to allow transcription to proceed, is Immovable and is not 
altered during subsequent divisions and further development of 
that cell. However, at least in the Drosophila heat shock
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protein genes this is not so (Wu et »1, 1979a). The change in 
transcription and DNase I sensitivity of these genes brought 
about by a heat shock is reversible. Once the cells are allowed 
to recover from the heat shock, the DNase I sensitivity, and 
presumably the chromatin configuration it reflects, returns to 
its pre-heat-shock state.
How the DNase I sensitive state is initiated in the first
place and maintained is not known. The high mobility group (IMG)
proteins, in particular HMG 14 and HMG 17, have been shown to be
associated with the transcribed gene Itself (Ueisbrod and
Ueintraub, 1981) but not the entire, slightly DNase I sensitive
domain. Although HMG 14 and 17 specifically bind to active genes,
perhaps at the nucleosome level they do not make an inactive gene
active (Weisbrod and Weintraub, 1981). Their role could therefore
be in maintaining the active state rather than in initiating the
change in chromatin configuration. The change in configuration is
detectable, at least in respect of HMG 14 and 17 binding, at the
nucleosome level, ie salt-washed nucleosomes from active genes 
that are depleted in non-histone proteins bind to HMG 14 and 17, 
whilst salt-washed nucleosomes containing
inactive sequences do not. However, no differences in protein and 
DNA content or physical properties have been seen between 
nucleosomes that bind and those that do not bind these HMG 
proteins (Ueisbrod and Ueintraub, 1981).
The rlbosomal RNA genes of Xenopus laevls erythrocytes 
are not transcribed in the mature cell, although rRNA synthesis 
would have occurred at earlier developmental stages, nor are RNA 
polymerase I molecules present in the mature erythrocyte 
(Hentschell and Tata, 1978). These genes are therefore 
untranscribed and inactive and should be expected to be resistant
I

FIGURE 7.1
D i g e s t i o n  o f  E r y t h r o c y t e  DNA by D N a s e  I .
450 pi of erythrocyte nuclei ln RSB at a DNA concentration
of 1 mg/ml were digested at 37*C with 20 pg/ml D N a se  I (o--o).
At times during this incubation a 25 pi sample was removed, 
gently spun ln an Eppendorf mlcrofuge and the Ol^of the 
supernatant determined. A parallel assay (+— —►) was carried out, 
starting at a DNase I concentration of 20 pg/ml, but after 30 
minutes this was Increased to 50 pg/ml.
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to DNase I digestion.
Previous chapters show that I have Identified a protein In a 
total oocyte extract, which brings about the transcription of the 
inactive rlbosomal RNA genes of erythrocyte nuclei. To 
Investigate whether this transcription of the erythrocyte rDNA is 
accompanied by an alteration in chromatin configuration, a series 
of DNasel digestions and hybridization analyses were carried out 
to determine whether the ribosomal RNA genes of oocyte-treated 
nuclei were DNase I sensitive.
Effect of DNase I on Erythrocyte Nuclei.
Erythrocyte nuclei were incubated in RSB (Ueintraub and 
Groudine, 1976) with DNase I for Increasing lengths of time. To 
determine the incubation time required to achieve 5-10Z 
digestion, the nuclei were spun out of the buffer and the 
absorbance at 260 nm of the supernatant measured [FIG 7.1]. About 
30Z of the DNA remains undigested despite the addition of excess 
DNase I. It takes 5 minutes for the DNase I to release 5-10Z of 
the total DNA from the nuclei. This incubation time was used in 
all subsequent digestions.
Hybridization Conditions.
The conditions used were chosen in order to maximize the 
hybridization of the probe to the tested DNA - in this case 
3H-pX1101 and total X.laevls DNA - whilst minimizing the 
non-specific binding of the probe DNA to the nitrocellulose 
filter. Thus PVP, Flcoll and non-competing bacterial RNA were 
used in a standard SOZ formamide, 3xSSC, DNA/DNA hybridization at
X v v *  I

Time (hours)
FICURE 7.2
Optimum Time for DUA-DNA Hybridizations.
Eight vials were set up, each containing two Identical 
nitrocellulose filters loaded with 1 pg total X.laevls DNA, 
Hybridization buffer (50% formamide pH 7.0, 3xSSC, 0.2% BSA, 
Ficoll, PVP and 0.25 mg/ml yeast tRNA) and 50 ng probe ( 3H 
pXHOl, 2.2xl03 cpm/pg) In final volume of 100 pi. These were 
Incubated for up to 49.5 hours at 37*C and at times during this 
Incubation a vial was removed and the filters washed (2xSSC, 3x30 
minute washes) and dried. The filters were counted after the last
time point In a Packard scintillation counter.
FIGURE 7.3
D N a s e  I  S e n s i t i v i t y  o f  t h e  R l b o s o m a l  RNA g e n e s  I n  E r y t h r o c y t e  
a n d  L i v e r  N u c l e i .
Nitrocellulose filters loaded with DNA from undigested liver
(O--0) and erythrocyte (o---o) nuclei and DNase I digested liver
(■--■) and erythrocyte (e---•) nuclei were hybridized for 24
hours with increasing amounts of^H-pXllOl (2.2xlC?cpm/jig) in a 
volume of lOOpl of probe + buffer/2 duplicate filters. These were 
washed in 2xSSC after the hybridization, dried and counted. 
Results are expressed in this graph (and in Figures 7.4-7.6, 7.9, 
7.11-7.14 and 7.16-7.23) as cpm bound/pg nuclear DNA.
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3 7 ° C .  D e n a t u r e d  X . l a e v i s  DNA was l o a d e d  onto n i t r o c e l l u l o s e  
filters a n d  hybridized under these conditions to denatured, 
n i c k - t r a n s l a t e d  ^H-pX1101. This probe contains a single copy of 
the rlbosomal RNA gene repeat. The hybridization was allowed to 
continue for 24 hours, which gives the highest amount of 
hybridization [FIG 7.2], before being washed and counted in a 
Packard Scintillation counter.
DNase I Sensitivity of the Rlbosomal RNA Genes in Liver and 
Erythrocyte Nuclei.
Erythrocyte nuclei exhibit no rRNA synthesis, their RNA 
polymerase I molecules were lost before maturation and almost all 
of the transcription in vitro seen is as a result of the slow 
elongation of the final RNA polymerase II transcripts (Hentschell 
and Tata, 1978). Liver nuclei, on the other hand, are actively 
transcribing their rlbosomal gene6; 30.1Z of their total 
transcription is as a result of RNA polymerase I activity [FIG 
3.26]. So it is not surprising that the rDNA from liver nuclei 
was more sensitive to DNase I digestion than bulk DNA, but 
equally resistant in erythrocyte nuclei [FIG 7.3]. Both type6 of 
nuclei hybridized%-pXl 101 equally well after incubation in the 
absence of DNase I, indicating that the reduced hybridization to 
rDNA seen when liver nuclei are digested with DNase I, is not as 
a result of a nuclease present in the nuclear preparation.

12 FIG U R E 7.4
FIGURES 7.4, 7.5, 7.6
DNase I Sensitivity of the rDNA In the Erythrocyte Nuclei 
Preincubated with an Oocyte or Egg Extract.
Figure 7.4
Erythrocyte nuclei were preincubated in the normal way with an
oocyte (• •) or egg (+-- *■) extract. After 60 minutes the
nuclei were spun down, washed with 0.5xRB and taken up at a DNA 
concentration of 1 mg/ml in RSB. These were DNased and the DNA 
extracted and loaded onto nitrocellulose filters in the normal 
way. Hybridizations were carried out as described in Figures 7.2 
and 7.3 (probe^H-pXHOl at 2.2xlC? cpm/pg). As controls, total DNA
(o--o) and DNA from DMased liver nuclei ( □-- □) were also
hybridized in the same way.
Figure 7.5
Erythrocyte nuclei were preincubated in the normal way with an 
oocyte extract, washed with 0.5xRB and taken up in RSB at 1 mg
DNA/ml. The nuclei were either incubated with (•--•) or without
DNase I (+-- h), before the DNA was extracted. Hybridizations
were carried out as described previously (probe3H-pX1101 at
2.2xl0^ cpm/pg). (o--o) total DHA; (Q--□) DNA from DNased liver
nuclei.
Figure 7.6
Erythrocyte nuclei were preincubated in the normal way with egg 
extract plus Fr-18, washed with 0.5xRB and taken up in RSB at 1
mg DNA/ml. The nuclei were either Incubated with <p a) or
without DNase I (+— -+), before the DNA was extracted. 
Hybridizations were carried out as described previously (probe
3H-pX1101 at 2.2xlC?cpm/pg).(o--o) total DNA; (a--• ) DNA from
oocyte treated DNased erythrocyte nuclei.
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It is possible to induce erythrocyte nuclei to synthesize 
rRNA by preincubating them with an oocyte extract. Nuclei 
preincubated in this way were Incubated with DNase I such that 
5-10Z of their DNA was solubilized, and the remainder was 
extracted. Nuclei preincubated with an egg extract were also 
treated with DNase 1. Pre-treatment with an egg extract has no 
effect on the DNase 1 sensitivity of the rDNA in erythrocyte 
nuclei [FIG 7.4], whereas pre-treatment with an oocyte extract 
does. In such nuclei, the ribosomal genes are DNase I-sensitive, 
although not quite as sensitive as the rDNA of liver nuclei.
This increase in DNase I sensitivity in oocyte-treated 
nuclei is not a reflection of any nucleases that are present in 
the oocyte extract Itself. When the DNA from nuclei preincubated 
with an oocyte extract was extracted without the DNase I step, no 
increased sensitivity of the rDNA is seen [FIG 7.5].
Egg-treated erythrocyte nuclei can also be Induced to 
transcribe rRNA if Fr-18 is present during the preincubation. 
Nuclei preincubated in this way also show an Increased 
sensitivity of their rDNA to DNase I digestion [FIG 7.6]. The 
degree of sensitivity is similar to that seen in oocyte-treated 
nuclei. It Is not brought about by specific nucleases within the 
column fraction &lnce if the nuclei are not treated with DNase I 
after the preincubation, the DNA extracted does not show this 
reduced rDNA content.
Thus the appearance of transcription by RNA polymerase I

FIGURE 7.7
E f f e c t  o f  a  D N a se  I  H y p e r s e n s i t i v e  S i t e .
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when erythrocyte nuclei are treated with an oocyte extract or an 
egg extract plus Fr-18, Is mirrored In the chromatin structure. 
The rONA becomes more open and accessible to DNase I as a result 
of these treatments. Whether the whole gene or just part of It Is 
sensitive, can be determined by a variation on the above 
hybridization method. If the DNase I-treated nuclear DNA Is 
digested with a restriction enzyme and run out on an agarose gel,
blotted onto a nitrocellulose filter (Southern, 1975) and then
32probed with a P-probe, the bands seen on the autoradiogram of 
the washed filter will depend on how many times the particular 
restriction enzyme cuts the gene being probed for. For Instance, 
an Eco RI restriction digest of total Xenopus laevls DNA, 
probed b^^P-pX1101 will reveal two bands of about 4.8 kb and 6.63 
kb representing the two Eco Rl sites within the rRNA gene. If on 
repeating with DNA from DNase I digested, oocyte extract-treated 
nuclei, one band Is fainter than the other, once proper account 
Is taken of the size difference between the fragments, It can be 
said that the fainter fragment Is preferentially digested by 
DNase I. That Is, It is In a more open configuration than the 
other part of the gene. The presence of a hypersensitive site (Wu 
et al, 1979a) of acute DNase I sensitivity would be seen by 
an increase In the number of bands present or a decrease In size 
of a band [FIG 7.7], since a "hot spot", under this analysis acts 
as an extra restriction site. Thus the simple hybridization 
analysis used here measured the rate at which a given region Is 
digested to non-hybrldizable fragments. The blot method, outlined 
above, reflects the possibility of Introducing the first nuclease 
cut Into a fragment which may, or may not, be homogeneously more 
accessible to the DNase I molecules. Therefore, a genomic region 
which Is more rapidly converted to non-hybridlzable fragments 
must also be more sensitive using the blot hybridization assay,
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FIGURE 7.8
Presence or Absence of an Hypersensitive Site In rDNA.
Erythrocyte nuclei in RSB at Img DNA/ml were digested with 
DNase I such that only 0.5 - 1% of the DHA is lost, after the 
digestion the Incubations were made 12.5 mM EDTA, 0.5% SDS and 
the DNA extraction procedure carried on from this point. The DNA 
from nuclei preincubated with buffer (Track B) and oocyte extract 
prior to DNase I digestion (Track C) as well as total DNA (Track 
A) was digested with Eco RI, run on a 1% agarose gel (2 pg 
digested DNA/slot) and transferred to a nitrocellulose filter 
(Southern, 1975) which was probed witl?^P-pX1101 (2x10^ cpm/pg).
FIGURE 7.8
Presence or Absence of an Hypersensitive Site In rDNA.
Erythrocyte nuclei in RSB at lmg DNA/ml were digested with 
DNase I such that only 0.5 - 1% of the DNA is lost, after the 
digestion the incubations were made 12.5 nM EDTA, 0.5Z SDS and 
the DNA extraction procedure carried on from this point. The DNA 
from nuclei preincubated with buffer (Track B) and oocyte extract 
prior to DNase I digestion (Track C) as well as total DNA (Track 
A) was digested with Eco RI, run on a 1Z agarose gel (2 pg 
digested DNA/slot) and transferred to a nitrocellulose filter 
(Southern, 1975) which was probed witl?^P-pXl 101 (2x10^ cpm/pg).
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Presence or Absence cf  an Hype r s e n s i t i v e  S i t e  in rI'NA.
Erythrocyte  nucle i  in RSB at lag DNA/ml were d i ges ted  with 
DNase I such that only 0.5 - 1* o f  the ENA i s  l o s t ,  a f t e r  the 
d i g e s t i o n  the incubat ions were icade 12.5 mM EDTA, 0.5/1 SDS and 
the DNA ex t ra c t i on  procedure c ar r i e d  on from th is  point .  The ENA 
fror_ nucle i  preincubated with bu f f e r  (Track B) and oocyte  ex tract  
p r i o r  to ENase I d i g e s t i o n  (Track C) as wel l  as to ta l  LNA (Track 
A) was d igested with Eco HI, run on a IX agarose gel  (2 pg 
d i ges ted  ENA/slot) and t rans fe r red  to a n i t r o c e l l u l o s e  f i l t e r  
(Southern,  l975l which was pr- bed w i t n ’ P - p X l l l 1 (2x1c cpr./pg)*
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but the reciprocal Is not necessarily true. For example, the 
presence of specific DNase I cleavage points also results In the 
disappearance of a given restriction fragment. So whilst the 
procedure used standardly here will not detect a hypersensitive 
site in the way that a blot-transfer hybridization of 
electrophoresed DNA will, it does give a more accurate 
quantitative assay of the DNase I sensitivity of the gene as a 
whole.
To determine whether there is a hypersensitive site 
associated with the rlbosomal genes, and to see if one part of 
the gene is more sensitive to DNase I digestion than the rest, 
the method outlined above was carried out. There is no 
hypersensitive site associated with the ribosomal genes from 
either buffer or oocyte-treated nuclei [FIG 7.8]; neither is one 
part of the gene digested preferentially by DNase I - all of the 
gene is equally sensitive, both transcribed and non-transcribed 
sequences.
The above changes in DNase I sensitivity of the rlbosomal 
genes were all seen in nuclei where transcription was occurring. 
It could be that it is transcription per se that causes the 
DNase 1 sensitivity and not the change to a more open chromatin 
configuration that allows the RNA polymerase molecules access to 
the gene. However, this would not explain why the non-transcrlbed 
spacer region is as sensitive as the transcribed region of the 
rRNA genes in oocyte-treated nuclei, or why large domains of 
sensitive DNA have been shown to extend for several kb around the 
transcribed gene sequence (Weisbrod and Weintraub, 1981).
Erythrocyte nuclei were preincubated in such a way that

FIGURE 7.9
DNase I Sensitivity of rDNA in Preincubated Erythrocyte Nuclei 
where Transcription was Inhibited.
Erythrocyte nuclei were preincubated for 60 minutes with an
oocyte extract and 100 pg/ml Actlnomycln D (o-- o) or Fr-18 alone
(+— -+) before being washed in 0.5xRB, digested with DNase I and 
the DNA extracted. Hybridizations were carried out as previously 
described (probe^H-pXllOl at 2.2x10^ cpm/pg), with total DNA
(o-- o) and DNA from erythrocyte nuclei preincubated with an
oocyte extract prior to DNase I digestion (e-- e) also Included.
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none, or very little, transcription of the ribosomal genes could 
take place. When erythrocyte nuclei are preincubated with Fr-18 
alone, no transcription can be measured over that seen In control 
nuclei, since RNA polymerase I Is absent. By omitting a RNA 
polymerase source, the effect of Fr-18 by itself on the rDNA can 
be seen. If RNA polymerase I molecules are necessary to Induce 
DNase I sensitivity - although the effect on leaving them out of 
the preincubation and adding them at the beginning of the 
transcription assay [TABLE 5.6] would Indicate that they are not 
- no increased sensitivity of the rDNA should be seen. 
Erythrocyte nuclei were also preincubated with an oocyte extract 
plus actinomycin D. Although this will not prevent the initial 
binding of the RNA polymerase I molecules on the genes, it will 
prevent further elongation (Wldnell and Tata, 1966; TABLE 3.5).
When the erythrocyte nuclei were preincubated with only 
Fr-18, there was an increase in the DNase I sensitivity of the 
rDNA but not to the same extent as seen in oocyte treated nuclei 
[FIG 7.9]. The nuclei preincubated with an oocyte extract plus 
actinomycin D also showed that their rDNA was more sensitive to 
DNase I, but it was not as sensitive as when actinomycin was 
absent, but more so than if only Fr-18 was added. This difference 
between the sensitivities of the rDNA in these variously treated 
nuclei could be explained in one of the two following ways. 
Either only a few rRNA gene repeats are sensitized in nuclei 
pre-treated with Fr-18, and more when the nuclei are pre-treated 
with oocyte extract plus actinomycin D; or only part of the rRNA 
gene is made accessible to DNase I in nuclei preincubated with 
Fr-18, and more of the gene repeat is opened up and accessible in 
the nuclei preincubated with oocyte extract and Actinomycin D. 
Results given above show that the whole gene repeat is sensitive
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FIGURE 7.10
Restriction Map of Xenopus laevls Rlbosomal DN'A.
Data from Boseley e£ al (1978,1979).
E - Eco RI 
B - Bam HI
P - Pst I
-110-
to DNase I in nuclei preincubated with an oocyte extract alone.
In order to determine which of these two possibilities is 
the correct one, a series of ribosomal gene fragments were used 
as probes [FIG 7.10]. pXlrl08 and pXlr212 are the two Eco RI 
fragments of the ribosomal gene repeat. pXlrl08 contains all of 
the non-transcribed spacer flanked by the last 490 bp of the 28S 
gene and the first 2.52 kb of the 40S transcript; the latter 
Includes all of the external transcribed spacer. pXlr212 only 
contains transcribed sequence, it completes the gene repeat with 
the central part of the 40S precursor. L-108 is a 2.18 kb
fragment cut from pXlrl08 and contains the final 490 bp of the
28S gene and 1.69 kb of the non-transcrlbed spacer. pXlrl4 is a 
subclone of pXlrl08 containing a 1.57 kb Pst 1 fragment 
encompassing all of the external transcribed spacer and the first 
600 bp or so of the 18S gene sequence, it contains no
non-transcrlbed spacer. If the difference between the rDNA from 
nuclei treated with Fr-18 and oocyte extract is just a reflection 
of the numbers of ribosomal genes fully accessible to DNase I, 
then all of the above probes will give the same degree of 
hybridization as seen in Fig 7.9, in which pXllOl was the probe. 
If, on the other hand, this amount of hybridization is a
reflection of the different degrees of openness of the ribosomal 
genes, different probes will hybridize to differing extents 
depending on whether they cover the DNase I sensitive region or 
not.
When the rDNA of erythrocyte nuclei treated with oocyte 
extract in the presence of actlnomycin D is probed with pXlr212 a 
high degree of sensitivity to DNase I is revealed [FIG 7.11]. 
This contrasts with the intermediate sensitivity seen when pXllOl
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FIGURE 7.11 FIGURE 7.12
FIGURES 7.11 - 7.14
DNase I Sensitivity of Parts of the rRNA Gene In Erythrocyte 
Nuclei.
The DNAs described in Figure 7.9 were hybridized with the 
four rDNA probes shown in Figure 7.10 as described previously.
(o— o) Total DNA
(•--• ) DNA from erythrocyte nuclei preincubated with an
oocyte extract before DNase I digestion.
(D--D) DNA from erythrocyte nuclei preincubated with an
oocyte extract and Actinomycin D prior to DNase I 
digestion.
(+--+) DNA from erythrocyte nuclei preincubated with Fr-18
only before DNase I digestion. 7
7Figure 7.11 probe P-pXlr212, specific activity 1.5x10 cpm/pg
Figure 7.12 probe^P-pXlr 108, specific activity 5.6x10^  cpm/pg
Figure 7.13 probe^P-L-108, specific activity 1 . 8 x 1 ( 7  cpm/pg
32 6probe P-pXlrl4, specific activity 1.1x10 cpm/pgFigure 7.14
- in­
is the probe. In contrast Fr-18 alone does not make the portion 
of the ribosomal gene represented by pXlr212 as DNase I 
sensitive.
Probing with pXlrl08 gives another pattern of hybridization 
[FIG 7.12]; rDNA from nuclei preincubated with Fr-18 is again 
slightly sensitive to DNase I digestion, but rDNA from nuclei 
pre-treated with an oocyte extract and actinomycin D Is also only 
slightly sensitive to DNase I , although more so than the Fr-18 
treated nuclei. In both cases, the degree of sensitivity Is not 
as great as In rDNA from oocyte-treated nuclei. Thus in nuclei 
treated with actinomycin D plus oocyte extract, It seems that 
part of of the ribosomal gene homologous to pXlrl08 is much less 
open and accessible to DNase I digestion than that hybridizing to 
pXlr212.
When fragment L-108 was used as a probe [FIG 7.13], the rDNA 
from Fr-18 treated nuclei was shown to be insensitive to DNase I 
digestion; the amount of hybridization seen is comparable to that 
found using untreated DNase I digested nuclei. The same region in 
oocyte plus actinomycin D treated nuclei is only slightly 
sensitive to DNase I, whilst in oocyte treated nuclei it is as 
sensitive as any other region of the ribosomal gene. In 
comparison, probing with pXlrl4, which contains the beginning of 
the transcribed region as opposed to Its end [FIG 7.14], shows 
that this region Is equally DNase I sensitive in all three types 
of treated nuclei.
Thus probing with these four ribosomal gene fragments 
suggests that the degree of hybridization seen in Figure 7.9 is a 
result of differences in the chromatin configuration of different

TABLE 7.1
DNase I Sensitivity of Regions of the Ribosomal RNA Gene 
Repeat.
DNA Source; Erythrocyte nuclei preincubated with 
extracts prior to DNase I digestion;
Probe Total DNA oocyte extract oocyte extract Fr-18
+ Actlnomycin D
pXlr212 100 69.6 66.9 94.7
pXlrlOB 100 64.0 82.8 87.8
L-108 100 68.4 86.6 98.6
pXlr14 100 65.0 62.9 59.8
These data are calculated from the cpo bound/pg nuclear DNA 
at the maximum amount of probe used for each experiment as shown 
In Figures 7.11-7.14. They represent the percentage binding of 
the probe to the DNA assuming that the value for undigested DNA 
is 100Z.
NTS N T S
rDNA 4 KN^ Z W WWYYa
ETS 1AS 28 S
Nuclei Preincubated with; 
oocyte extract
oocyte extract +ActinomycinD 
F r -18
------- sensitive region
FIGURE 7.15
Differential DNase Sensitivity of the rDNA from Erythrocyte 
Nuclei.
Data for this figure comes from Figures 7.11 - 7.15.
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regions within the ribosomal genes. In nuclei preincubated with 
an oocyte extract, all of the gene repeat is equally sensitive to 
DNase I [FIG 7.8; FIGS 7.11-14; TABLE 7.1], such that the 5X of 
the DNA lost by DNase I digestion contains about 3SZ of the 
ribosomal gene sequences. When transcription in these nuclei is 
prevented by the addition of actlnomycin D, only the transcribed 
region is sensitive to DNase I and not the non-transcribed spacer 
sequence [FIG 7.15]. In such nuclei the addition of DNase I 
results in the loss of about 35Z of the sequences represented by 
pXlrl4 and pXlr212, whilst only 17.2Z of pXlrl08 sequence and 
11.4Z of L-108 sequence. The small, but measurable sensitivity 
can be accounted for by the transcribed sequence found in both 
pXlrl4 and L-108, leaving the non-transcrlbed spacer DNase I 
resistant. Incubation of erythrocyte nuclei with Fr-18 alone 
results in only the first part of the ribosomal gene becoming 
DNase I sensitive. Thus 40.7Z of the pXlrl4 sequence is lost by 
DNase I digestion, but none (2.1Z) of the L-108 sequence. The 
slight loss (12Z) of the pXlrl08 sequence is presumably because 
it contains the pXlrl4 sequence within it. There is very little 
loss (5.8Z) of pXlr212 sequence which probably represents the 
extreme 5' end of the sequence, ie that in the 28S region, being 
DNase I sensitive, whilst the rest of the sequence is resistant.
Fr-18 therefore acts, at least in part, by altering the 
conformation of the chromatin structure of the ribosomal genes. 
It does this without the presence of RNA polymerase I which 
transcribes these genes. The alteration in chromatin conformation 
to a more open and DNase I accessible form is limited to the 
beginning of the gene sequence coding for the 40S precursor [FIG 
7.15]. The end of this region and the non-transcrlbed spacer are 
unaffected. The amount of DNase I sensitivity seen when pXlrlOS
is used as probe can be accounted for by the sensitivity of the 
beginning of the transcribed region contained within this probe. 
The reduplicated promoter region (Moss and Blrnstiel, 1979) 
located within the non-transcribed spacer does not appear to 
react to Fr-18 and to becone DNase 1 sensitive, ie Fr-18 appears 
to bind to a region in or near the external transcribed spacer 
that is not reduplicated. When RNA polymerase I is present, this 
area of more open chromatin structure is extended along the gene 
somewhat, however, it still does not extend into the 
non-transcribed spacer. The DNase I sensitivity of this region is 
only altered when the gene is being transcribed. This could, 
perhaps, simply be due to the bulky RNA polymerases and attached 
transcript that would exist either side of the non-transcribed 
spacer, forcing this region into a more open conformation. This 
does not explain why the newly initiated, but non-transcribing, 
RNA polymerase I molecules of the nuclei preincubated with an 
oocyte extract and actinomycin D cause the gene to become DNase I 
sensitive. These molecules are not as bulky as ones that are 
transcribing as they are not associated with the growing rRNA 
transcript, so their ability to have such a far reaching effect 
on the chromatin structure 7 kb away is uncertain. It does not 
explain either, why, if their physical presence is all that is 
needed for DNase I sensitivity to extend into the gene, this 
change in conformation does not extend in the opposite direction 
into the non-transcribed spacer. On the other hand the 
actinomycin D might not only be preventing RNA polymerase 1 
elongation but also inhibiting some other component of the oocyte 
extract, for example a nlcking-closlng enzyme or gyrase that 
would, once initiated by the presence of the relevant component 
of Fr-18, open it out in a S' to 3' direction relative to 
transcription. If a molecule like this is responsible for opening
up the rlbosomal genes, it must be present In egg extracts, since 
Fr-18 plus egg extract also cause the entire ribosomal gene to 
become DNase I sensitive. Likewise it should also be present in 
the crude RNA polymerase preparation used in some of the 
transcription assays if the transcription seen in the oocyte 
column assays is paralleled by an increase in the DNasel 
sensitivity of the rlbosomal genes, since the crude RNA 
polymerase preparation can be used in place of an egg extract in 
the oocyte column transcription assay with Identical results as 
regards transcription, albeit at a slightly lower level. Oocyte 
fraction 18 Itself contains no nicking-closing enzyme or gyrase, 
and these by themselves - as seen by the addition of oocyte 
fractions 10-12 [FIG 5.6] - have no effect at all on
transcription. So both would have to be present for the entire 
gene to become DNase I sensitive, Fr-18 directing the action of 
the gyrase or nicking-closlng enzyme. Of course, some other 
entirely different mechanism might be responsible for this 
phenomenon.
The control of ribosomal gene activity has been linked to
the degree of méthylation of the cytosine bases in the
non-transcrlbed spacer (Bird et al, 1981). The onset of
déméthylation in two defined regions (Bird and Southern, 1978) 
has been correlated with the onset of ribosomal RNA synthesis 
during embryogenesis. This pattern of déméthylation is inherited 
by all subsequent somatic cells, such that even erythrocytes, 
which do not synthesize rRNA, have these regions of déméthylation 
in their rlbosomal non-transcrlbed spacer sequences. However, the 
rRNA of the closely related X.borealis remains demethylated 
at these sites throughout its development and no méthylation - 
déméthylation cycle is seen, even though the pattern of rRNA
synthesis appears to be the same as in X.laevls (Macleod and 
Bird, 1982). Thus deaethylation cannot be the sole requirement 
for ribosomal gene transcription, since the erythrocyte nucleus 
requires more than active RNA polymerase I to transcribe these 
genes [FIG 3.17]. Whether Fr-18 can only bring about a change in 
chromatin conformation in demethylated ribosomal genes or in 
vivo also signals for the demethylation event cannot be decided 
by using the erythrocyte nuclei.
DNase I Sensitivity of Other Genes.
The oocyte extract, or rather one component from it, has a 
very specific effect on rRNA transcription. It does this by 
opening up the ribosomal genes beginning, at the 3' end of the 
AOS precursor sequence. However, it might have this effect on a 
variety of genes, which because of their small number or the 
restrictions of the transcription assay are not detected. 
Therefore, a series of genes were studied, to see if there was 
any change in their DNase I sensitivity state on preincubation of 
the erythrocyte nuclei with an egg or oocyte extract. The DNase I 
sensitivity of these genes in liver nuclei was also determined.
The genes studied were histone H4 (probe pcXIHAWl, Turner 
and Woodland, 1982), the oocyte specific 5S RNA (probe Xlo31, 
Federoff and Brown, 1978), and the transfer RNA genes for 
methionine 1, phenylalanine, asparagine, alanine, leucine, lysine 
and tyrosine (probe At210, Clarkson et al, 1978; Bryan et 
al, 1981). These are all transcribed at a high rate during 
oogenesis. The DNase I sensitivity of the globin genes (probe 
Cl3), which Is  only transcribed in erythropoietic cells was also
investigated

!FIGURES 7.16, 7.17
DNase I Sensitivity of the Globln Genes In X.laevls Erythrocyte 
and Liver Nuclei.
Figure 7.16
^P-C13 (1.1x1(7 cpm/pg) was hybridized to the following DNA
samples, as described previously: total DNA from erythrocyte
(o--o) and liver nuclei (□--□), as well as DNA from erythrocyte
(•--•) and liver (+-- F) nuclei that had been digested with
DNase I.
Figure 7.17
^P-C13 (l. 1x1(7 cpm/pg) was hybridized to the following DNA
samples, as described previously: total DNA (o--o), DNA from
erythrocyte nuclei that had been digested with DNase I (•--•)
and from erythrocyte nuclei that had been preincubated with an
oocyte (□--O) or egg (+— -+) extract prior to the DNase I
digestion.
DNase I Sensitivity of Genes Transcribed by RNA Polymerase II
1. Globin.
Globin genes are active In the Immature erythrocytes of 
Xenopus, but not In the adult cells. However, the latter *I,
contain RNA polymerase II molecules tightly bound to the 
chromatin (Hentschell and Tata, 1978) and In avian erythrocytes 
It has been shown that these are present on the globln genes 
(Garigllo £t al, 1981). In this sense the globin genes could 
be described as "active", even though their activity Is nothing 
more than a very slow elongation of the final globln mRNA 
transcript. This correlates with the observation that In avian 
erythrocytes, globin sequences are preferentially digested by 
DNase I (Welntraub and Groudlne, 1976; Stadler e_t al, 1980; 
Bellard et al, 1980). The same Is true for the erythrocyte 
nuclei used here [FIG 7.16], but not for the liver nuclei which 
do not synthesize globin. The sensitive state of the globin genes 
in the erythrocyte nucleus is not altered by pre-treatment of the 
nuclei by either an egg or oocyte extract [FIG 7.17].
2. Histone H4.
Like globin, these genes are transcribed by RNA polymerase
II, however, histone H4 synthesis occurs in all actively dividing 
cells during S phase. Transcription of the histone H4 genes also 
occurs at a vary high rate during oogenesis. So if Fr-18 were 
having a general effect on all genes transcribed during 
oogenesis, it should change the DNase I sensitivity state of the 
histone H4 genes. When the DNase I sensitivity of the histone H4 
genes was determined for both types of nuclei [FIG 7.18] it could
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DNase I Sensitivity of Genes Transcribed by RNA Polymerase II.
1. Globin.
Globin genes are active in the Immature erythrocytes of 
Xenopus, but not in the adult cells. However, the latter 
contain RNA polymerase II molecules tightly bound to the 
chromatin (Hentschell and Tata, 1978) and in avian erythrocytes 
it has been shown that these are present on the globin genes 
(Gariglio £t al, 1981). In this sense the globin genes could 
be described as "active", even though their activity is nothing 
more than a very slow elongation of the final globin mRNA 
transcript. This correlates with the observation that in avian 
erythrocytes, globin sequences are preferentially digested by 
DNase I (Ueintraub and Groudine, 1976; Stadler e£ al, 1980; 
Bellard et al, 1980). The same is true for the erythrocyte 
nuclei used here [FIG 7.16], but not for the liver nuclei which 
do not synthesize globin. The sensitive state of the globin genes 
in the erythrocyte nucleus is not altered by pre-treatment of the 
nuclei by either an egg or oocyte extract [FIG 7.17].
2. Histone H4.
Like globin, these genes are transcribed by RNA polymerase 
II, however, histone H4 synthesis occurs in all actively dividing 
cells during S phase. Transcription of the histone H4 genes also 
occurs at a very high rate during oogenesis. So if Fr-18 were 
having a general effect on all genes transcribed during 
oogenesis, it should change the DNase I sensitivity state of the 
histone H4 genes. When the DNase I sensitivity of the histone H4
genes was determined for both types of nuclei [FIG 7.18] it could

fFIGURES 7.18, 7.19
DNase I Sensitivity of the Histone H4 Genes In X.laevls
Erythrocyte and Liver Nuclei.
Figure 7.18
^P-pcXlH4Wl ( 1.6x1(7 cpm/pg) was hybridized to the following DNA 
samples, as described previously: total DNA from erythrocyte
(o--o) and liver nuclei (C-□), as well as DNA from erythrocyte
(•--•) and liver (+-+) nuclei that had been digested with
DNase I.
Figure 7.19
^P-pcXlH4Wl (1.6x1(7 cpm/ug) was hybridized to the following DNA
samples, as described previously: total DNA (o--o), DNA from
erythrocyte nuclei that had been digested with DNase I (•-- •)
and from erythrocyte nuclei that had been preincubated with an 
oocyte (Q □) or egg (+--*-) extract prior to the DNase I
digestion
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be seen that the hlstoae H4 genes are Insensitive to DNase I In 
the erythrocyte nuclei and sensitive In the liver nuclei. 
Insensitivity In the erythrocyte is expected, since these cells 
have abandoned division. Although liver cells can be stimulated 
to rapid division by partial hepatectomy, little division occurs 
In the normal adult liver from which the nuclei were derived. 
However, whether there Is no histone mRNA synthesis in liver and 
other non-S phase cells has yet to be determined. Pre-treatment 
with an oocyte extract does not alter the insensitive state of 
erythrocyte histone H4 genes [FIG 7.19]. The oocyte extract used 
was a whole ovary preparation and therefore contained oocytes at 
all stages of development. Histone mRNA is synthesized in 
pre-vitellogenic oocytes (Darnborough and Ford, 1976; Ruderman 
and Pardue, 1977; van Dongen et^  a_l, 1981), but further 
synthesis may occur later on during oogenesis (Anderson and 
Smith, 1978). Preincubating the erythrocyte nuclei with an egg 
extract also does not have any effect on the DNase I sensitivity 
of these genes.
The crude approach of DNase I solubilization is capable of 
detecting different DNase I sensitivities of genes active in one 
cell type and inactive in another, as well as different genes 
with different activities in the same cell type. An oocyte 
extract made from oocytes at all stages of oogenesis has no 
effect on modifying the DNase I sensitivity of the histone H4 
genes, even though histone mRNA production is a major feature of 
oogenesis. Neither has it an effect on desensitizing the active 
globln genes of the erythrocyte nucleus. It would appear that the 
effect of the oocyte extract is confined to the ribosomal RNA 
genes on the basis of these hybridizations.

!FIGURES 7.20, 7.21
DNase I Sensitivity of the 5Sooc RNA Genes In X.laevls 
Erythrocyte and Liver Nuclei.
Figure 7.20
V|-pXlo31 (5.5x10^  cpm/pg) was hybridized to the following DNA 
samples, as described previously: total DNA from erythrocyte
(o--o) and liver nuclei (□--□), as well as DNA from erythrocyte
(•--«) and liver (+— -+) nuclei that had been digested with
D N a s e  I .
Figure 7.21
H^-pXlo31 (5.5x10^ cpm/pg) was hybridized to the following DNA
samples, as described previously: total DNA (o--o), DNA from
erythrocyte nuclei that had been digested with DNase I (•--•)
a n d  f r o m  e r y t h r o c y t e  n u c l e i  t h a t  h a d  b e e n  p r e i n c u b a t e d  w i t h  a n  
o o c y t e  ( p ------ C j  o r  e g g  ( + ------- *■) e x t r a c t  p r i o r  t o  t h e  D N a s e  I
digestion
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The DNase I Sensitivity of Genes Transcribed_by RNA Polymerase
III.
1. 5Sooc RNA.
There are two types of 5S rlbosomal RNA genes In Xenopus 
laevls, the oocyte specific (5Sooc) and somatic (5Ssom) genes 
(Wegnez et_ al, 1972; Ford and Southern, 1973). The 5Sooc 
genes are a family of about 20,000 genes per haploid genome 
(Brown et al^ , 1971), interspersed with an equal number of 
pseudogenes, the latter representing residues 1-101 of the normal 
120 bp gene (Jacq ejt al, 1977). Transcripts of this 
pseudogene ill vivo have never been detected, but their 
occurrence remains a possibility (Killer and Melton, 1981). The 
5Sooc genes are transcribed exclusively during oogenesis, whilst 
in other cells it is the much smaller number (400 copies per 
haploid genome; (Peterson e£ al_, 1980) of 5Ssom genes which 
is used (Wegnez et_ al, 1972; Ford and Southern, 1973). This 
number is far too small for the somatic genes to be detected by 
the straightforward hybridization experiments used here. However, 
calculation of a rough gene number from Figure 7.20 (21,262 +/-
1000 copies per haploid genome) confirms that the 5Sooc genes are 
being measured in these hybridizations. Thi6 calculation is based 
on a double reciprocal plot of the data in Figure 7.20 
(y»0.00061+0.09057x) and
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on the assumption that the probe used has plasmid tails on the 
insert of SO bp. If the plasmid was not degraded into smaller 
fragments but remains intact during the nick-translation 
(unlikely since DNase I was used in the reaction mix) a value of 
11,000 +/- 1000 copies per haploid genome is calculated. It can 
be seen both from Figure 7.20 and Table 7.2 that the 5Sooc genes 
are sensitive to DNase I in both liver and erythrocyte nuclei. No 
5S genes are transcribed in erythrocytes, which have lost all of 
their RNA polymerase III molecules during maturation (Hentschell 
and Tata, 1978), nor are the 5Sooc genes believed to be 
transcribed by liver nuclei (Korn and Gurdon, 1981), where the 
SSsom genes should provide all of the 5S rRNA required. Maternal 
5Sooc genes would not have been active since oogenesis, a period 
of at least 2 years. In the case of the paternal 5Sooc genes, it 
is not known if they were ever active during gametogenesls, but 
this seems unlikely, since the accumulation of vast numbers of 
ribosomes, transcribed in part from the SSooc genes, is a feature 
of oogenesis and not spermatogenesis. Thus this half of the 5Sooc 
gene complement has probably been inactive for a minimum of 4 
years (2 life cycles).
Incubation of the erythrocyte nuclei with an oocyte or an 
egg extract before DNase I digestion [FIG 7.21] neither Increases 
nor decreases the degree of DNase I sensitivity of the 5Sooc 
genes.
2. tRNA genes
As seen for the 5Sooc genes, the tRNA genes studied (tRNA 
Metl, Phe, Tyr, Asn, Ala, Leu, Lys) are equally sensitive to 
DNase I in erythrocyte and liver nuclei [FIG 7.22]. This is

FIGURES 7.22. 7.23
DNase I Sensitivity of a selection of tRNA Genes In X.laevls 
Erythrocyte and Liver Nuclei.
Figure 7.22
^H"At210 (3.9xl0^cpm/ug) was hybridized to the following DNA 
samples, as described previously: total DNA from erythrocyte
(o--o) and liver nuclei (0---O), as well as DNA from erythrocyte
(•--e) and liver (+ +) nuclei that had been digested with
DNase I.
Figure 7.23
^H~ At210 (3.9x10^ cpm/ug) was hybridized to the following DNA
samples, as described previously: total DNA (o o), DNA from
erythrocyte nuclei that had been digested with DNase I (•-- •)
and from erythrocyte nuclei that had been preincubated with an 
oocyte ( □ -- O) or egg (+--- +) extract prior to the DNase I
dlgestlon.
TABLE 7.2
DNase I Sensitivity of Various Genes In Erythrocyte and Liver 
Nuclei.
Percentage binding of probe;
DNA Source rDNA Globin Histone
H4
5Sooc tRNA
Total undigested 
Erythrocyte Nuclei
100 100 100 100 100
x DNase 1 
Liver Nuclei
100 42.5 100 34.9 51.0
x DNase 1 54.5 100 28.5 39.5 47.8
These data are calculated from the cpm bound/pg nuclear DNA 
at the maximum amount of probe used for each experiment, as shown 
in Figures 7.3, 7.16, 7.18, 7.20, 7.22.
despi te the f ac t  that ,  although the tRNA genes are t ranscr ibed in 
liver nuclei, they are not transcribed in in erythrocyte nuclei. 
The RNA polymerase 111 molecules are lost from the maturing 
erythrocyte (Hentschell and Tata, 1978). Like the 5Sooc genes, 
these tRNA genes do not alter their DNase 1 sensitive state when 
the erythrocyte nuclei are pre-treated with either an egg or an 
oocyte extract [FIG 7.23].
Thus the genes transcribed by RNA polymerase 111 seem to be 
DNase I sensitive regardless of their transcriptional activity. 
This is not due to an artefact in the preparation of the nuclei 
since the other genes studied, rRNA, histone H4 and globln, do 
not show unexpectedly high DNase I sensitivity [TABLE 7.2). It 
could be argued that any gene that has been transcribed at a 
given stage of the life cycle of an organism remains DNase 1 
sensitive, even if the gene is not transcribed later (Uelntraub 
and Groudlne, 1976; Young e_t al, 1978). This argument could 
be used to explain the sensitivity of the tRNA genes in the 
erythrocyte nuclei. However, it i6 harder to sustain this 
argument in the case of the 5Sooc genes, which show a similar 
DNase I sensitivity. It would mean that all the genes ever active 
in oocytes (and this would probably amount to about 15Z of the 
DNA; Davidson, 1976) are always in the sensitive state, even when 
they pass through the male for one or more generations (as 50Z of 
the 5Sooc genes have done). The insensitivity of the histone H4 
and ribosomal RNA genes in the erythrocyte nuclei is also 
inconsistent with this idea, since these genes must have been 
active in erythroblasts. It seems more likely that the genes 
transcribed by KNA polymerase 111 have a different structure from
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other genes, at least In their Inactive state, with the result
that they are always DNase I sensitive. One possibility Is that
the difference simply relates to their very small size and tandem
repetition. A number of genes transcribed by RNA polymerase II
have been shown to have sites hypersensitive to DNase I
associated with them (Kuo e_t al, 1979; Wu, 1980; Keene ejt
al, 1981; Samal et al, 1981), and for some genes these
sites are always sensitive, regardless of the activity of the
genes (Wu, 1980). In genes which are not tandemly repeated, or
where the repeat length is several kb long, cutting these sites
does not release the gene from the nucleus. The whole SSooc gene
tandem repeat, on the other hand, is only about 700 bp in
Xenopus laevla, and should a hypersensitive site exist, the
small fragment of chromatin might leave the nucleus, even if its
microstructure was like that of larger inactive genes. If this is
the explanation of my results there would have to be
hypersensitive sites present in inactive RNA polymerase III
genes, just as in the Drosophila heat shock protein genes (Wu,
1980) and histone genes (Samal et al, 1981). The position of
the SS genes in Xenopus could also add to their ease of
digestion by DNase I and subsequent loss from the nucleus.
Location at the ends of the chromosomes (Pardue et al, 1973)
might make them more vunerable to digestion by DNase I. This,
however, does not explain the DNase I sensitivity of the tRNA
(Pardue e£ al, 1973)
genes which are scattered throughout the genonejT Whatever the 
reason for the DNase I sensitivity of these RNA polymerase III 
transcribed genes, in their inactive, non-transcrlbed state, 
unlike the RNA polymerase I and II transcribed genes, the DNase I 
solubilization cannot be taken as an indication of the activity 
of these genes.
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The component of the oocyte extract that brings about RNA 
polymerase I transcription In erythrocyte nuclei acts only on the 
rlbosomal genes. Other genes, eg histone H4, that are also 
transcribed at a high rate during oogenesis are not affected. 
Neither are the globln genes which would not be transcribed 
during oogenesis or even early embryogenesis. The 5S and tRNA 
genes though, do not seem to conform to the simple DNase I 
sensitive-active gene rule, so any effect that an oocyte extract 
might be having on these genes cannot be seen. The change In 
chromatin conformation of the rlbosomal genes, presumably 
starting at the 5' end of the transcribed region, allows for 
accurate transcription of the gene. This transcription Itself 
might keep the rest of the gene In a more relaxed state, or a 
wave of change to a different chromatin configuration might 
occur, starting at the 5* end of the gene and moving along the 
chromatin. This wave, since Fr-18 on its own has only an effect 
on the beginning of the gene, may be set up by other non-specific 
oocyte and egg components, which would require Fr-18 for 
specificity and direction. In this case, the second component 
cannot be bringing about a wave of demethylation along the gene.
The areas of undermethylation in the ribosomal gene repeat are 
located within the non-transcribed spacer, not the transcribed 
region (Bird et al, 1981) and the erythrocyte rDNA is already 
undermethylated. Erythrocyte rDNA is also DNase I insensitive so 
it is not the demethylation event that causes this change from  ^
from DNase I resistant to DNase I sensitive. Newly synthesized 
rRNA is not seen until the mid-late blastula stage of 
embryogenesis (Shlokawa et al. 1981a, b), no rRNA transcripts
can be seen in the very earliest stages. Bird et al (1981) 
have shown that during this time in X.laevls, but not in the
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closely related species X.borealis (Macleod and Bird, 1982), 
there Is a shift towards the rlbosomal genes becoming 
undermethylated at the two specific sites which parallels the 
appearance of the new rRNA. This is also paralleled by the 
appearance of the "oocyte" component that brings about specific 
rRNA synthesis in erythrocyte nuclei. So it might be expected 
that the rDNA from early cleavage embryos is DNase I resistant, 
and that from neurula stage embryos is DNase I sensitive. It is 
not possible to say if the déméthylation event comes first and 
acts as a signal to the Fr-18, or the other way round, or in the 
light of more recent work (Macleod and Bird, 1982) it may well be 
that the déméthylation event has nothing to do with rRNA gene 
control. Fr-18 certainly acts on undermethylated chromatin. To 
see if it has any effect on methylated rDNA, the assays would 
have to be repeated using early cleavage embryo or sperm nuclei.
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CHAPTER VIII; CONCLUSIONS.
The erythrocyte nuclei of Xenopus laevle are 
transcriptionally Inactive, most of the small amount of 
radioactive precursor Incorporated when they are placed In a 
transcription assay is due to the elongation of the final RNA 
polymerase II transcripts. Although some RNA polymerase III 
transcription is measured, it is at a very low level. RNA 
polymerase I activity is not seen, these molecules are lost 
during erythrocyte maturation (Hentschell and Tata, 1978) and are 
not sequestered in the nucleus as tightly bound transcriptional 
complexes. This is in marked contrast to the amount of RNA 
synthesis seen during oogenesis. In oocytes, transcription 
proceeds rapidly, at least in part to provide the RNA species 
needed for the early division stages of embryogenesis and beyond. 
Enough ribosomes are produced to last the developing embryo to 
the swimming tadpole stage (Brown and Gurdon, 1964), amounting to 
4 pg rRNA (Perkowska e_t al, 1968) which is transcribed by the 
vitellogenic oocyte.
By mixing the inactive rRNA genes of an erythrocyte nucleus 
and the soluble proteins from an oocyte it has been possible to 
induce these inactive genes to be transcribed. This transcription 
involves new initiation by the RNA polymerase I molecules. The 
transcription of the rRNA genes is not simply a reflection of the 
presence of RNA polymerase I molecules in the oocyte extract, 
since RNA polymerase I molecules on their own do not transcribe 
rDNA in the erythrocyte nuclei,A soluble protein extract from 
unfertilised eggs, although containing comparable amounts of RNA 
polymerase, does not elicit transcription by RNA polymerase I 
when mixed with erythrocyte nuclei. This parallels the lack of
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transcriptlon seen In unfertilized eggs. Presumably the egg 
extract lacks the oocyte component that brings about RNA 
polymerase I activity on inactive rDNA chromatin. There is a good 
correlation between the ability of an oocyte, egg or embryo 
extract to do this and the activity of the ribosomal genes in the 
cells from which the extract is made. Prevltellogenic oocyte 
extracts, early cleavage and blastula embryo extracts are unable 
to Induce RNA polymerase I to transcribe erythrocyte rDNA, whilst 
vitellogenic oocyte extracts and gastrula and later stage embryo 
extracts can do so. In all extracts the amount of RNA polymerase 
I remains the same. It is a reasonable proposition that the 
reason small oocytes, eggs and cleaving embryos fail to make rRNA 
is the same as the failure of their extracts to Induce it in 
erythrocyte nuclei. If this is so rRNA transcription is 
controlled by an activating molecule or molecules that are not 
detectable in young oocytes, unfertilized eggs and early cleavage 
embryos. Unfotunately another possibility is that the stimulating 
molecule is present in the inactive cells and is lost during 
extraction.
Column chromatography of the oocyte extract revealed a 
single peak of stimulatory activity both on Sephadex G100 and 
DEAE cellulose columns. This is as a result of a small protein 
(molecular weight about 21000 daltons) that is heat and trypsin 
sensitive. This peak, termed Fr-18, is found in all protein 
extracts that bring about RNA polymerase I transcription in the 
erythrocyte nuclear assay. Although RNA polymerase I was used to 
identify and locate Fr-18, it appears that Fr-18 acts 
Independently of the RNA polymerase, by associating with the 
nuclei during the prelncubatlon.
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By studying the chroostln conformation of the erythrocyte 
rDNA using DNase I, It has been shown that Incubating the nuclei 
with an oocyte extract, but not an egg extract, causes the DNase 
I resistant rDNA to become DNase I sensitive. During the 
Induction of rRNA synthesis the entire rRNA gene repeat, both 
transcribed and non-transcrlbed sequences, become DNase I 
sensitive, as Is also the case if the erythrocyte nuclei are 
preincubated with an egg extract and Fr-18. Since no change Is 
seen in any of the other genes Investigated, the alteration In 
conformation must be limited to the rRNA genes. Fr-18 Interacts 
with the beginning of the rRNA gene, at the external transcribed 
spacer, or Just beyond it. The site might be co-extenslve with 
the rRNA promoter site (Moss, 1982), but no effect Is seen on the 
two reduplicated promoters (Moss and Blrnstiel, 1979), located In 
the non-transcrlbed spacer. There Is no evidence for a DNase I 
hypersensitive site at any point in the rRNA gene repeat, so 
Fr-18 cannot be interacting with, or producing such a structure. 
Alone It only causes a small region of the rRNA gene to become 
DNase 1 sensitive. If the nuclei are preincubated with an oocyte 
extract and Actinomycin D such that the RNA polymerase I 
molecules can Initiate, but not elongate, more of the gene 
becomes DNase I sensitive, but only the transcribed sequences and 
not the non-transcribed spacer.
Therefore Fr-18 would appear to act on a specific site at 
about the beginning of the transcribed sequence, causing a shift 
to a DNase I sensitive state. Exactly how this Is achieved Is not 
clear. The oocyte extract contains more than just Fr-18 and RNA 
polymerases, so some other specific or non-specific factor could 
be necessary to propagate the DNase I sensitive state from the 
start given by Fr-18. This factor would have to be present In the
egg extract even though alone It cannot Induce rRNA synthesis«
Since the crude RNA polymerase preparation can substitute for egg
extract in inducing rRNA synthesis, the factor is also likely to
be present here. However, I have not shown that the crude RNA
polymerase preparation plus Fr-18 changes the conformation of
«
erythrocyte rDNA.
Further experiments to determine how Fr-18 interacts with 
the rDNA need to be carried out. In particular, whether Fr-18 
binds to the rDNA and, if it does so, to which particular 
sequence. The mode of action of the change to a DNase I sensitive 
state also requires further investigation, especially the 
interaction of Fr-18 with the non-specific factor (which also 
should be identified) necessary for full DNase I sensitivity. It 
could also be possible to set up a X.laevls RNA polymerase I 
transcription system using the rDNA plasmids, to determine 
whether Fr-18 directs RNA polymerae I under these circumstances. 
Fr-18 should ideally be further purified, perhaps by raising a 
monoclonal antibody and using this both for further purification 
and studying the location of Fr-18 within the oocyte nucleus 
using fluorescent techniques. This should also reveal whether 
there are any differences between the oocyte active component and 
that found in neurula embryos.
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t h e i r  e f f e c t  o n  t h e  s l o w  (  a  c h a n n e l  I t  c a n  h e  e s t i m a t e d  f r o m  
t h e  d a t a  o f  F ig .  2  t h a t  I .  m e a s u r e d  a f t e r  C  i n j e c t i o n  a m o u n t s  
m a x i m a l l y  t o  1 .3  x  1 0  "  m o l  o f  C V  e n t e r i n g  t h e  c e l l  d u r i n g  
e a c h  d e p o l a r i z a t i o n .  T a k i n g  i n t o  a c c o u n t  a n  a v e r a g e  t o t a l  c e l l  
v o l u m e  o f  3 0  p i  a n d  a  c y t o s o l i c  s p a c e  o f  - 5 0 %  o f  t h e  t o t a l  c e l l  
v o l u m e ,  t h i s  i n d i c a t e s  t h a t  t h e  i n t r a c e l l u l a r  C a 2 '  c o n c e n t r a t i o n  
w a s  e l e v a t e d  h v  1 .3  p .V I d u r i n g  d e p o l a r i z a t i o n .  T h i s  c r u d e  e s t i ­
m a t i o n  c o u l d  i n d i c a t e  t h a t  m o r e  t h a n  j u s t  t h e  t r i g g e r  c a l c i u m  
e n t e r s  i s o l a t e d  c e l l s  t h r o u g h  m a x i m a l l y  p h o s p h o r y l a t e d  C a 2 ‘ 
c h a n n e l s .
T h e  n a t u r e  a n d  l o c a l i z a t i o n  o f  t h e  p r o t e i n s  p h o s p h o r y l a t c d  
b y  i n j e c t e d  C  h a v e  n o t  b e e n  d e t e r m i n e d .  S t u d i e s  i n  i n t a c t  h e a r t s  
s t i m u l a t e d  b y  a d r e n a l i n e  i n d i c a t e  a  r a p i d  p h o s p h o r y l a t i o n  o f  a  
s a r c o l e m m a l  p r o t e i n  o f  m o l e c u l a r  w e i g h t  2 7 , 0 0 0  t r e f  1 5 ) .
S e v e r a l  g r o u p s  h a v e  s h o w n  t h a t  a  2 2 , 0 0 0  o r  1 1 , 0 0 0  m o l e c u l a r  
w e i g h t  p e p t i d e  i s  p h o s p h o r y l a t e d  b y  a n  e n d o g e n o u s  c y c l i c  
A M P - d e p e n d e n t  p r o t e i n  k i n a s e  i n  p u r i f i e d  s a r c o l e m m a l  m e m ­
b r a n e s '  '  V I n  a d d i t i o n ,  s o m e  e v i d e n c e  h a s  b e e n  o b t a i n e d  t h a t  
in eu ro  p h o s p h o r y l a t i o n  o f  t h i s  p e p t i d e  i s  a s s o c i a t e d  w i t h  a n  
i n c r e a s e d  C a ‘ * u p t a k e  b y  s a r c o l e m m a l  v e s i c l e s " “. T h u s ,  t h e r e  
is  a  g r o w i n g  b o d y  o f  e v i d e n c e  s u p p o r t i n g  t h e  c o n c e p t  t h a t  c y c l i c  
A M P - d e p e n d e n t  p r o t e i n  k i n a s e  a n d  p h o s p h o r y l a t i o n  o f  d i s t i n c t  
m e m b r a n e  p r o t e i n s  a r e  i n t i m a t e l y  i n v o l v e d  i n  t h e  r e g u l a t i o n  
o f  / „  o f  m y o c a r d i a l  c e l l s .
T h i s  w o r k  w a s  s u p p o r t e d  b y  g r a n t s  f r o m  D e u t s c h e  F o r ­
s c h u n g s g e m e i n s c h a f t  t o  W . T .  ( S F B  3 8 ,  M e m b r a n f o r s c h u n g ,  
P r o j e k t  G l ) a n d  t o  F . H .  ( H o  5 7 9 / 5  a n d  5 7 9 / 6 - 1 )  a n d  b y  F o n d s  
d e r  C h e m i s c h e n  I n d u s t r i e .
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T h e  D N a s e  I s e n s it iv ity  o f  
Xcnoptts laevis g e n e s  
tra n scr ib e d  b y  R N A  p o ly m e r a se  III
J .  C o v e n e y  &  I I .  R .  W o o d l a n d
D e p a r t m e n t  o f  B io lo g ic a l  S c ie n c e s .  U n iv e r s i ty  o f  W a rw ic k .  
C o v e n t r v  C V 4  7 A 1 .. U K
S i n c e  t h e  i n i t i a l  d i s c o v e r y  t h a t  t h e  D N a s e  I s e n s i t i v i t y  o f  t h e  
g l o h i n  g e n e s  i n  d i f f e r e n t  c e l l  t y p e s  c o r r e l a t e s  w i t h  g l o h i n  g e n e  
e x p r e s s i o n 1, t h i s  r e l a t i o n s h i p  h a s  b e e n  s h o w n  t o  h o l d  t r u e  f o r  
a  v a r i e t y  o f  g e n e s ,  i n c l u d i n g  t h e  g e n e s  f o r  o v a l b u m i n 2, c o n a l -  
b u m i n ' ,  a -  a n d  / 3 - g l o b i n  i n  c h i c k e n *  5, s e v e r a l  h e a t - s h o c k  p r o ­
t e i n s  i n  D r o s o p h ila ''1, t h e  r - c h r o m a t i n  o f  T e tr a h y m e n a “ a n d  
t h e  v i r a l  p o l y o m a  m i n i c h r o m o s o m e ' .  A l t h o u g h  g e n e s  t r a n ­
s c r i b e d  b y  R N A  p o l y m e r a s e s  I  a n d  I I  h a v e  b e e n  s t u d i e d  e x t e n ­
s i v e l y ,  t h e  g e n e s  t r a n s c r i b e d  b y  R N A  p o l y m e r a s e  I I I  h a v e  n o t .  
W e  h a v e  t h e r e f o r e  i n v e s t i g a t e d  t h e  D N a s e  I  s e n s i t i v i t y  o f  t r a n s ­
f e r  R N A  ( t R N A l  a n d  o o g e n e t i c  5 S  R N A  g e n e s  i n  t h e  l i v e r  
a n d  e r y t h o c y t e  n u c l e i  o l  X e n n p u s  la e v is .  T h e  o o g e n e t i c  5 S  
g e n e s  a r c  n o t  t r a n s c r i b e d  i n  a n y  k n o w n  s o m a t i c  c e l l 10 " ,  a n d  
t R N A  g e n e s  a r e  t r a n s c r i b e d  i n  t h e  h e p a t o c y t e  b u t  a r e  i n a c t i v e  
i n  t h e  e r y t h r o c y t e .  W e  s h o w  h e r e  t h a t ,  a l t h o u g h  i n  t h e s e  t w o  
c e l l  t y p e s  t h e  c o r r e s p o n d e n c e  b e t w e e n  D N a s e  I  s e n s i t i v i t y  a n d  
g e n e  t r a n s c r i p t i o n  h o l d s  g o o d  f o r  g l o b i n  a n d  t h e  r i b o s o m a l  
g e n e s ,  t h e  t R N A  a n d  o o g e n e t i c  5 S  g e n e s  a r e  D N a s e  I  s e n s i t i v e  
i n  b o t h  l i v e r  a n d  e r y t h r o c y t e  n u c l e i .  T h u s  f o r  t h e  g e n e s  t r a n ­
s c r i b e d  b y  p o l y m e r a s e  I I I  t h e  c o r r e s p o n d e n c e  o f  s e n s i t i v i t y  a n d  
e x p r e s s i o n  b r e a k s  d o w n .
T h e r e  a r e  t w o  t y p e s  o f  5 S  r i b o s o m a l  g e n e  i n  .V . la e v is : o o c y t e  
s p e c i f i c  ( 5 S chki a n d  s o m a t i c  ( 5 S „ , T h e  5 S „ ,K g e n e s  a r e  a  
f a m i l y  o f  a b o u t  2 ( 1 ,0 0 0  g e n e s  p e r  h a p l o i d  g e n o m e 12, i n t e r ­
s p e r s e d  w i t h  a n  e q u a l  n u m b e r  o f  5 S  p s e u d o g e n e s ,  r e p r e s e n t i n g  
r e s i d u e s  1 - 1 0 1  o f  t h e  n o r m a l  1 2 0  b p  g e n e 15. T r a n s c r i p t s  o f  t h e  
p s e u d o g e n e  in v iv o  h a v e  n e v e r  b e e n  d e t e c t e d ,  b u t  t h e i r  o c c u r ­
r e n c e  r e m a i n s  a  p o s s i b i l i t y 14. T h e  5 S „ ,„  g e n e s  a r e  t r a n s c r i b e d  
e x c l u s i v e l y  d u r i n g  o o g e n e s i s ,  w h i l s t  i n  o t h e r  c e l l s  i t  i s  t h e  5 S „ „  
g e n e s  ( o f  w h i c h  t h e r e  a r c  f e w e r ,  a b o u t  4 0 0 / 15 w h i c h  a r e  
u s e d 1" T h i s  n u m b e r  is  f a r  t o o  s m a l l  f o r  t h e  s o m a t i c  g e n e s  t o  
b e  d e t e c t e d  b y  t h e  s t r a i g h t f o r w a r d  h y b r i d i z a t i o n  e x p e r i m e n t s  
d e s c r i b e d  h e r e .  A  r o u g h  c a l c u l a t i o n  o f  g e n e  n u m b e r  f r o m  F ig  
l a  1 1 1 , 000- 21,0 0 0  c o p i e s  o f  t h e  g e n e  p e r  p s e u d o g e n e  r e p e a t  
p e r  h a p l o i d  g e n o m e ,  d e p e n d i n g  o n  t h e  a m o u n t  o f  v e c t o r  
s e q u e n c e s  i n v o l v e d  in  t h e  h y b r i d i z a t i o n )  c o n f i r m s  t h a t ,  i n  e f f e c t ,
was -midi mi
w e  m e a s u r e  o n l y  5 S . . V g e n e s  i n  t h e s e  h y b r i d i z a t i o n s .  F i g u r e  l a  
a n d  T a b l e  1 s h o w  t h a t  t h e  5 S „ ,„  g e n e s  a r e  s e n s i t i v e  t o  D N a s e  
I i n  b o t h  l i v e r  a n d  e r y t h r o c y t e  n u c l e i .  N o  5 S  g e n e s  a r e  t r a n ­
s c r i b e d  in  e r y t h r o c y t e s ,  w h i c h  h a v e  l o s t  a l l  R N A  p o l y m e r a s e  
I I I  m o l e c u l e s  d u r i n g  m a t u r a t i o n 15, n o r  a r e  t h e  5 S ^ K g e n e s  
b e l i e v e d  t o  b e  t r a n s c r i b e d  i n  h e p a t o c y t e s ” . I n  t h e  l a t t e r  c e l l s ,  
t h e  5 S „ , m g e n e s  s h o u l d  p r o v i d e  a l l  t h e  5 S  R N A .  T h e s e  g e n e s  
a r e  h i d d e n  b y  t h e  5 0  t i m e s  m o r e  n u m e r o u s  5 S „ ^  g e n e s .
E q u a l l y  s u r p r i s i n g  is  t h e  f i n d i n g  ( F i g .  1 6 )  t h a t  c e r t a i n  o f  t h e  
t R N A  g e n e s ,  w h i c h  a r e  t r a n s c r i b e d  i n  t h e  h e p a t o c y t e  b u t  n o t  
in  t h e  e r y t h r o c y t e ,  a r e  e q u a l l y  s e n s i t i v e  i n  b o t h  t y p e s  o f  n u c l e u s .  
T h e  p r o b e  u s e d  c o n t a i n s  t w o  t R N A M*' g e n e s  a n d  o n e  e a c h  o f  
t h e  t R N A s  a c c e p t i n g  p h e n y l a l a n i n e ,  t r y o s i n e ,  a s p a r a g i n e ,  
a l a n i n e ,  l e u c i n e  a n d  l y s i n e 1“ . T h e  c o m p l e t e  3 . 1 8 k i l o b a s e  ( k b )  
u n i t  i s  r e p e a t e d  a b o u t  1 0 0  t i m e s  p e r  h a p l o i d  g e n o m e " ' .  T h e  
p r o b e  p r o b a b l y  r e v e a l s  a l l  o f  t h e s e  t R N A  s p e c i e s  p r e s e n t  i n  
t h e  g e n o m e ,  b u t  s o m e  o f  t h e m  m a y  b e  p s e u d o g e n e s  a n d  n e v e r  
e x p r e s s e d .  E v e n  i f  t h i s  w e r e  t h e  c a s e ,  i t  w o u l d  n o t  a l t e r  t h e  
c o n c l u s i o n  t h a t  t h e s e  t R N A  g e n e s  a r e  h y p e r s e n s i t i v e  t o  D N a s e  
I ,  e v e n  w h e n  t h e y  a r c  n o t  e x p r e s s e d .
T h u s  i n  b l o o d  a n d  l i v e r  c e l l s ,  m a n y ,  a n d  p e r h a p s  a l l ,  g e n e s  
t r a n s c r i b e d  b y  p o l y m e r a s e  H I  s e e m  t o  b e  D N a s e  I s e n s i t i v e ,  
r e g a r d l e s s  o f  t h e i r  t r a n s c r i p t i o n a l  a c t i v i t y .  M a t e r n a l  5 S , . K g e n e s  
h a v e  n o t  b e e n  a c t i v e  s i n c e  o o g e n e s i s ,  a  p e r i o d  o f  a t  l e a s t  2  y r .  
I n  t h e  c a s e  o f  t h e  p a t e r n a l  5 S , „ .  g e n e s ,  i t  i s  n o t  k n o w n  w h e t h e r  
t h e y  w e r e  e v e n  a c t i v e  d u r i n g  g a m e t o g e n e s i s ,  b u t  t h i s  s e e m s  
u n l i k e l y  a s  t h e  a c c u m u l a t i o n  o f  v a s t  n u m b e r s  o f  r i b o s o m e s ,  
t r a n s c r i b e d  in  p a r t  f r o m  t h e  5 S „ „  g e n e s ,  w h i c h  is  a  f e a t u r e  o f  
o o g e n e s i s ,  d o e s  n o t  o c c u r  d u r i n g  s p e r m a t o g e n e s i s .  T h u s  t h i s  
h a l f  o f  t h e  5 S o .„  g e n e  c o m p l e m e n t  m a y  h a v e  b e e n  i n a c t i v e  f o r  
a s  m u c h  a s  4  y r  ( t w o  l i f e  c y c l e s  I.
T a b le  1 D e g r e e  o f  h y b r id i z a t io n  o f  v a r io u s  p r o b e s  t o  D N a s e  I - d ig e s te d  
e r y th r o c y t e  a n d  l iv e r  n u c le i  a s  a  p e r c e n ta g e  o f  b in d in g  lo  u n d ig e s t e d  
D N A
\  P r o b e  b in d in g
D N A 5 S „ k
R ib o s o m a l  
t R N A  D N A G lo b in
T o t a l ,  u n d ig e s t e d t o n 1 0 0 t o o 1 0 0
E r t h r o c y t e  n u c le i ;
5 %  D N a s e  I d ig e s t i o n 3 4 .9 5 1 .0 1 0 0 4 2 .5
L iv e r ;
5 ° o  D N a s e  1 d ig e s t i o n .39.5 4 7  8 5 4 .5 1 0 0
T h e  d a t a  a r e  c a l c u l a t e d  f r o m  t h e  e x p e r i m e n t s  s h o w n  in  F ig s  1 a n d  
2 . T h e  s a t u r a t i o n  v a lu e s  w e re  c a l c u l a t e d  b y  f i t t in g  s t r a ig h t  l in e s  t o  
d o u b le  r e c ip r o c a l  p l o t s  u s in g  l i n e a r  r e g r e s s io n  b y  le a s t  s q u a r e s
(0 1982 Macmillan Journal» I id
_____________ _________
5 7 8 S a t u r e  V o l .  2 9 8  5  A u g u s t  1 9 8 2
t h e i r  e f f e c t  o n  t h e  s l o w  C a 2 '  c h a n n e l .  I t  c a n  h e  e s t i m a t e d  f r o m  
t h e  d a t a  o f  F ig .  2  t h a t  / .  m e a s u r e d  a f t e r  C  i n j e c t i o n  a m o u n t s  
m a x i m a l l y  t o  1 . 3 *  1 0  ' ' ’ m o l  o f  C a "  e n t e r i n g  t h e  c e l l  d u r i n g  
e a c h  d e p o l a r i z a t i o n .  T a k i n g  i n t o  a c c o u n t  a n  a v e r a g e  t o t a l  c e l l  
v o l u m e  o f  3 0  p i  a n d  a  c y t o s o l i c  s p a c e  o f  ~ 5 0 %  o f  t h e  t o t a l  c e l l  
v o l u m e ,  t h i s  i n d i c a t e s  t h a t  t h e  i n t r a c e l l u l a r  C a 2 '  c o n c e n t r a t i o n  
w a s  e l e v a t e d  b y  1 .3  p M  d u r i n g  d e p o l a r i z a t i o n .  T h i s  c r u d e  e s t i ­
m a t i o n  c o u l d  i n d i c a t e  t h a t  m o r e  t h a n  j u s t  t h e  t r i g g e r  c a l c i u m  
e n t e r s  i s o l a t e d  c e l l s  t h r o u g h  m a x i m a l l y  p h o s p h o r y l a t c d  C a 2 '  
c h a n n e l s .
T h e  n a t u r e  a n d  l o c a l i z a t i o n  o f  t h e  p r o t e i n s  p h o s p h o r y l a t e d  
b y  i n j e c t e d  C  h a v e  n o t  b e e n  d e t e r m i n e d .  S t u d i e s  i n  i n t a c t  h e a r t s  
s t i m u l a t e d  b y  a d r e n a l i n e  i n d i c a t e  a  r a p i d  p h o s p h o r y l a t i o n  o f  a  
s a r c o l e m m a l  p r o t e i n  o f  m o l e c u l a r  w e i g h t  2 7 , 0 0 0  <r e f  1 5 ) .
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Xenopus laevis g en es  
tra n scr ib ed  by  R N A  p o ly m e r a se  III
J .  C o v e n e y  &  H .  R .  W o o d l a n d
D e p a r t m e n t  o f  B io lo g ic a l  S c ie n c e s , U n iv e r s ity  o f  W a rw ic k .  
C o v e n t r y  C V 4  7 A I . ,  U K
S i n c e  t h e  i n i t i a l  d i s c o v e r y  t h a t  t h e  D N a s e  I  s e n s i t i v i t y  o f  I h e  
g l o h i n  g e n e s  i n  d i f f e r e n t  c e l l  t y p e s  c o r r e l a t e s  w i t h  g l o b i n  g e n e  
e x p r e s s i o n ' ,  t h i s  r e l a t i o n s h i p  h a s  b e e n  s h o w n  t o  h o l d  t r u e  f o r  
a  v a r i e t y  o f  g e n e s ,  i n c l u d i n g  t h e  g e n e s  f o r  o v a l b u m i n 2, c o n a l -  
h u m i n ' ,  o r-  a n d  f t - g l o b i n  in  c h i c k e n 4 5, s e v e r a l  h e a t - s h o c k  p r o ­
t e i n s  in  D r o s o p h i l a t h e  r - c h r o m a t i n  o f  T e tr a h y m e n a * a n d  
t h e  v i r a l  p o l y o m a  m l m c h r o m n s o m e " .  A l t h o u g h  g e n e s  t r a n ­
s c r i b e d  b y  R N A  p o l y m e r a s e s  1 a n d  I I  h a v e  b e e n  s t u d i e d  e x t e n ­
s i v e l y ,  t h e  g e n e s  t r a n s c r i b e d  b y  R N  A  p o l y m e r a s e  I I I  h a v e  n o t .  
W e  h a v e  t h e r e f o r e  i n v e s t i g a t e d  t h e  D N a s e  I s e n s i t i v i t y  o f  t r a n s ­
f e r  R N A  ( t R N A )  a n d  o o g e n e t i c  5 S  R N A  g e n e s  i n  t h e  l i v e r  
a n d  e r y l h o c y t e  n u c l e i  o f  X e n o p u s  laev is . T h e  o o g e n e t i c  5 S  
g e n e s  a r c  n o t  t r a n s c r i b e d  in  a n y  k n o w n  s o m a t i c  c e l l 1011, a n d  
t R N A  g e n e s  a r e  t r a n s c r i b e d  in  t h e  h e p a t o c y t e  b u t  a r e  i n a c t i v e  
i n  t h e  e r y t h r o c y t e .  W e  s h o w  h e r e  t h a t ,  a l t h o u g h  i n  t h e s e  t w o  
c e l l  t y p e s  t h e  c o r r e s p o n d e n c e  b e t w e e n  D N a s e  I  s e n s i t i v i t y  a n d  
g e n e  t r a n s c r i p t i o n  h o l d s  g o o d  f o r  g l n b i n  a n d  t h e  r i b o s o m a l  
g e n e s ,  t h e  t R N A  a n d  o o g e n e t i c  5 S  g e n e s  a r e  D N a s e  I s e n s i t i v e  
i n  b o t h  l i v e r  a n d  e r y t h r o c y t e  n u c l e i .  T h u s  f o r  t h e  g e n e s  t r a n ­
s c r i b e d  b y  p o l y m e r a s e  I I I  t h e  c o r r e s p o n d e n c e  o f  s e n s i t i v i t y  a n d  
e x p r e s s i o n  b r e a k s  d o w n .
T h e r e  a r c  t w o  t y p e s  o f  5 S  r i b o s o m a l  g e n e  i n  .Y . laevis  : o o c y t e  
s p e c i f i c  l 5 S , . ^ i  a n d  s o m a t i c  ( S S . , m ) ' " " .  T h e  5 S „ ,„  g e n e s  a r e  a  
f a m i l y  o f  a b o u t  2 0 , 0 0 0  g e n e s  p e r  h a p l o i d  g e n o m e 12, i n t e r ­
s p e r s e d  w i t h  a n  e q u a l  n u m b e r  o f  5 S  p s e u d o g e n e s ,  r e p r e s e n t i n g  
r e s i d u e s  1 - 1 0 1  o f  t h e  n o r m a l  1 2 0  h p  g e n e " .  T r a n s c r i p t s  o f  t h e  
p s e u d o g e n e  in v ivo  h a v e  n e v e r  b e e n  d e t e c t e d ,  b u t  t h e i r  o c c u r ­
r e n c e  r e m a i n s  a  p o s s i b i l i t y 14. T h e  S S ,,*  g e n e s  a r e  t r a n s c r i b e d  
e x c l u s i v e l y  d u r i n g  o o g e n e s i s ,  w h i l s t  i n  o t h e r  c e l l s  i t  is  t h e  5 S „ ,m 
g e n e s  ( o f  w h i c h  t h e r e  a r e  f e w e r ,  a b o u t  4 0 0 ) "  w h i c h  a r c  
u s e d ' "  "  T h i s  n u m b e r  is  f a r  t o o  s m a l l  f o r  t h e  s o m a t i c  g e n e s  t o  
b e  d e t e c t e d  b y  t h e  s t r a i g h t f o r w a r d  h y b r i d i z a t i o n  e x p e r i m e n t s  
d e s c r i b e d  h e r e .  A  r o u g h  c a l c u l a t i o n  o f  g e n e  n u m b e r  f r o m  F ig  
l a  1 1 1 , 0 0 0 - 2 1 , 0 0 0  c o p i e s  o f  t h e  g e n e  p e r  p s e u d o g e n e  r e p e a t  
p e r  h a p l o i d  g e n o m e ,  d e p e n d i n g  o n  t h e  a m o u n t  o f  v e c t o r  
s e q u e n c e s  i n v o l v e d  in  t h e  h y b r i d i z a t i o n )  c o n f i r m s  t h a t ,  in  e f f e c t .
S e v e r a l  g r o u p s  h a v e  s h o w n  t h a t  a  2 2 , 0 0 0  o r  1 1 , 0 0 0  m o l e c u l a r  
w e i g h t  p e p t i d e  i s  p h o s p h o r y l a t c d  b y  a n  e n d o g e n o u s  c y c l i c  
A M P - d e p e n d e n t  p r o t e i n  k i n a s e  i n  p u r i f i e d  s a r c o l e m m a l  m e m ­
b r a n e s '  14 I n  a d d i t i o n ,  s o m e  e v i d e n c e  h a s  b e e n  o b t a i n e d  t h a t  
in vitro  p h o s p h o r y l a t i o n  o f  t h i s  p e p t i d e  is  a s s o c i a t e d  w i t h  a n  
i n c r e a s e d  C a ‘ ‘ u p t a k e  b y  s a r c o l e m m a l  v e s i c l e s ' ‘ . T h u s ,  t h e r e  
is  a  g r o w i n g  b o d y  o f  e v i d e n c e  s u p p o r t i n g  t h e  c o n c e p t  t h a t  c y c l ic  
A M P - d e p e n d e n t  p r o t e i n  k i n a s e  a n d  p h o s p h o r y l a t i o n  o f  d i s t i n c t  
m e m b r a n e  p r o t e i n s  a r e  i n t i m a t e l y  i n v o l v e d  i n  t h e  r e g u l a t i o n  
o f  / „  o f  m y o c a r d i a l  c e l l s .
T h i s  w o r k  w a s  s u p p o r t e d  b y  g r a n t s  f r o m  D e u t s c h e  F o r ­
s c h u n g s g e m e i n s c h a f t  t o  W . T .  ( S F B  3 8 ,  M e m b r a n f o r s c h u n g ,  
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w e  m e a s u r e  o n l y  5 S „ ,„  g e n e s  i n  t h e s e  h y b r i d i z a t i o n s .  F i g u r e  l a  
a n d  T a b l e  1 s h o w  t h a t  t h e  5 S ,* »  g e n e s  a r e  s e n s i t i v e  t o  D N a s e  
I i n  b o t h  l i v e r  a n d  e r y t h r o c y t e  n u c l e i .  N o  5 S  g e n e s  a r e  t r a n ­
s c r i b e d  in  e r y t h r o c y t e s ,  w h i c h  h a v e  l o s t  a l l  R N A  p o l y m e r a s e  
I I I  m o l e c u l e s  d u r i n g  m a t u r a t i o n " ' ,  n o r  a r e  t h e  5 S „  g e n e s  
b e l i e v e d  t o  b e  t r a n s c r i b e d  i n  h e p a t o c y t e s " .  I n  t h e  l a t t e r  c e l l s ,  
t h e  5 S ,„ „ , g e n e s  s h o u l d  p r o v i d e  a l l  t h e  5 S  R N A .  T h e s e  g e n e s  
a r e  h i d d e n  b y  t h e  5 0  t i m e s  m o r e  n u m e r o u s  5 S » « , g e n e s .
E q u a l l y  s u r p r i s i n g  is  t h e  f i n d i n g  ( F i g .  1 6 )  t h a t  c e r t a i n  o f  t h e  
t R N A  g e n e s ,  w h i c h  a r e  t r a n s c r i b e d  i n  t h e  h e p a t o c y t e  b u t  n o t  
in  t h e  e r y t h r o c y t e ,  a r e  e q u a l l y  s e n s i t i v e  i n  b o t h  t y p e s  o f  n u c l e u s .  
F h c  p r o b e  u s e d  c o n t a i n s  t w o  t R N A M"  g e n e s  a n d  o n e  e a c h  o f  
t h e  t R N A s  a c c e p t i n g  p h e n y l a l a n i n e ,  t r y o s i n e .  a s p a r a g i n e ,  
a l a n i n e ,  l e u c i n e  a n d  l y s i n e 1“ . T h e  c o m p l e t e  3 . 1 8 k i ! o b a s e  ( k b )  
u n i t  is  r e p e a t e d  a b o u t  1 0 0  t i m e s  p e r  h a p l o i d  g e n o m e '" .  T h e  
p r o b e  p r o b a b l y  r e v e a l s  a l l  o f  t h e s e  t R N A  s p e c i e s  p r e s e n t  in  
t h e  g e n o m e ,  b u t  s o m e  o f  t h e m  m a y  b e  p s e u d o g e n e s  a n d  n e v e r  
e x p r e s s e d .  E v e n  i f  t h i s  w e r e  t h e  c a s e ,  i t  w o u l d  n o t  a l t e r  t h e  
c o n c l u s i o n  t h a t  t h e s e  t R N A  g e n e s  a r c  h y p e r s e n s i t i v e  t o  D N a s e  
I .  e v e n  w h e n  t h e y  a r c  n o t  e x p r e s s e d .
T h u s  i n  b l o o d  a n d  l i v e r  c e l l s ,  m a n y ,  a n d  p e r h a p s  a l l ,  g e n e s  
t r a n s c r i b e d  b y  p o l y m e r a s e  I I I  s e e m  t o  b e  D N a s e  I  s e n s i t i v e ,  
r e g a r d l e s s  o f  t h e i r  t r a n s c r i p t i o n a l  a c t i v i t y .  M a t e r n a l  5 S , . K g e n e s  
h a v e  n o t  b e e n  a c t i v e  s i n c e  o o g e n e s i s ,  a  p e r i o d  o f  a t  l e a s t  2  y r .  
I n  t h e  c a s e  o f  t h e  p a t e r n a l  5 S « *  g e n e s ,  i t  i s  n o t  k n o w n  w h e t h e r  
t h e y  w e r e  e v e n  a c t i v e  d u r i n g  g a m e t o g e n e s i s ,  b u t  t h i s  s e e m s  
u n l i k e l y  a s  t h e  a c c u m u l a t i o n  o f  v a s t  n u m b e r s  o f  r i b o s o m e s ,  
t r a n s c r i b e d  in  p a r t  f r o m  t h e  5 S ,,.*  g e n e s ,  w h i c h  is  a  f e a t u r e  o f  
o o g e n e s i s ,  d o e s  n o t  o c c u r  d u r i n g  s p e r m a t o g e n e s i s .  T h u s  t h i s  
h a l f  o f  t h e  S S o o . g e n e  c o m p l e m e n t  m a y  h a v e  b e e n  i n a c t i v e  f o r  
a s  m u c h  a s  4  y r  ( t w o  l i f e  c y c l e s ) .
T a b le  1 D e g r e e  o f  h y b r id iz a t io n  o f  v a r io u s  p r o b e s  t o  D N a s e  I - d ig c s te d  
e r y th r o c y te  a n d  l iv e r  n u c le i  as  a  p e r c e n t a g e  o f  b in d in g  to  u n d ig e s te d  
D N A
°o P ro b e  b in d in g
R ib o s o n ia l
D N A 5 So,* t R N A D N A G lo b in
T o ta l ,  u n d ig e s t e d 1 0 0 1 0 0 1 0 0 1 0 0
F .r th ro c y te  n u c l e i ;
5 %  D N a s e  I d ig e s t i o n 3 4 .9 5 1 0 1 0 0 4 2 .5
l i v e r ;
5°«» D N a s e  I d ig e s t i o n .19 5 4 7  8 5 4 .5 1 0 0
T h e  d a t a  a r e  c a l c u l a t e d  f ro m  th e  e x p e r i m e n t s  s h o w n  in  F ig s  1 a n d  
2 . T h e  s a t u r a t io n  v a lu e s  » e r e  c a l c u l a t e d  b y  f i t t in g  s t r a ig h t  l in e s  to  
d o u b le  r e c ip r o c a l  p lo t s  u s in g  l in e a r  r e g r e s s io n  by  le a s t  s q u a r e s
(KOS «S Vi HZ lIO S n  -JUSOI mi <0 1982 Macmillan Journal« I id
I t  m i g h t  h e  s u s p e c t e d  t h a t  t h e s e  r e s u l t s  r e f l e c t  a n  a i t e f a c t  in  
t h e  p r e p a r a t i o n  a n d  d i g e s t i o n  o f  t h e  n u c l e i ,  a n d  t h e r e f o r e  t h a t  
m a n y  o t h e r  g e n e s  w o u l d  a l s o  s h o w  u n e x p e c t e d l y  h i g h  n u c l e a s e  
s e n s i t i v i t y .  H o w e v e r ,  m e a s u r e m e n t  o f  t h e  c o n c e n t r a t i o n s  o f  
s e v e r a l  o t h e r  g e n e s  in  t h e  s a m e  D N A  s a m p l e s  y i e l d e d  t h e  
p r e d i c t e d  r e s u l t s .  F o r  e x a m p l e ,  r i b o s o m a l  g e n e s  a r e  n o t  t r a n ­
s c r i b e d  i n  e r y t h r o c y t e s " ' ,  n o r  is  R N A  p o l y m e r a s e  I  p r e s e n t  i n  
t h e i r  n u c l e i ,  b u t  t h e  o p p o s i t e  is  t r u e  o f  l i v e r .  A s  e x p e c t e d  t h e  
r i b o s o m a l  D N A  f r o m  l i v e r  w a s  m o r e  s e n s i t i v e  t o  D N a s e  I 
d i g e s t i o n  t h a n  b u l k  D N A ,  b u t  e q u a l l y  r e s i s t a n t  i n  e r y t h r o c y t e s  
( F i g  2 a ) .  G l o b i n  g e n e s  a r e  a c t i v e  i n  t h e  i m m a t u r e  e r y t h r o c y t e  
o f  X e n o p u s,  b u t  n o t  i n  t h e  a d u l t  c e l l .  T h e  l a t t e r ,  h o w e v e r ,  
c o n t a i n s  R N A  p o l y m e r a s e  I I  m o l e c u l e s  t i g h t l y  b o u n d  t o  t h e  
c h r o m a t i n * 1' ’ a n d  i n  a v i a n  e r t h r o c y t c s  t h e  f r o z e n  p o l y m e r a s e s  
a r e  t o  b e  f o u n d  o n  t h e  g l o b i n  g e n e s ’ ” . I n  t h i s  s e n s e  t h e  g l o b i n  
g e n e s  c o u l d  b e  r e g a r d e d  a s  a c t i v e  g e n e s ' ,  w h i c h  c o r r e l a t e s  w  i t h  
t h e  o b s e r v a t i o n  t h a t  i n  a v i a n  e r t h r o c y t e s ,  g l o b i n  s e q u e n c e s  a r e  
p r e f e r e n t i a l l y  d i g e s t e d  b y  D N a s e  I ‘ 4 \  T h e  s a m e  is  t h e  c a s e  i n  
h u m a n  e r y t h r o c y t e s  ( F ig .  2 b ) ,  b u t  n o t  h c p a t o c y t e s ,  w h i c h  d o  
n o t  s y n t h e s i z e  g l o b i n .  O u r  r e s u l t s  c o n f i r m  t h o s e  o f  o t h e r s '  ’ , 
a n d  s h o w  t h a t  t h e  c r u d e  a p p r o a c h  o f  D N a s e  I s o l u b i l i z a t i o n  is  
c a p a b l e  o f  d e t e c t i n g  d i f f e r e n t  D N a s e  I s e n s i t i v i t y  i n  g e n e s  a c t i v e  
i n  o n e  c e l l  t y p e  a n d  i n a c t i v e  i n  a n o t h e r .
T h e  r e s u l t s  o f  F i g s  I  a n d  2  s h o w  a  s i n g l e  t i m e  p o i n t  o f  
d i g e s t i o n  a n d  l e a v e  o p e n  t h e  p o s i b i l i t y  t h a t  t h e  i n a c t i v e  t R N A  
o r  5 S  g e n e s  s h o w  d i f f e r e n t  k i n e t i c s  o f  d i g e s t i o n  f r o m  a c t i v e  
g e n e s .  F i g u r e  .3 s h o w s  t h a t  t h i s  is  n o t  t h e  c a s e ;  i n  f a c t .  5S ™ * 
g e n e s  d e m o n s t r a t e  e v e n  g r e a t e r  s e n s i t i v i t y  t o  D N a s e  I t h a n  d o  
t h e  a c t i v e  r i b o s o m a l  g e n e s  o f  l i v e r .
I t  h a s  b e e n  a r g u e d ' : ' t h a t  a n y  g e n e  t h a t  h a s  b e e n  t r a n s c r i b e d  
a t  a  g i v e n  s t a g e  o f  t h e  l i f e  c y c l e  o f  a n  o r g a n i s m  r e m a i n s  D N a s e  
I s e n s i t i v e ,  e v e n  i f  t h e  g e n e  b e c o m e s  i n a c t i v e  l a t e r .  T h i s  a r g u -
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F ig . 1 D N a s e  I s e n s i t i v i t y  o f  5 S  ( a )  a n d  t R N A  ib) g e n e s  in  
e r y th r o c y te  a n d  l i v e r  n u c le i .  E r y t h r o c y t e  n u c le i  w e re  p r e p a r e d  
a c c o rd in g  t o  th e  m e t h o d  o f  re f . 2 6  a n d  th e  l i v e r  n u c le i  b y  th e  
m e th o d  o f  S c r ib l e r  a n d  W e b e r 27. N u c le i  f r o m  th e  tw o  t i s s u e s  w e re  
d ig e s te d  w i th  p a n c r e a t i c  D N a s e  I ( 2 0  p .g  m l l ) f o r  5 m in ,  w h ic h  
is s u ff ic ie n t t o  r e l e a s e  5 - 1 0 %  o f  th e  D N A  f r o m  th e  n u c le i  T h e  
n u c le i  w e r e  p e l l e t e d  b y  c e n t r i f u g a t io n  fo r  a fe w  s e c o n d s  in  a n  
E p p c n d o r f  m ic r o f u g e  a n d  th e i r  D N A  e x t r a c t e d  a c c o r d in g  t o  th e  
m e th o d  o f  W e i n t r a u b  a n d  G r o u d i n e 1. T h e  a l k a l i - d e n a t u r e d  D N A  
w a s  lo a d e d  o n t o  n i t r o c e l lu lo s e  f i l t e r s 2* a n d  h y b r id i z e d  w i th  n ic k -  
t r a n s l a te d  r e c o m b i n a n t  D N A 2^ c o n ta in in g  t h e  r e le v a n t  g e n e  
s e q u e n c e s .  T h is  p r o c e d u r e  w ill n o t  d e t e c t  a  h y p e r s e n s i t i v e  s i t e ' 1 
in  th e  w a y  th a t  a  b l o t - t r a n s f e r  h y b r id i z a t io n  o f  c l e c t r o p h o r e s e d  
D N A  w o u ld ,  b u t  it  g iv e s  a m o r e  q u a n t i t a t i v e  a s s a y  o f  th e  D N a s e
I s e n s i t iv i ty  o f  t h e  g e n e s  a s  a w h o l e ' .  T h e  5 S <>oc p r o b e  u s e d  w a s  
p X lo 3 1  w h ic h  c o n t a in s  a s in g le  r e p e a t  o f  th e  5 S  g e n e  p lu s  a 
p s c u d o g e n e 31. I t  w a s  l a b e l le d  w ith  3H - d C T P  t o  a  s p e c if ic  a c t iv i ty  
o f  5 .5  x  1 0*  c .p .m .  jxg 1 T h e  tR N A  p r o b e  u s e d  w a s  A t 2 1 0 . w h ic h  
c o n ta in s  t w o  c o p ie s  o f  t R N A i 1' '  a n d  o n e  c o p y  e t c h  o f  t R N A ph*, 
t R N A lj,M. t R N A 1 ” , i R N A a *p , i R N A a u  a n d  t R N A T>'  t r e f s  1 8 . 
19) it w a s  l a b e l l e d  w ith  3H - d C T P  to  a  s p e c if ic  a c t iv i ty  o f  3 .9  x 
10  c .p .m . p.g  \  U n d i g e s t e d  l iv e r  D N A  g a v e  a  r e s u l t  i d e n t i c a l  t o  
t h a t  f o r  e r y th r o c y t e ,  s o  th e  d a t a  a r e  n o t  s h o w n . O , U n d ig e s t e d  
e r y th r o c y te  D N A ,  A, d ig e s te d  e r y th r o c y t e  D N A .  # ,  d ig e s t e d  
l iv e r  D N A .
ufi p ro b e ng probe
Fig- 2 D N a s e  I s e n s i t iv ity  o f  r i b o s o m a l  K N A  ( a )  a n d  g lo b in  1 b) 
g e n e s  in  e r y th r o c y t e  a n d  l iv e r  n u c le i .  T h e  D N A  s a m p le s  a n d  
p r o c e d u r e s  w e r e  a s  fo r  F ig  1. T h e  r i b o s o m a l  p r o b e  u s e d  w a s  
p X I r l O l ,  c o n s t r u c t e d  b y  D r  R . R e e d e r :  i t  c o n ta in s  a  c o m p le t e  
r e p e a t  o f  t o .  4 0 S  p r e c u r s o r  p lu s  n o n - t r a n s e n b e d  s p a c e r .  I t  w a s  
n i c k - t r a n s l a t e d  w i th  'H - d C T P t o 2 . 2 x  1 0 4 c .p .m  p g ~ ' . T h e  g lo b in  
p r o b e  w a s  l a b e l l e d  w ith  ,2 P - d G T P  t o  1 .1  x  1 0 7 c .p .m . t ig  ' . I t  w as 
a  g il t  f r o m  D r  R . V, . O ld .  a n d  c o n t a in s  a n —3 0 0  b p  s e q u e n c e  
c o m p l e m e n ta r y  t o  a  g lo b in  m R N A .  O ,  U n d i g e s t e d  e r y th r o c y te  
D N A  d iv e r  g a v e  id e n t ic a l  r e s u l t s ) ;  L ,  D N a s e  I - d ig c s te d  e r y t h ­
r o c y te  D N A  0 .  D N a s e  I - d ig c s t e d  l iv e r  D N A .
m e n t  c o u l d  b e  u s e d  t o  e x p l a i n  t h e  s e n s i t i v i t y  o f  t h e  t R N A  g e n e s  
i n  t h e  e r y t h r o c y t e  n u c l e i .  I t  i s  h a r d e r ,  h o w e v e r ,  t o  s u s t a i n  t h i s  
a r g u m e n t  i n  t h e  c a s e  o f  t h e  5 S ,* *  g e n e s ,  w h i c h  s h o w  a  s i m i l a r  
D N a s e  I s e n s i t i v i t y  I t  w o u l d  m e a n  t h a t  a n y  g e n e  a c t i v e  in  
o o c y t e s  l a n d  t h i s  w o u l d  p r o b a b l y  a m o u n t  t o  — 1 5 %  o f  t h e  
D N A J , I w o u l d  a l w a y s  h e  in  t h e  s e n s i t i s e  s t a t e ,  e v e n  w h e n  it 
p a s s e d  t h r o u g h  t h e  m a l e  f o r  o n e  o r  m o r e  g e n e r a t i o n s  ( a s  5 0 " o  
o f  t h e  5 S , . k g e n e s  h a v e  d o n e i .  T h e  i n s e n s i t i v i t y  o f  r i b o s o m a l  
g e n e s  in  t h e  e r y t h r o c y t e  n u c l e i  is  a l s o  i n c o n s i s t e n t  w i t h  t h i s  
i d e a ,  s i n c e  t h e s e  g e n e s  m u s t  h a v e  b e e n  a c t i v e  i n  e r y t h r o b l a s t s .  
I t  s e e m s  m o r e  l i k e l y  t h a t  t h e  g e n e s  t r a n s c r i b e d  b y  R N A  p o l y ­
m e r a s e  I I I  h a v e  a  d i f f e r e n t  s t r u c t u r e  f r o m  o t h e r  g e n e s ,  a t  l e a s t  
i n  t h e i r  i n a c t i v e  s t a t e ,  w i t h  t h e  r e s u l t  t h a t  t h e y  a r c  a l w a y s  D N a s e  
I s e n s i t i v e .  T h e  d i f f e r e n c e  m i g h t  s i m p l y  r e l a t e  t o  t h e i r  v e r y  
s m a l l  s i z e  a n d  t a n d e m  r e p e t i t i o n .  S e v e r a l  R N A  p o l y m e r a s e
Fig- 3  T  im e  c o u r s e  o f  D N a s e  I d ig e s t i o n .  E r y th r o c y te  a n d  liv e r  
n u c le i  w e re  d i g e s t e d  w ith  2 0  n g  m l 1 D N a s e  1 fo r  i n c r e a s in g  
p e r io d s  o i  t im e ,  t h e  r e a c t io n  w a s  s to p p e d  b y  th e  a d d i t i o n  o f  S D S  
a n d  E D T A  t o  a  f in a l c o n c e n t r a t i o n  o f  0 .5 %  S D S ,  1 2 .5  m M  E D T A ,  
a n d  th e  D N A  e x t r a c t e d  a s  p r e v io u s ly  d e s c r i b e d .  O n e  p.g D N A  
f r o m  e a c h  t i m e  p o in t  w a s  lo a d e d  o n t o  d u p l i c a t e  n i t r o c e l lu lo s e  
f i l te r s ,  w h ic h  w e r e  h y b r id iz e d  in  a f in a l  v o l u m e  o f  2 0 0  m-I w i th  
e i t h e r  2 5 0  n g  , ! P - p X l r l 0 1  o r  2 0 0  n g  , J P - p X l o 8  fo r  2 4  h  b e f o r e  
w a s h in g  a n d  c o u n t in g .  p X I r l O l  a n d  p X l o 8  w e re  l a b e l l e d  w i th  
32P - d C T P  t o  a s p e c if ic  a c t iv i ty  o f  5 . 6  x  1 0 7 a n d  3 .6  x  
1 0 7 c .p .m . | i g  1 r e s p e c t iv e ly ;  p X lo 8  c o n t a in s  t h r e e  c o p ie s  o f  th e  
g c n c - p s c u d o g e n c  5 S  r e p e a t 32. F u r t h e r  d e t a i l s  a r e  g iv e n  in  F ig . 1 
le g e n d .  E r y t h r o c y t e  r ib o s o m a l  g e n e s ;  O ,  l i v e r  r ib o s o m a l  g e n e s ,  
▲ . e r y th r o c y t e  5 S  g e n e s ,  # ,  l i v e r  5 S  g e n e s .
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I I - t r a n s c r i b e d  g e n e s  h a v e  b e e n  s h o w n  l o  b e  a s s o c i a t e d  w i t h  
s i t e s  h y p e r s e n s i t i v e  t o  D N a s e  l " ' 7 ,2 '  a n d  f o r  s o m e  g e n e s  t h e s e  
s i t e s  a r e  a lw  a y s  s e n s i t i v e ,  r e g a r d l e s s  o f  t h e  a c t i v i t y  o f  t h e  g e n e s ' .  
F o r  g e n e s  i n  w h i c h  s m a l l  u n i t s  a r e  t a n d e m l y  r e p e a t e d  t h i s  m i g h t  
b e  a  s e r i o u s  p r o b l e m .  W e  h a v e  t h e r e f o r e  e x a m i n e d  t h e  5 S „ ,<  
r e p e a t  u n i t  b y  d i g e s t i n g  t h e  D N A  s a m p l e s  o f  F ig .  3  w i t h  t h e  
r e s t r i c t i o n  e n z y m e  / / i n d i l l ,  r u n n i n g  t h e  d i g e s t e d  D N A s  o n  
a g a r o s e  g e l s ,  t r a n s f e r r i n g  t h e m  t o  n i t r o c e l l u l o s e  a n d  p r o b i n g  
w i t h  p X i o 3 1 .  H in d lU  c u t s  o n c e  w i t h i n  t h e  5 S ,* *  
g e n e / p s e u d o g e n e  r e p e a t ,  y i e l d i n g  a  7 0 0  b p  f r a g m e n t .  I f  a  
h y p e r s e n s i t i v e  s i t e  w e r e  p r e s e n t  i t  w o u l d  a c t  l i k e  a n o t h e r  r e s t r i c ­
t i o n  s i t e ,  g i v i n g  a  d e f i n e d  f r a g m e n t  o r  f r a g m e n t s  s m a l l e r  t h a n  
7 0 0  b p .  T h e  7 0 0  b p  r e p e a t  d i s a p p e a r e d  w i t h  t h e  e x p e c t e d
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Is  a v ia n  a d e n o -a s s o c ia te d  virus  
an e n d o g e n o u s  v iru s o f  c h ic k e n  c e lls?
G. J. Dawson*, V. J. Yates, P. W. Chang 
& J. J. Oprandy
D e p a r t m e n t  o f  A n im a l  a n d  V e te r i n a r y  S c ie n c e ,
U n iv e r s i t y  o f  R h o d e  I s la n d ,  K in g s to n ,  R h o d e  I s la n d  0 2 8 8 1 ,  U S A
The adeno-associated viruses (AAV) are defective parvoviruses 
which produce infective progeny only in cells co-infected with 
a ‘helper’ adenovirus (Ad)1. Both human and simian AAV 
have been recovered from human and simian primary cell 
cultures following their inoculation with ‘AAV-free’ Ad. 
Whereas some studies have suggested that AAV exists in a 
latent state in these cells2 3, others have indicated that the AAV 
genome is capable of establishing and maintaining a latent state 
in defined laboratory conditions4'7 which mimic the situation 
proposed for the ‘latent’ AAV recovered from human and 
simian tissues. Here, avian adeno-associated virus (AAAV) 
was consistently recovered from limiting dilutions of purified 
and unpurified avian Ad stocks propagated in embryonating 
chicken eggs derived from two independently raised flocks of 
White Leghorn (WL) chickens but not when these Ad stocks 
were propagated in duck ceils. These observations suggest that 
AAAV is a latent endogenous virus of at least some flocks of 
WL chickens.
I n f e c t i o u s  A A V  h a s  b e e n  v e r t i c a l l y  t r a n s m i t t e d  in  uleru  in  
b o t h  n a t u r a l l y  o c c u r r i n g  a n d  e x p e r i m e n t a l l y  i n d u c e d  i n f e c t i o n s  
o f  h e n s ' 7 a n d  i n  e x p e r i m e n t a l l y  i n f e c t e d  m i c e ' “ . A n  a d v a n t a g e  
o f  u s i n g  c h i c k e n s  f o r  v i r o l o g i c a l  s t u d i e s  is  t h e  a v a i l a b i l i t y  o f  
s p e c i f i c  - p a t h o g e n - f r e e  ( S P F )  e m b r y o n a t i n g  e g g s  d e r i v e d  f r o m  
W L  c h i c k e n s  w h i c h  h a d  n o t  b e e n  e x p o s e d  t o  a v i a n  A d  o r  t o  
A A A V .  B y  u s i n g  S P F  e m b r y o s ,  t h e  p o s s i b i l i t y  o f  a n  m  ulero  
i n f e c t i o n  w i t h  e i t h e r  i n f e c t i o u s  Ad o r  A A A V  w a s  e l i m i n a t e d .  
A n t i b o d i e s  t o  a v i a n  A d  o r  AAAV w e r e  n o t  d e t e c t e d  e i t h e r  in  
t h e  S P F  c h i c k e n s  d u r i n g  s e r o l p g i e a l  s u r v e y s  c o n d u c t e d  b y  t h e  
p r o d u c e r  o r  i n  t h e  y o l k s  o f  S P F  e m b r y o s  w e  t e s t e d  u s i n g  t h e  
v i r u s  n e u t r a l i z a t i o n  t e s t  a n d  t h e  e n z y m e - l i n k e d  i m m u n o s o r b e n t
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a s s a y "  " .  ( W e  h a d  p r e v i o u s l y  d e m o n s t r a t e d  t h a t  y o l k  a n t i b o d y  
l e v e l s  t o  a v i a n  A d  a n d  A A A V  w e r e  s i m i l i a r  o r  i d e n t i c a l  t o  
t h o s e  p r e s e n t  in  h e n s  e x p e r i m e n t a l l y  i n f e c t e d  w i t h  t h e s e  
v i r u s e s  ' . )
T w o  a v i a n  A d  s t r a i n s ,  C E L O  v i r u s  ( s e r o t y p e  1 )  a n d  I r i s h  
s t r a i n  5 0 6  ( s e r o t y p e  4 ) ,  w e r e  t r e a t e d  w i t h  a n t i s e r u m  t o  A A A V  
a n d  i n o c u l a t e d  in  c h i c k e n  e m b r y o  k i d n e y  ( C E K I  c e l l s  p r e p a r e d  
f r o m  S P F  e m b r y o s .  V a r i o u s  d i l u t i o n s  o f  t h e  c e l l  l y s a t e  w e r e  
i n o c u l a t e d  i n t o  s e t s  o f  1 0 - d a y - o l d  e m b r y o n a t i n g  e g g s .  T h e  
a l l a n t o a m n i o t i c  f l u i d s  w e r e  c o l l e c t e d  a n d  t e s t e d  f o r  A A A V  a s  
d e s c r i b e d  i n  T a b l e  1 . l e g e n d .  A A A V  w a s  d e t e c t e d  in  a l l  i n o c u ­
l a t e d  e g g s  b y  t h e  s e c o n d  p a s s a g e ,  e v e n  t h o u g h  t h e s e  A d  s t o c k s  
w e r e  p r e t r e a t e d  w i t h  A A A V  a n t i s e r u m  o f  h i g h  t i t r e .  B e c a u s e  
o u r  a n t i s e r u m  m a y  n o t  h a v e  n e u t r a l i z e d  a l l  o f  t h e  A A A V ,  t h e  
C E L O  v i r u s  s t o c k  w a s  p u r i f i e d  a s  i n d i c a t e d  ( T a b l e  1 , e x p e r i ­
m e n t  2 1. T h r e e  s u c c e s s i v e  i s o p y c n i c  c e n t r i f u g a t i o n s  w e r e  p e r f o r -  
m e d 12,13 t o  s e p a r a t e  p o s s i b l e  c o n t a m i n a t i n g  A A A V  ( b u o y a n t  
d e n s i t y  1 . 3 8  a n d  1 . 4 2  g e m  3) f r o m  C E L O  v i r u s  ( b u o y a n t  
d e n s i t y  1 . 3 4  g  c m  3) . A A A V  w a s  n o t  d e t e c t e d  w h e n  t h i s  p u r i f e d  
s t o c k  w a s  e x a m i n e d  b y  e l e c t r o n  m i c r o s c o p y .  T w o  t h o u s a n d  
C E L O  v i r u s  p a r t i c l e s  w e r e  c o u n t e d  w i t h o u t  d e t e c t i n g  a  s i n g l e  
A A A V  p a r t i c l e .  H o w e v e r ,  A A A V  w a s  d e t e c t e d  in  a l l  e m b r y o s  
i n f e c t e d  w i t h  p u r i f i e d  C E L O  v i r u s  ( T a b l e  1 , e x p e r i m e n t  2 ) .  I n  
s o m e  c a s e s ,  t h e  a l l a n t o a m n i o t i c  f l u i d s  o f  e g g s  i n o c u l a t e d  w i t h  
h i g h e r  d i l u t i o n s  o f  C F . l . O  v i r u s  ( f o r  e x a m p l e ,  e g g s  i n o c u l a t e d  
w i t h  a  1 0 ' *  d i l u t i o n  o f  C E L O  v i r u s )  h a d  A d  a n t i g e n s  b u t  n o t  
A A A V  a n t i g e n s  u n t i l  t h e  s e c o n d  p a s s a g e .  T h e s e  r e s u l t s  s u g ­
g e s t e d  t h a t  s e v e r a l  c y c l e s  o f  v i r a l  r e p l i c a t i o n  a r e  n e e d e d  t o  
p r o d u c e  e n o u g h  A A A V  t o  b e  d e t e c t e d  b y  t h e  a g a r  g e l  p r e c i p i t a ­
t i o n  t e s t .  S i m i l a r  r e s u l t s  w e r e  o b t a i n e d  w h e n  t h e  a b o v e  e x p e r i ­
m e n t  w a s  r e p e a t e d  u s i n g  e m b r y o n a t i n g  e g g s  f r o m  a  s e c o n d  
f l o c k  o f  W L  h e n s  h o u s e d  in  i s o l a t i o n  a t  t h e  U n i v e r s i t y  o f  R h o d e  
I s l a n d  E x p e r i m e n t a l  F a r m .
O u r  f i n d i n g s  w e r e  o f  g r e a t  c o n c e r n  b e c a u s e  t h e  u s u a l  m e a n s  
o f  a s s a y i n g  A A A V  i n v o l v e d  i n o c u l a t i n g  e m b r y o n a t i n g  e g g s  
w i t h  C E L O  v i r u s  a n d  v a r i o u s  d i l u t i o n s  o f  A A A V .  I n  p r e v i o u s  
s t u d i e s  t h e  i n c u b a t i o n  p e r i o d  w a s  l i m i t e d  t o  9 6  h  w h e n  t h e  
C E L O  v i r u s  i n o c u l u m  w a s  10* p l a q u e - f o r m i n g  u n i t s  (PFU) p e r  
m l .  A A A V  w a s  o n l y  d e t e c t e d  w h e n  a d d e d  t o  t h i s  s y s t e m ;  e g g s  
i n o c u l a t e d  w i t h  C E L O  v i r u s  a l o n e  d i d  n o t  p r o d u c e  d e t e c t a b l e  
A A A V  a n t i g e n s  I n  t h e  p r e s e n t  s t u d y ,  A A A V  w a s  i n v a r i a b l y  
p r o d u c e d  i n  e m b r v o n a t i r g  e g g s  w h e n  e i t h e r  t h e  i n c u b a t i o n  t i m e
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